{
    "testId": 396305007,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 122,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 0,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 0,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 3582,
    "averageTimeSpentInSeconds": 0,
    "otherAverageTimeSpentInSeconds": 63,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 11352,
            "questionIndex": 12506,
            "questionText": "<p>A 22-year-old woman comes to the office for routine annual examination.&nbsp; The patient has regular menses typically lasting 4 or 5 days with minimal cramping on the first day.&nbsp; Her last menstrual period was 3 weeks ago.&nbsp; She normally has no midcycle pain, but for 2 days she has had a mild, sharp pain in her left lower abdomen.&nbsp; The patient has had no nausea, vomiting, dysuria, or changes in bowel movements.&nbsp; She has no chronic medical conditions or previous surgeries.&nbsp; The patient is sexually active and uses a copper-containing intrauterine device (IUD) for contraception.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Vital signs are normal.&nbsp; BMI is 22 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The abdomen is mildly tender over the left lower quadrant.&nbsp; On speculum examination, the cervix appears normal and without lesions.&nbsp; The IUD strings are visualized at the external cervical os.&nbsp; The uterus is small and mobile, and a 4-cm nontender mass is palpable in the left adnexa.&nbsp; Pelvic ultrasonography reveals a 4-cm simple left ovarian cyst with normal Doppler flow.&nbsp; Urine pregnancy test is negative.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"1127\" src=\"https://www.uworld.com/media/L17431.png\" ></p><p><strong>Adnexal masses</strong> are common and typically benign in women of reproductive age.&nbsp; However, patients with a new adnexal mass require assessment for emergency gynecologic conditions (eg, ectopic pregnancy, torsion) or possible malignancy (eg, epithelial ovarian cancer).&nbsp; Clinical features concerning for malignancy include postmenopausal age, chronic or worsening pelvic pain, and mass symptoms (eg, bloating, constipation).</p><p>Initial evaluation of an adnexal mass is with a pregnancy test and a <strong>pelvic ultrasound</strong>.&nbsp; Pelvic ultrasound visualizes ovarian blood flow (ie, Doppler flow), mass size, and internal mass features.&nbsp; On ultrasound, malignant masses typically appear complex (ie, solid and cystic) with irregular, thickened internal septations.</p><p>In contrast, this patient&#39;s midcycle, mild abdominal pain (ie, mittelschmerz) is most likely caused by a <strong>physiologic corpus luteum cyst</strong> related to recent ovulation.&nbsp; The diagnosis can be confirmed by ultrasound, which typically reveals a <strong>simple-appearing ovarian cyst</strong> with <strong>normal Doppler flow</strong>.&nbsp; Because physiologic ovarian cysts resolve spontaneously, the best next step in management is <strong>observation and repeat examination</strong> in 6 weeks.</p><p><strong>(Choice A)</strong>&nbsp; Aspiration of ovarian cyst fluid is rarely indicated because cyst fluid cytology is typically not diagnostic for malignancy; in addition, spillage of cyst contents can increase cancer staging if the mass is malignant.</p><p><strong>(Choice B)</strong>&nbsp; CA-125 can be measured in postmenopausal women with ovarian cancer to monitor disease progression or response to chemotherapy.&nbsp; However, in premenopausal women, CA-125 testing has low sensitivity and specificity, and is not indicated in this patient with a benign-appearing ovarian cyst.</p><p><strong>(Choice C)</strong>&nbsp; In contrast to this patient with a physiologic corpus luteum cyst, those with malignant adnexal masses (eg, complex appearance, thick septations) typically undergo a CT scan of the abdomen and pelvis to assess for metastases.&nbsp; CT scan findings can guide the use of adjuvant chemotherapy in patients prior to surgical staging.</p><p><strong>(Choice E)</strong>&nbsp; An ovarian cystectomy may be indicated if this patient&#39;s symptoms worsen or the cyst increases in size; however, physiologic ovarian cysts, such as this one, typically resolve without treatment.</p><p><strong>Educational objective:</strong><br>In premenopausal women, adnexal masses are typically benign, are related to ovulation, and resolve spontaneously.&nbsp; Therefore, premenopausal patients with simple-appearing ovarian cysts are managed with observation and repeat examination.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3170,
            "topic": "Ovarian cancer",
            "titleId": 3170,
            "title": "Ovarian cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aspiration of ovarian cyst fluid",
                    "choiceNumber": 1,
                    "correctTaken": 284,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CA-125 testing",
                    "choiceNumber": 2,
                    "correctTaken": 122,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the abdomen and pelvis",
                    "choiceNumber": 3,
                    "correctTaken": 115,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observation and repeat examination in 6 weeks",
                    "choiceNumber": 4,
                    "correctTaken": 4148,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ovarian cystectomy",
                    "choiceNumber": 5,
                    "correctTaken": 316,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "832",
                    "mediaDataId": 0,
                    "title": "The menstrual cycle",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27175840",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of adnexal masses.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27175840",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25406094",
                    "mediaDataId": 0,
                    "title": "The characteristic ultrasound features of specific types of ovarian pathology (review).",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25406094",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 5,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 5058,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 82,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 9,
            "dailyTimeSpentReview": 9,
            "dailyTimeSpent": 5,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 13729,
            "questionIndex": 15119,
            "questionText": "<p>A 60-year-old woman comes to the office for evaluation of postmenopausal bleeding.&nbsp; The patient went through menopause at age 53 and did not use menopausal hormone therapy.&nbsp; Four months ago, she noticed some postcoital bleeding that resolved within a day.&nbsp; For the last 3 months, the patient has had daily vaginal spotting and sometimes has bleeding similar to the first day of her menstrual cycle.&nbsp; She has obstructive sleep apnea and hyperlipidemia.&nbsp; Pap test last year was normal.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 130/80 mm Hg and pulse is 68/min.&nbsp; BMI is 34 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The abdomen is soft and nontender.&nbsp; Speculum examination shows a small amount of blood in the vaginal vault and a normal cervix.&nbsp; Bimanual examination reveals right adnexal fullness and a slightly enlarged uterus.&nbsp; Hemoglobin is 11.8 g/dL.&nbsp; Pelvic ultrasound shows an 11-cm solid ovarian mass and no free fluid in the pelvis.&nbsp; Endometrial biopsy shows complex hyperplasia without atypia.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40814\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Granulosa cell tumor</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Sex cord&ndash;stromal tumor</li><li>&#8593; Estradiol</li><li>&#8593; Inhibin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Complex ovarian mass</li><li>Juvenile subtype<ul style=\"list-style-type:circle;\"><li>Precocious puberty</li></ul></li><li>Adult subtype<ul style=\"list-style-type:circle;\"><li>Breast tenderness</li><li>Abnormal uterine bleeding</li><li>Postmenopausal bleeding</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Histopathology</strong></p></td><td><ul><li>Call-Exner bodies (cells in rosette pattern)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Endometrial biopsy (endometrial cancer)</li><li>Surgery (tumor staging)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s postmenopausal bleeding and <strong>large ovarian mass</strong> are most likely due to a <strong>granulosa cell tumor</strong>, an ovarian <strong>sex cord&ndash;stromal tumor</strong>.&nbsp; The ovarian stroma, which is primarily composed of granulosa cells, produces the ovarian estrogen supply.&nbsp; Granulosa cells convert testosterone to estradiol (via aromatase) and secrete inhibin (which typically inhibits FSH); therefore, uncontrolled proliferation of these cells, as seen in a granulosa cell tumor, results in high estradiol and inhibin levels.</p><p>Women with an adult subtype granulosa cell tumor have <strong>chronic, unopposed estrogen</strong> exposure that can result in <strong>endometrial hyperplasia</strong> or cancer (eg, <strong>postmenopausal bleeding</strong>).&nbsp; Additional clinical features may include breast tenderness and mass-effect symptoms (eg, abdominal distension, ovarian torsion).&nbsp; Due to the association of granulosa cell tumors with endometrial cancer, patients with a suspected granulosa cell tumor require an endometrial biopsy prior to surgical staging to help guide management.&nbsp; After surgical management, inhibin levels can be monitored to evaluate for disease progression or recurrence.</p><p><strong>(Choice A)</strong>&nbsp; Brenner tumors are a rare, benign subtype of epithelial ovarian tumor that is typically found incidentally in asymptomatic patients.&nbsp; There is no association with endometrial hyperplasia.</p><p><strong>(Choice B)</strong>&nbsp; Embryonal carcinoma is a type of ovarian germ cell tumor that occurs typically in young women.&nbsp; Embryonal carcinoma secretes alpha-fetoprotein and hCG rather than estradiol and therefore is not associated with endometrial hyperplasia.</p><p><strong>(Choice D)</strong>&nbsp; Mature teratomas (dermoid cysts) are benign germ cell tumors that are more common in younger women (age 10-30).&nbsp; Mature teratomas do not secrete estrogen; however, some can secrete thyroid hormone (eg, struma ovarii).</p><p><strong>(Choice E)</strong>&nbsp; Metastatic gastric carcinoma can affect the ovary (ie, Krukenberg tumor) and cause a nontender adnexal mass.&nbsp; Patients with gastric cancer typically present with weight loss and persistent abdominal pain rather than postmenopausal bleeding.</p><p><strong>(Choice F)</strong>&nbsp; Yolk sac tumors are germ cell tumors that are more common in young women and secrete alpha-fetoprotein.&nbsp; Because yolk sac tumors grow rapidly, patients typically have an acute onset of pelvic pain rather than abnormal uterine or postmenopausal bleeding.</p><p><strong>Educational objective:</strong><br>Granulosa cell tumors are malignant sex cord&ndash;stromal tumors of the ovary that secrete estradiol.&nbsp; Patients typically present with a large ovarian mass and postmenopausal bleeding (due to associated endometrial hyperplasia from chronic unopposed estrogen exposure).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3170,
            "topic": "Ovarian cancer",
            "titleId": 3170,
            "title": "Ovarian cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Brenner tumor",
                    "choiceNumber": 1,
                    "correctTaken": 1352,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Embryonal carcinoma",
                    "choiceNumber": 2,
                    "correctTaken": 623,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Granulosa cell tumor",
                    "choiceNumber": 3,
                    "correctTaken": 13799,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mature teratoma",
                    "choiceNumber": 4,
                    "correctTaken": 585,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Metastatic gastric carcinoma",
                    "choiceNumber": 5,
                    "correctTaken": 135,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Yolk sac tumor",
                    "choiceNumber": 6,
                    "correctTaken": 281,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "69",
                    "mediaDataId": 0,
                    "title": "Rare ovarian tumors",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "760",
                    "mediaDataId": 0,
                    "title": "Evaluation of an ovarian mass",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18815151",
                    "mediaDataId": 0,
                    "title": "Granulosa cell tumor of the ovary:  tumor review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18815151",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24426698",
                    "mediaDataId": 0,
                    "title": "Recent advances in granulosa cell tumor ovary:  a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24426698",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29198337",
                    "mediaDataId": 0,
                    "title": "Ovarian sex-cord stromal tumours and small cell tumours:  pathological, genetic and management aspects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29198337",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 3,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 16775,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 82,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1,
            "dailyTimeSpentReview": 1,
            "dailyTimeSpent": 3,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 4810,
            "questionIndex": 4810,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td bgcolor=\"#c0c0c0\">The following vignette applies to the next <strong>2</strong> items.&nbsp; The items in the set must be answered in sequential order.&nbsp; Once you click <strong>Proceed to Next Item</strong>, you will not be able to add or change an answer.</td></tr></tbody></table><p>A 67-year-old woman comes to the office with severe vulvar itching and burning for the past 6 months.&nbsp; The patient has tried over-the-counter, topical lubricants for her symptoms without relief.&nbsp; She is no longer sexually active because vaginal penetration is not possible due to pain.&nbsp; Medical history includes type 1 diabetes mellitus that is well controlled with insulin.&nbsp; The patient had a total vaginal hysterectomy at age 48 for adenomyosis.&nbsp; She previously had no abnormal Pap tests and has not had cervical cancer screening since the hysterectomy.&nbsp; Vital signs are normal.&nbsp; Physical examination shows thin, dry, white, plaque-like vulvar skin with loss of the labia minora.&nbsp; There is clitoral hood retraction.&nbsp; Excoriations are present bilaterally on the vulva.</p><p><strong>Item 1 of 2</strong></p><p>Which of the following is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"2178\" src=\"https://www.uworld.com/media/L16392.jpg\" ></p><p>This patient has <strong>vulvar lichen sclerosus</strong>, a chronic inflammatory disease common in postmenopausal women, particularly in those with an autoimmune disease (eg, type 1 diabetes mellitus).&nbsp; In early stages of the disease, the vulva thins, causing hypopigmented (white) areas and increasing skin sensitivity that results in intense <strong>vulvar itching and burning</strong> (and associated erosions and excoriations).&nbsp; Chronic irritation and scratching transform the thinned skin to <strong>thickened, white vulvar plaques</strong> (ie, lichenification), often with perianal skin thickening in a classic figure-eight pattern.&nbsp; In severe cases, normal anatomic structures may be obliterated or atrophied, leading to <strong>loss of the labia minora</strong> and clitoral hood retraction, which can result in <strong>dyspareunia</strong> (as in this patient) and urinary symptoms (eg, dysuria, nocturia).&nbsp; Although lichen sclerosus can be clinically diagnosed, a <strong>vulvar punch biopsy</strong> is recommended to confirm the diagnosis and rule out vulvar cancer (which can occur in patients with prolonged or persistent lichen sclerosus).</p><p><strong>(Choices A and E)</strong>&nbsp; A potassium hydroxide preparation and yeast culture of skin scrapings are performed in patients with candida intertrigo.&nbsp; Candida intertrigo is more common in patients with diabetes mellitus and causes vulvar pruritus; however, patients typically have red, erythematous lesions with associated satellite lesions that can extend to the inner thighs and groin, which are not seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; The genitourinary syndrome of menopause (also known as vulvovaginal atrophy) is caused by low estrogen levels; however, this condition is diagnosed clinically rather than by serum estrogen level measurement.&nbsp; Vulvovaginal atrophy can cause vulvar pruritus and dyspareunia but does not cause white plaques or involve the perianal region.</p><p><strong>(Choice C)</strong>&nbsp; Pap testing assesses for cervical and vaginal malignancies, which can occur secondary to chronic inflammation.&nbsp; Although lichen sclerosus causes chronic inflammation, it spares the vagina and does not increase the risk of these malignancies.&nbsp; In addition, Pap testing is not recommended in women age &gt;65 or in those who have had a hysterectomy and no prior abnormal Pap tests.</p><p><strong>Educational objective:</strong><br>Vulvar lichen sclerosus is a chronic inflammatory condition that can present with vulvar pruritus, white vulvar plaques, and loss of normal architecture (eg, loss of labia minora).&nbsp; A vulvar punch biopsy is recommended to confirm the diagnosis and rule out vulvar cancer.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 9152,
            "topic": "Vulvar carcinoma",
            "titleId": 9152,
            "title": "Vulvar carcinoma",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 4810,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Potassium hydroxide preparation",
                    "choiceNumber": 1,
                    "correctTaken": 988,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum estrogen level",
                    "choiceNumber": 2,
                    "correctTaken": 2363,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal Pap test",
                    "choiceNumber": 3,
                    "correctTaken": 408,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vulvar punch biopsy",
                    "choiceNumber": 4,
                    "correctTaken": 13566,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Yeast culture",
                    "choiceNumber": 5,
                    "correctTaken": 660,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "51",
                    "mediaDataId": 0,
                    "title": "Vulvar lichen sclerosus",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28661705",
                    "mediaDataId": 0,
                    "title": "Lichen sclerosus in women:  a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28661705",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 17995,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 4811,
            "questionIndex": 4811,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>The patient is diagnosed with lichen sclerosus.&nbsp; Which of the following is the best treatment option for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36006\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Vulvar lichen sclerosus</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Prepubertal girls &amp; perimenopausal or postmenopausal women</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Thin, white, wrinkled skin over the labia majora/minora; atrophic changes that may extend over the perineum &amp; around the anus</li><li>Excoriations, erosions, fissures from severe pruritus</li><li>Dysuria, dyspareunia, painful defecation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Work-up</strong></p></td><td><ul><li>Punch biopsy of adult-onset lesions to exclude malignancy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Superpotent corticosteroid ointment</li></ul></td></tr></tbody></table></div><p>The treatment of <strong>lichen sclerosus</strong> is aimed at improving symptoms (eg, vulvar pain and pruritus) and to possibly prevent further disease progression.&nbsp; The <strong>first-line treatment</strong> is with <strong>superpotent topical corticosteroids</strong> (eg, clobetasol), which decreases the chronic inflammation associated with lichen sclerosus.&nbsp; In addition, continued topical corticosteroid therapy may also prevent disease progression to vulvar intraepithelial neoplasia or vulvar cancer.&nbsp; Patients may also use topical emollients for daily symptom management.</p><p><strong>(Choices A and E)</strong>&nbsp; Cryotherapy and topical imiquimod are treatment options for condyloma acuminata (ie, genital warts), caused by human papillomavirus types 6 and 11.&nbsp; Neither is indicated in the management of lichen sclerosus.</p><p><strong>(Choice B)</strong>&nbsp; A radical vulvectomy is reserved for the treatment of biopsy-proven vulvar cancer.&nbsp; Surgery is not recommended for most cases of lichen sclerosus because postoperative scarring can exacerbate symptoms and disease progression.</p><p><strong>(Choice D)</strong>&nbsp; Vaginal estrogen cream is used in the treatment of the genitourinary syndrome of menopause (also known as vulvovaginal atrophy).</p><p><strong>Educational objective:</strong><br>First-line treatment of vulvar lichen sclerosus is with superpotent topical corticosteroids (eg, clobetasol), which decreases chronic inflammation, thereby improving symptoms and potentially preventing disease progression.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 9152,
            "topic": "Vulvar carcinoma",
            "titleId": 9152,
            "title": "Vulvar carcinoma",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 4810,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 1,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cryotherapy",
                    "choiceNumber": 1,
                    "correctTaken": 362,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Radical vulvectomy",
                    "choiceNumber": 2,
                    "correctTaken": 334,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Topical corticosteroids",
                    "choiceNumber": 3,
                    "correctTaken": 14462,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Topical estrogen",
                    "choiceNumber": 4,
                    "correctTaken": 1921,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Topical imiquimod",
                    "choiceNumber": 5,
                    "correctTaken": 832,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": true,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "51",
                    "mediaDataId": 0,
                    "title": "Vulvar lichen sclerosus",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27232363",
                    "mediaDataId": 0,
                    "title": "Lichen sclerosus-presentation, diagnosis and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27232363",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23329078",
                    "mediaDataId": 0,
                    "title": "Diagnosis and treatment of lichen sclerosus:  an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23329078",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 9,
            "notes": null,
            "peopleTaken": 17916,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1,
            "dailyTimeSpentReview": 1,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 7003,
            "questionIndex": 7003,
            "questionText": "<p>A 29-year-old woman comes to the office due to infertility.&nbsp; She has had unprotected intercourse with her husband regularly for the past year and has not become pregnant.&nbsp; The patient&#39;s last menstrual period was 3 weeks ago.&nbsp; Her menses occur every 28-30 days and last 4-5 days.&nbsp; The patient has severe lower abdominal pain that begins the day before her menses and is only partially relieved by ibuprofen.&nbsp; She was treated for gonococcal cervicitis at age 19.&nbsp; The patient takes a prenatal vitamin daily and does not use tobacco, alcohol, or recreational drugs.&nbsp; Her husband, age 31, recently had a normal semen analysis.&nbsp; The patient&#39;s blood pressure is 126/70 mm Hg and pulse is 85/min.&nbsp; BMI is 31 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Examination shows a small uterus with a cervix that appears laterally displaced; there is pain with cervical manipulation.&nbsp; Which of the following is the most likely cause of this patient&#39;s infertility?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32451\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Endometriosis</strong></p></td></tr><tr><td style=\"width: 30%;\"><p align=\"center\"><strong>Pathogenesis</strong></p></td><td style=\"width: 70%;\"><ul><li>Ectopic implantation of endometrial glands</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Dyspareunia</li><li>Dysmenorrhea</li><li>Chronic pelvic pain</li><li>Infertility</li><li>Dyschezia</li><li>Cyclic dysuria, hematuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Physical examination</strong></p></td><td><ul><li>Immobile uterus</li><li>Cervical motion tenderness</li><li>Adnexal mass</li><li>Rectovaginal septum, posterior cul-de-sac, uterosacral ligament nodules</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Direct visualization &amp; surgical biopsy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Medical (oral contraceptives, NSAIDs)&nbsp;</li><li>Surgical resection</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>NSAIDs</strong> = nonsteroidal anti-inflammatory drugs.</p></td></tr></tbody></table></div><p>This patient with severe dysmenorrhea and infertility (ie, no conception &#8805;12 months at age &lt;35) most likely has <strong>endometriosis</strong> caused by extrauterine, <a href=\"1139\">ectopic endometrial implants</a>.&nbsp; Extrauterine endometrial implants proliferate and shed with menses (eg, severe pain starting before menses); because shedding occurs within the abdomen and has no outlet, patients can develop intraabdominal inflammation followed by intraabdominal (ie, <strong>extrauterine</strong>) <strong>adhesion formation</strong>, which, in turn, distorts pelvic organ anatomy and function.</p><p>Various implant locations (eg, uterus, bladder, bowel) can cause different presenting symptoms.&nbsp; Many patients have <strong>severe dysmenorrhea</strong> but seek medical attention only for <strong>infertility</strong>.&nbsp; Infertility occurs due to impaired tubal function (eg, tubal occlusion, decreased fimbrial mobility) from chronic inflammation and extrauterine adhesion formation.&nbsp; With continued inflammation, patients can also develop <strong>intraabdominal fibrosis</strong>, which causes anatomic distortion of other pelvic structures.&nbsp; This commonly presents as <strong>lateral cervical displacement</strong> or pain with cervical manipulation (ie, <strong>cervical motion tenderness</strong>).</p><p>Patients with dysmenorrhea and infertility due to suspected endometriosis require operative laparoscopy, which offers a definitive diagnosis (eg, visual inspection, biopsy) and improvement in pain symptoms and fertility by restoring normal pelvic anatomy.</p><p><strong>(Choice A)</strong>&nbsp; Chronic endometritis, which is characterized by inflammation inside the uterine cavity, can cause infertility by creating intrauterine, not extrauterine, adhesions that prevent pregnancy implantation.&nbsp; However, due to the formation of intrauterine adhesions, patients typically have abnormal uterine bleeding (eg, secondary amenorrhea) rather than regularly timed menses (eg, every 28-30 days).&nbsp; Unlike the extrauterine adhesions caused by endometriosis, the intrauterine adhesions caused by endometritis do not distort other pelvic structures and would not cause lateral cervical displacement.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"4775\">Endometrial polyps</a> are benign growths of endometrial glands and stroma that can contribute to infertility; however, they typically present with painless intermenstrual spotting rather than dysmenorrhea and do not cause cervical motion tenderness.</p><p><strong>(Choice D)</strong>&nbsp; Submucosal <a href=\"4394\">fibroids</a> may impinge on the endometrial lining and impair fertility; however, patients typically have heavy, prolonged menstrual bleeding rather than regular menses.&nbsp; In addition, submucosal fibroids do not cause cervical motion tenderness or lateral cervical displacement because they are intrauterine.</p><p><strong>(Choice E)</strong>&nbsp; A unicornuate uterus may cause obstetric complications but does not typically interfere with pregnancy implantation.&nbsp; In addition, it does not cause pelvic pain.</p><p><strong>Educational objective:</strong><br>Endometriosis (ie, endometrial tissue implanting outside of the uterus) can cause dysmenorrhea and infertility due to chronic intraabdominal inflammation and pelvic anatomy distortion.&nbsp; On examination, patients may have lateral cervical displacement or cervical motion tenderness.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 13887,
            "topic": "Endometriosis",
            "titleId": 13887,
            "title": "Endometriosis",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chronic endometritis",
                    "choiceNumber": 1,
                    "correctTaken": 700,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial polyp",
                    "choiceNumber": 2,
                    "correctTaken": 116,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometriosis",
                    "choiceNumber": 3,
                    "correctTaken": 2989,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Submucosal fibroids",
                    "choiceNumber": 4,
                    "correctTaken": 685,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Unicornuate uterus",
                    "choiceNumber": 5,
                    "correctTaken": 571,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "59",
                    "mediaDataId": 0,
                    "title": "Endometriosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "36387918",
                    "mediaDataId": 0,
                    "title": "Endometriosis-associated infertility: from pathophysiology to tailored treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/36387918",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "35568524",
                    "mediaDataId": 0,
                    "title": "Infertility workup: identifying endometriosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/35568524",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 79,
            "notes": null,
            "peopleTaken": 5061,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 13388,
            "questionIndex": 14767,
            "questionText": "<p>A 56-year-old woman comes to the office for a routine health maintenance examination.&nbsp; She has been postmenopausal for 4 years and is not using hormone therapy.&nbsp; The patient had a normal screening mammogram last year.&nbsp; Pap testing 3 years ago was normal, but human papillomavirus testing was not performed.&nbsp; The patient has well-controlled hypertension and hyperlipidemia.&nbsp; She had 2 cesarean deliveries and a tubal ligation with her last delivery at age 30.&nbsp; Blood pressure is 130/90 mm Hg and pulse is 72/min.&nbsp; BMI is 38 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination is normal.&nbsp; Speculum examination shows no cervical abnormalities.&nbsp; Her Pap test shows endometrial cells and no cervical intraepithelial lesions.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This postmenopausal woman has <strong>endometrial cells on Pap testing</strong>.&nbsp; The reporting of endometrial cells on Pap tests is age based:</p><ul><li><p>Women age &lt;45 do not have endometrial cells reported on their Pap tests because this is a common, benign finding, particularly if Pap testing is performed during the first 10 days of the menstrual cycle.</p></li><li><p>In contrast, women age &#8805;45 do have endometrial cells reported on their Pap tests because this finding is more concerning for an abnormality.&nbsp; In this age group, particularly in <strong>postmenopausal women</strong>, endometrial shedding may be due to <strong>endometrial hyperplasia/cancer</strong>, regardless if the patient has no other symptoms (eg, postmenopausal or abnormal uterine bleeding).&nbsp; The risk of endometrial hyperplasia/cancer is further increased if the patient has additional risk factors (eg, <strong>obesity</strong>, prior chronic anovulation).</p></li></ul><p>Therefore, postmenopausal women with endometrial cells on Pap testing require further evaluation with an <strong>endometrial biopsy</strong>.&nbsp; Patients diagnosed with endometrial cancer typically undergo a hysterectomy with bilateral salpingo-oophorectomy for treatment <strong>(Choice C)</strong>.</p><p><strong>(Choices A and D)</strong>&nbsp; <a href=\"5031\">Colposcopy</a> and <a href=\"5281\">loop electrosurgical excision procedure</a> evaluate for cervical cancer in patients with either abnormal cervical cytology (ie, cervical intraepithelial lesions) or gross abnormalities of the cervix (eg, friable or fungating lesion).&nbsp; This patient has a normal-appearing cervix and no cervical intraepithelial lesions on Pap testing.</p><p><strong>(Choice E)</strong>&nbsp; This patient with no cervical intraepithelial lesions (ie, negative cervical cytology) on Pap testing may resume a normal cervical cancer screening schedule (eg, 3-5 years, depending on presence of HPV cotesting).&nbsp; Repeat cervical cancer screening in 1 year is not indicated in this patient.</p><p><strong>Educational objective:</strong><br>Postmenopausal women with endometrial cells on Pap testing require an endometrial biopsy to evaluate for endometrial hyperplasia/cancer.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3399,
            "topic": "Endometrial cancer",
            "titleId": 3399,
            "title": "Endometrial cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Colposcopy",
                    "choiceNumber": 1,
                    "correctTaken": 2958,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 8219,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hysterectomy and bilateral salpingo-oophorectomy",
                    "choiceNumber": 3,
                    "correctTaken": 117,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Loop electrosurgical excision procedure",
                    "choiceNumber": 4,
                    "correctTaken": 228,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat cervical cancer screening in 1 year",
                    "choiceNumber": 5,
                    "correctTaken": 5143,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "49",
                    "mediaDataId": 0,
                    "title": "Endometrial cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "615",
                    "mediaDataId": 0,
                    "title": "Cervical dysplasia and cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22706861",
                    "mediaDataId": 0,
                    "title": "Histologic follow-up in patients with Papanicolaou test findings of endometrial cells: results from a large academic women&#39;s hospital laboratory.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22706861",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23635684",
                    "mediaDataId": 0,
                    "title": "2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23635684",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28486237",
                    "mediaDataId": 0,
                    "title": "Evaluating the age cutoff criterion for reporting benign-appearing endometrial cells in routine pap tests: an 8-year retrospective review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28486237",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29021811",
                    "mediaDataId": 0,
                    "title": "Significance of finding benign endometrial cells in women 40-45 versus 46 years or older on Papanicolaou tests and histologic follow-up.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29021811",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 16665,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 49,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 10972,
            "questionIndex": 12110,
            "questionText": "<p>A 26-year-old woman comes to the emergency department due to a bump on her vaginal introitus.&nbsp; The patient first noticed the mass 2 days ago, but it has increased in size and now causes discomfort when she walks or exercises.&nbsp; She had unprotected sex with a new partner 6 weeks ago and has had 10 lifetime partners.&nbsp; The patient had an abnormal Pap test last year but had a normal colposcopy.&nbsp; She smokes a half pack of cigarettes daily but does not use alcohol or illicit drugs.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 110/60 mm Hg, and pulse is 80/min.&nbsp; On pelvic examination, the pubic hair is shaved.&nbsp; There is a 4-cm, mobile, soft, nontender cystic mass behind the right posterior labium majus that extends into the vagina.&nbsp; The remainder of the examination is normal.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"15256\" src=\"https://www.uworld.com/media/L40012.jpg\" ></p><p>This patient has a <strong>Bartholin duct cyst</strong>, which occurs due to blockage of the Bartholin gland duct.&nbsp; The Bartholin glands are located bilaterally at the posterior vaginal introitus and have ducts that drain into the vulvar vestibule at the 4 and 8 o&#39;clock positions to provide vulvovaginal lubrication.&nbsp; The Bartholin glands are not palpable unless ductal blockage occurs, resulting in mucoid fluid buildup and cyst formation.</p><p>Women with small Bartholin duct cysts are often asymptomatic and may be diagnosed incidentally on routine examination.&nbsp; In contrast, larger cysts (as seen in this patient) cause increased tissue tension and friction, resulting in <strong>vaginal pressure and discomfort</strong> with sexual activity, walking, or sitting (all of which apply direct pressure on the vulva and cyst).&nbsp; On pelvic examination, a <strong>soft</strong>, <strong>mobile</strong>, <strong>nontender</strong>, <strong>cystic mass</strong> is palpated <strong>behind the posterior labium majus</strong> with possible extension into the vagina.&nbsp; Asymptomatic cysts can be managed expectantly; symptomatic cysts require incision and drainage with possible <a href=\"17364\">Word catheter placement</a>.</p><p><strong>(Choice B)</strong>&nbsp; A Bartholin gland abscess can develop from an infected cyst; however, patients have additional findings of localized erythema and induration and a tender, fluctuant mass (not seen in this patient).</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"5033\">Condylomata acuminata</a> appear as groups of smooth papules or sessile, verrucous growths typically caused by human papillomavirus types 6 and 11.</p><p><strong>(Choice D)</strong>&nbsp; Condylomata lata&mdash;a feature of secondary syphilis&mdash;are gray-white, raised lesions affecting mucous membranes (eg, mouth, perineum); there is no associated cyst formation.</p><p><strong>(Choice E)</strong>&nbsp; Epidermal inclusion cysts appear as raised, mobile, flesh-colored nodules sometimes associated with a central punctum.</p><p><strong>(Choice F)</strong>&nbsp; Hidradenitis suppurativa creates inflamed, purulent nodules in intertriginous areas (eg, axilla, inguinal region) that cause draining sinuses and scarring; disease is typically multifocal and painful.</p><p><strong>(Choice G)</strong>&nbsp; Lymphogranuloma venereum presents as small, painless papules or pustules that ulcerate.&nbsp; Advanced stages develop painful, swollen lymph nodes that coalesce to form buboes, which may rupture.</p><p><strong>Educational objective:</strong><br>Large, symptomatic Bartholin duct cysts can present with vaginal discomfort and pressure with sexual activity, walking, or sitting.&nbsp; Physical examination reveals a soft, mobile, nontender mass located behind the posterior labium majus with possible extension into the vagina.&nbsp; Treatment of symptomatic Bartholin duct cysts is with incision and drainage.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 17520,
            "topic": "Bartholin duct cyst and abscess",
            "titleId": 17520,
            "title": "Bartholin duct cyst and abscess",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bartholin duct cyst",
                    "choiceNumber": 1,
                    "correctTaken": 16251,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bartholin gland abscess",
                    "choiceNumber": 2,
                    "correctTaken": 1355,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Condylomata acuminata",
                    "choiceNumber": 3,
                    "correctTaken": 508,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Condylomata lata",
                    "choiceNumber": 4,
                    "correctTaken": 327,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Epidermal inclusion cyst",
                    "choiceNumber": 5,
                    "correctTaken": 1366,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hidradenitis suppurativa",
                    "choiceNumber": 6,
                    "correctTaken": 188,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lymphogranuloma venereum",
                    "choiceNumber": 7,
                    "correctTaken": 214,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "40",
                    "mediaDataId": 0,
                    "title": "Bartholin gland cyst and abscess",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24914884",
                    "mediaDataId": 0,
                    "title": "Lesions of the Bartholin gland:  a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24914884",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25963974",
                    "mediaDataId": 0,
                    "title": "Management of Bartholin&#39;s cyst and abscess using the Word catheter:  implementation, recurrence rates and costs.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25963974",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26195958",
                    "mediaDataId": 0,
                    "title": "Clinical pathology of Bartholin&#39;s glands:  a review of the literature.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26195958",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 20209,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 124190,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 16066,
            "questionIndex": 17508,
            "questionText": "<p>A 57-year-old postmenopausal woman comes to the office due to vaginal spotting and increasing pelvic pressure.&nbsp; For the past few months, the patient has had pelvic pressure with some associated constipation, for which she takes fiber supplements with no relief.&nbsp; For the last week, she has also had vaginal spotting and occasional passage of small blood clots.&nbsp; The patient was diagnosed with breast cancer 3 years ago and has been taking tamoxifen for the past 2 years because she could not tolerate the adverse effects of aromatase inhibitors.&nbsp; She has no other chronic medical conditions, and her only surgeries were 3 cesarean deliveries in her 30s.&nbsp; Vital signs are normal.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; A large, irregular mass is palpable above the symphysis pubis, but there is no fluid wave or tenderness to palpation.&nbsp; On pelvic examination, there are no cervical or vaginal lesions; a small amount of blood is seen at the cervical os.&nbsp; The uterus appears well supported and does not descend with the Valsalva maneuver.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T35150\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Uterine sarcoma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Pelvic radiation</li><li>Tamoxifen use</li><li>Postmenopausal patients</li></ul></td></tr><tr><td><p align=\"center\"><strong>Presentation</strong></p></td><td><ul><li>Abnormal/postmenopausal bleeding</li><li>Pelvic pain or pressure</li><li>Uterine mass</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Ultrasound &plusmn; additional imaging</li><li>Endometrial biopsy</li><li>Histopathology of surgical specimen</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Hysterectomy</li><li>&plusmn; Adjuvant chemotherapy, radiation therapy</li></ul></td></tr></tbody></table></div><p>This patient with postmenopausal bleeding and a pelvic mass most likely has a <strong>uterine sarcoma</strong>, a rare but aggressive malignancy.&nbsp; Uterine sarcoma typically presents with a <strong>uterine mass</strong> (as in this patient&#39;s enlarged, irregularly shaped uterus) that causes <strong>bulk symptoms</strong> (eg, pelvic pressure, constipation) and abnormal or <strong>postmenopausal bleeding</strong>.&nbsp; Uterine sarcoma is often indistinguishable from benign leiomyomata (ie, uterine fibroids); however, it should be suspected in postmenopausal women who have taken tamoxifen or have other <strong>risk factors</strong> (eg, pelvic radiation).</p><p><strong>Tamoxifen</strong> is a selective estrogen receptor modulator used as an adjuvant treatment for breast cancer.&nbsp; Although tamoxifen has antagonist effects on the breast, it has <strong>estrogen agonist effects on the uterus</strong> and therefore increases the risk of uterine sarcoma and endometrial hyperplasia or cancer.&nbsp; For this reason, the FDA has issued a black box warning for patients and providers but recognizes that the benefits of tamoxifen therapy typically outweigh the risks for most patients with breast cancer.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"1210\">Adenomyosis</a> can present with an enlarged uterus and abnormal uterine bleeding (eg, heavy menses); however, patients have a symmetrically enlarged, globular uterus, not an irregular uterine mass.</p><p><strong>(Choice B)</strong>&nbsp; Choriocarcinoma (ie, gestational trophoblastic neoplasia) can present with an enlarged uterus and abnormal uterine bleeding after pregnancy.&nbsp; Choriocarcinoma affects women of childbearing age, making this diagnosis unlikely in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Metastatic cancer to the ovaries can cause a pelvic mass and bulk symptoms; however, it is typically associated with ascites (ie, fluid wave on palpation), which is not seen in this patient.&nbsp; In addition, breast cancer preferentially metastasizes to the lungs, liver, and bones, making this diagnosis less likely.</p><p><strong>(Choice D)</strong>&nbsp; Pelvic organ prolapse (eg, complete <a href=\"6260\">procidentia</a>) can cause pelvic pressure, constipation, and postmenopausal bleeding due to exposed, eroded vaginal mucosa.&nbsp; However, it typically presents with a vaginal, not abdominal, mass.&nbsp; In addition, this patient&#39;s uterus is well supported, making this diagnosis unlikely.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"18923\">Sarcoma botryoides</a>, a type of embryonal rhabdomyosarcoma, can present as a genitourinary mass, but it is typically vaginal and exclusively diagnosed in infants, not postmenopausal patients.</p><p><strong>Educational objective:</strong><br>Uterine sarcoma typically presents with postmenopausal bleeding and a uterine mass that causes bulk symptoms (eg, pelvic pressure, constipation).&nbsp; Tamoxifen use is a significant risk factor due to its estrogen agonist effects on the uterus.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3143,
            "topic": "Uterine fibroids",
            "titleId": 3143,
            "title": "Uterine fibroids",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "6",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adenomyosis",
                    "choiceNumber": 1,
                    "correctTaken": 1782,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Choriocarcinoma",
                    "choiceNumber": 2,
                    "correctTaken": 469,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Metastatic breast cancer",
                    "choiceNumber": 3,
                    "correctTaken": 1055,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic organ prolapse",
                    "choiceNumber": 4,
                    "correctTaken": 509,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sarcoma botryoides",
                    "choiceNumber": 5,
                    "correctTaken": 623,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine sarcoma",
                    "choiceNumber": 6,
                    "correctTaken": 12243,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "761",
                    "mediaDataId": 0,
                    "title": "Uterine sarcoma",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24848920",
                    "mediaDataId": 0,
                    "title": "Committee opinion no. 601: tamoxifen and uterine cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24848920",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24282897",
                    "mediaDataId": 0,
                    "title": "Uterine sarcoma after tamoxifen therapy for breast cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24282897",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 16681,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 11053,
            "questionIndex": 12194,
            "questionText": "<p>A 54-year-old woman, gravida 2 para 2, comes to the office due to several months of irregular vaginal spotting.&nbsp; The patient has had intermittent spotting with wiping after urination and has noticed some blood stains on her underwear, but she has had no large clots or abnormal vaginal discharge.&nbsp; Menopause occurred over a year ago and was complicated by severe hot flashes and night sweats.&nbsp; The patient was prescribed a transdermal estrogen patch and cyclic progesterone-only pills.&nbsp; She has been using the estrogen patches consistently but stopped taking the progesterone-only pills due to severe nausea.&nbsp; The patient has no chronic medical conditions and has had no surgeries.&nbsp; A Pap test 2 years ago was normal.&nbsp; Family history is noncontributory.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Vital signs are normal.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; On speculum examination, there are no cervical or vaginal lesions and there is no blood in the vagina.&nbsp; Bimanual examination reveals a small, mobile uterus and no adnexal masses.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"5477\" src=\"https://www.uworld.com/media/L16430.jpg\" ></p><p>Women with severe hot flashes during menopause, such as this patient, are often started on <strong>estrogen therapy</strong> (eg, estrogen transdermal patch) for symptom control.&nbsp; Although the estrogen helps with hot flashes, it can have a negative effect on the uterine lining by allowing for <strong>uncontrolled endometrial proliferation</strong>; therefore, women with a uterus require progesterone to protect the endometrium.&nbsp; However, progesterone can have intolerable side effects (eg, severe nausea) that may lead to its discontinuation.</p><p>When the endometrial lining becomes thickened, women can develop <strong>postmenopausal bleeding (PMB)</strong>, as seen in this patient&#39;s irregular vaginal spotting a year after menopause.&nbsp; Although most cases of PMB are benign, the most concerning cause is <strong>endometrial cancer</strong>, particularly in patients on unopposed estrogen therapy.&nbsp; Therefore, patients with PMB require evaluation of the endometrial lining with either a <strong>transvaginal ultrasound (TVUS)</strong> or endometrial biopsy.</p><p>Postmenopausal women should have a thin endometrium; a TVUS is a reasonable first step in evaluation as it is predictive of pathology and is not as invasive or uncomfortable as an endometrial biopsy.&nbsp; Women with an endometrium &#8804;4 mm require no additional evaluation.&nbsp; In contrast, those with an endometrium &gt;4 mm require an endometrial biopsy.</p><p><strong>(Choice B)</strong>&nbsp; Endometrial ablation is a procedure that destroys and scars the endometrium.&nbsp; It is not used as a treatment for PMB because it can prevent future endometrial evaluation and obscure malignancy.</p><p><strong>(Choices C and D)</strong>&nbsp; If this patient has a normal TVUS or endometrial biopsy, a progestin-containing intrauterine device can be placed to protect the endometrial lining while she continues estrogen therapy.&nbsp; In contrast, if the endometrial biopsy shows hyperplasia or cancer, the patient would require hysterectomy with bilateral salpingo-oophorectomy.</p><p><strong>(Choice E)</strong>&nbsp; Vaginal estrogen is used for vulvovaginal atrophy; it does not treat hot flashes.&nbsp; In addition, it should not be used until patients have completed the PMB evaluation.</p><p><strong>Educational objective:</strong><br>Patients with postmenopausal bleeding require evaluation for endometrial cancer with either a transvaginal ultrasound (TVUS) or endometrial biopsy.&nbsp; In women who initially undergo a TVUS, those with an endometrium &#8804;4 mm require no additional evaluation.&nbsp; In contrast, women with an endometrium &gt;4 mm require an endometrial biopsy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3399,
            "topic": "Endometrial cancer",
            "titleId": 3399,
            "title": "Endometrial cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Order a transvaginal pelvic ultrasound",
                    "choiceNumber": 1,
                    "correctTaken": 11948,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform an endometrial ablation",
                    "choiceNumber": 2,
                    "correctTaken": 882,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Place a progestin-containing intrauterine device",
                    "choiceNumber": 3,
                    "correctTaken": 2108,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schedule a hysterectomy with bilateral salpingo-oophorectomy",
                    "choiceNumber": 4,
                    "correctTaken": 302,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Switch from transdermal patch to vaginal estrogen",
                    "choiceNumber": 5,
                    "correctTaken": 1497,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "49",
                    "mediaDataId": 0,
                    "title": "Endometrial cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "80",
                    "mediaDataId": 0,
                    "title": "Evaluation of postmenopausal bleeding",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24377427",
                    "mediaDataId": 0,
                    "title": "Investigation of women with postmenopausal uterine bleeding: clinical practice recommendations.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24377427",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29683904",
                    "mediaDataId": 0,
                    "title": "ACOG committee opinion No. 734 summary: the role of transvaginal ultrasonography in evaluating the endometrium of women with postmenopausal bleeding.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29683904",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 16737,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 14305,
            "questionIndex": 15713,
            "questionText": "<p>A 34-year-old woman comes to the office to discuss the results of a recent CT scan.&nbsp; The patient was in a motor vehicle collision last week and underwent a CT scan of the abdomen and pelvis for possible intraabdominal trauma.&nbsp; The CT scan showed a markedly enlarged uterus with multiple intramural and pedunculated leiomyomata that did not compress the ureters or surrounding bowel.&nbsp; The patient has a monthly menstrual period with 4 days of light bleeding.&nbsp; She typically has abdominal cramping on the first day of her menstrual period, but usually does not require pain medication.&nbsp; The patient has no urinary frequency, urgency, chronic pelvic pain, or changes in bowel habits.&nbsp; She has no chronic medical conditions and takes no daily medications.&nbsp; The patient is in a monogamous, same-sex relationship and has no pain with intercourse.&nbsp; Vital signs are normal, and BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; An irregularly enlarged mass is palpated in the lower abdomen, consistent with uterine leiomyomata.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35149\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Uterine leiomyomas (fibroids)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Heavy, prolonged menses</li><li>Pressure symptoms<ul style=\"list-style-type:circle;\"><li>Pelvic pain</li><li>Constipation</li><li>Urinary frequency</li></ul></li><li>Obstetric complications<ul style=\"list-style-type:circle;\"><li>Impaired fertility</li><li>Pregnancy loss</li><li>Preterm labor</li></ul></li><li>Enlarged, irregular uterus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Work-up</strong></p></td><td><ul><li>Ultrasonography</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Asymptomatic: observation</li><li>Symptomatic: hormonal contraception, surgery</li></ul></td></tr></tbody></table></div><p>This patient has <strong>uterine leiomyomata</strong> (ie, <a href=\"4394\">fibroids</a>), benign smooth muscle (myometrial) tumors that are relatively common (up to 25%) in adult women.&nbsp; These tumors can increase the surface area of the endometrium and the overall size and bulk of the uterus as well as compress surrounding structures; however, some patients have no symptoms and are <strong>diagnosed incidentally</strong> on physical examination or imaging (as in this patient&#39;s CT scan after a motor vehicle collision).</p><p>Indications for treatment of uterine leiomyomata include:</p><ul><li>Heavy, prolonged menses (particularly if associated with anemia).</li><li>Chronic pelvic pain (eg, dyspareunia).</li><li>Bulk symptoms (eg, pelvic pressure, hydronephrosis, constipation).</li><li>Recurrent pregnancy loss.</li></ul><p>Patients with these clinical features can be managed medically or surgically (eg, myomectomy).</p><p>Although this patient has multiple, large intramural and pedunculated leiomyomata, she has light menses and no pelvic pain or bulk symptoms (eg, no ureter compression).&nbsp; In patients with <strong>asymptomatic fibroids</strong>, no additional management is indicated.&nbsp; They require <strong>observation and reassurance only</strong>.</p><p><strong>(Choices A and D)</strong>&nbsp; Combination oral contraceptive pills and progestin-containing intrauterine devices can be used in the treatment of symptomatic fibroids, but they are not required in the management of asymptomatic fibroids.&nbsp; In addition, this patient has a low risk for an unintended pregnancy (eg, monogamous, same-sex relationship), and the potential risks of these contraceptives (eg, venous thromboembolism, uterine perforation) outweigh their benefits.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"64343\">GnRH agonist therapy</a> (eg, leuprolide) is a treatment for symptomatic uterine fibroids and acts by decreasing pulsatile FSH and LH release, thereby decreasing estrogen levels.&nbsp; Low estrogen levels result in transient decreased leiomyoma size, which improves heavy menses and bulk symptoms.&nbsp; GnRH agonists are only used short-term (ie, preoperative) because long-term therapy is associated with an increased risk of osteoporotic fractures.</p><p><strong>(Choice E)</strong>&nbsp; Tranexamic acid is a nonhormonal medical treatment that acts by inhibiting fibrin degradation (ie, antifibrinolytic agent) to decrease heavy menstrual bleeding.&nbsp; This patient has light menses.</p><p><strong>Educational objective:</strong><br>Uterine leiomyomata (fibroids) are common, benign myometrial tumors that can cause a variety of symptoms but may be diagnosed incidentally.&nbsp; Indications for treatment include heavy menstrual bleeding, pelvic pain, and bulk symptoms.&nbsp; Patients with asymptomatic fibroids require observation and reassurance only.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3143,
            "topic": "Uterine fibroids",
            "titleId": 3143,
            "title": "Uterine fibroids",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Combination oral contraceptive pills",
                    "choiceNumber": 1,
                    "correctTaken": 1169,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "GnRH agonist therapy",
                    "choiceNumber": 2,
                    "correctTaken": 611,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observation and reassurance only",
                    "choiceNumber": 3,
                    "correctTaken": 13759,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progestin-containing intrauterine device",
                    "choiceNumber": 4,
                    "correctTaken": 301,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tranexamic acid",
                    "choiceNumber": 5,
                    "correctTaken": 102,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "47",
                    "mediaDataId": 0,
                    "title": "Uterine fibroids",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28084714",
                    "mediaDataId": 0,
                    "title": "Uterine fibroids: diagnosis and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28084714",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26275638",
                    "mediaDataId": 0,
                    "title": "Prevalence, morbidity, and current medical management of uterine leiomyomas.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26275638",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 44,
            "notes": null,
            "peopleTaken": 15942,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 86,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 13390,
            "questionIndex": 14769,
            "questionText": "<p>A 58-year-old, postmenopausal woman comes to the office due to increasing vulvar pain.&nbsp; The pain was initially mild and intermittent when it began several months ago but has worsened over the past few weeks.&nbsp; In addition, the patient has now developed odorless, pink-tinged vaginal discharge with pruritus.&nbsp; She also has had a few painful oral lesions in the past several months that she treated with topical anesthetics with minimal improvement.&nbsp; Review of systems is otherwise negative.&nbsp; The patient is not sexually active.&nbsp; On examination, the gingivae have a lacelike, reticular appearance, and there are multiple white plaques on the tongue and palate.&nbsp; The vulva is diffusely erythematous, and the labia minora have multiple glazed, brightly erythematous erosions bordered by white striae.&nbsp; The vaginal introitus is stenotic, and a limited speculum examination reveals a friable, erythematous vaginal epithelium with a serosanguinous discharge.&nbsp; The remainder of the physical examination is normal.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T43365\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Vulvar lichen planus</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Women age 50-60</li><li>Vulvar pain or pruritus</li><li>Dyspareunia</li><li>Erosive variant (most common):<ul style=\"list-style-type:circle;\"><li>Erosive, glazed lesions with white border</li><li>Vaginal involvement &plusmn; stenosis</li><li>Associated oral ulcers</li></ul></li><li>Papulosquamous variant:<ul style=\"list-style-type:circle;\"><li>Small pruritic papules with purple hue</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p style=\"margin-left:.35in;\">Vulvar biopsy</p></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><p style=\"margin-left:.35in;\">High-potency topical corticosteroids</p></td></tr></tbody></table></div><p>This patient has <strong>vulvar lichen planus</strong>, a chronic inflammatory condition that typically occurs in postmenopausal women.&nbsp; The most common type of vulvar lichen planus is the erosive variant, in which chronic inflammation causes <strong>desquamation and erosion</strong> of mucosal surfaces, including the vulva, vagina, and oral cavity (as seen in this patient).&nbsp; Clinical features of erosive lichen planus include:</p><ul><li><p><strong>Glazed, brightly erythematous vulvar erosions</strong> with a border of serpentine-appearing, white striae (ie, <strong>Wickham striae</strong>) that typically cause vulvar pain, pruritus, and dyspareunia.</p></li><li><p>Acute vaginal inflammation that causes friable vaginal mucosa and a <strong>serosanguinous vaginal discharge</strong>; chronic inflammation can eventually result in stenosis of the vaginal introitus.</p></li><li><p>Lacelike, reticular erosions on the gingivae and palate that cause painful oral ulcers and plaque formations on the tongue.</p></li></ul><p>Diagnosis may be made clinically but should be confirmed with a <strong>vulvar punch biopsy</strong> because the clinical features of lichen planus may overlap with those of vulvar cancer.&nbsp; Patients with lichen planus require evaluation of all mucosal surfaces because erosions may occur in the absence of other symptoms.&nbsp; First-line treatment is with <strong>high-potency topical corticosteroids</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Desquamative inflammatory vaginitis can cause vulvar pain and abnormal vaginal discharge.&nbsp; However, vulvar architecture is maintained (eg, no erosive vulvar lesions), and concomitant oral lesions would not be expected.</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"4597\">Lichen sclerosus</a> can present with vulvar pruritus and white vulvar plaques with associated erosions.&nbsp; However, patients with lichen sclerosus typically have no vaginal involvement, making the diagnosis unlikely in this patient with an erythematous vaginal epithelium and serosanguinous vaginal discharge.</p><p><strong>(Choice D)</strong>&nbsp; Vulvovaginal atrophy may present with vulvar pain and serosanguinous discharge; however, there is no association with either oral lesions or erosive vulvar lesions.</p><p><strong>(Choice E)</strong>&nbsp; Vulvovaginal candidiasis can present with vulvovaginal pruritus and erythema; however, these patients typically have a thick, white vaginal discharge rather than serosanguinous discharge and erosive lesions.&nbsp; Some patients (eg, immunosuppressed) can have accompanying <a href=\"17155\">oropharyngeal candidiasis</a>; however, the associated white oral plaques do not typically have a lacelike, reticular appearance (ie, Wickham striae).</p><p><strong>Educational objective:</strong><br>Vulvar lichen planus is a chronic inflammatory disorder that can present with multiple glazed, erythematous vulvar erosions bordered by white striae (ie, Wickham striae).&nbsp; Patients often have associated vaginal and oral lesions.&nbsp; Treatment is with topical corticosteroids.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 9152,
            "topic": "Vulvar carcinoma",
            "titleId": 9152,
            "title": "Vulvar carcinoma",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Desquamative inflammatory vaginitis",
                    "choiceNumber": 1,
                    "correctTaken": 2144,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lichen planus",
                    "choiceNumber": 2,
                    "correctTaken": 8136,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lichen sclerosus",
                    "choiceNumber": 3,
                    "correctTaken": 3911,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vulvovaginal atrophy",
                    "choiceNumber": 4,
                    "correctTaken": 412,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vulvovaginal candidiasis",
                    "choiceNumber": 5,
                    "correctTaken": 2007,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28778640",
                    "mediaDataId": 0,
                    "title": "Erosive lichen planus.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28778640",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26650696",
                    "mediaDataId": 0,
                    "title": "Genital lichen planus: update on diagnosis and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26650696",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25608255",
                    "mediaDataId": 0,
                    "title": "Lichen sclerosus and lichen planus in women and girls.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25608255",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24183096",
                    "mediaDataId": 0,
                    "title": "Erosive vulvar lichen planusa diagnosis not to be missed: a clinical review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24183096",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 16610,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 49,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 4773,
            "questionIndex": 4773,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td id=\"vignettedescriptor\">The following vignette applies to the next 2 items.&nbsp; The items in the set must be answered in sequential order.&nbsp; Once you click <strong>Proceed to Next Item</strong>, you will not be able to add or change an answer.</td></tr></tbody></table><p>A 25-year-old nulligravid woman comes to the office due to continued pelvic and lower back pain.&nbsp; The pain has worsened over the past year.&nbsp; It is constant but intensifies a few days before the patient&#39;s menstruation and improves toward the end of her cycle.&nbsp; The patient has been in a monogamous relationship for the past 4 years.&nbsp; She started taking ibuprofen and combined oral contraceptives 9 months ago when she began having pelvic pain, and they have minimally improved her pain.&nbsp; Temperature is 37.2 C (99 F) and blood pressure is 120/78 mm Hg.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Examination shows tenderness in the posterior vaginal fornix, decreased uterine mobility, and thickening of the uterosacral ligaments.&nbsp; No adnexal masses are palpated.&nbsp; Urine &#946;-hCG is negative.&nbsp; Hemoglobin is 12 g/dL and leukocytes are 8,200/mm<font size=\"2\"><sup>3</sup></font>.&nbsp; Transvaginal ultrasound reveals normal pelvic anatomy.</p><p><strong>Item 1 of 2</strong></p><p>Which of the following is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"4757\" src=\"https://www.uworld.com/media/L16433.jpg\" ></p>&nbsp;<p>This patient most likely has <strong>endometriosis</strong>, the development of endometrial glands and stroma outside the uterus.&nbsp; During the menstrual cycle, the ectopic endometrial tissue proliferates and sheds, but because the tissue is located within the abdominopelvic cavity with no outlet, this creates inflammation, resulting in dysmenorrhea (ie, painful menses).&nbsp; With continued inflammation, patients can also develop adhesions, fibrosis, and subsequent distortion of the adjacent pelvic anatomy, resulting in classic examination findings such as posterior fornix tenderness, <strong>decreased uterine mobility</strong>, and <strong>uterosacral ligament thickening</strong>.&nbsp; Transvaginal ultrasound is often normal (except in those with an endometrioma) because lesions are too small to detect on imaging.</p><p>Initial treatment of endometriosis is with nonsteroidal anti-inflammatory drugs (which decrease inflammation) and combined oral contraceptive pills (which suppress ovulation and reduce menstruation).&nbsp; However, in patients who <strong>fail medical management</strong>, a diagnostic <strong>laparoscopy</strong> is recommended because it allows for <strong>definitive diagnosis</strong> (via direct visualization and biopsy of lesions) and is <strong>therapeutic</strong> (via removal of endometriotic lesions) <strong>(Choice E)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; A CT scan cannot definitively diagnose endometriosis because the lesions are too small to visualize, and a CT scan is not indicated in patients with a normal pelvic ultrasound.</p><p><strong>(Choice B)</strong>&nbsp; An endometrial biopsy can diagnose endometrial cancer, which typically presents in high-risk (eg, obese) patients with abnormal uterine bleeding or postmenopausal bleeding.&nbsp; It is not indicated in patients with dysmenorrhea and regular ovulatory menstrual cycles.</p><p><strong>(Choice C)</strong>&nbsp; A hysterosalpingogram is used in the evaluation of female infertility.&nbsp; It assesses the uterine cavity for structural abnormalities (eg, intracavitary fibroids) and the fallopian tubes for obstruction, but it is not used to evaluate secondary dysmenorrhea.</p><p><strong>Educational objective:</strong><br>Endometriosis is initially treated with nonsteroidal anti-inflammatory drugs and combined oral contraceptives.&nbsp; Patients who fail medical therapy are recommended for laparoscopy, which can offer definitive diagnosis and treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 13887,
            "topic": "Endometriosis",
            "titleId": 13887,
            "title": "Endometriosis",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 4773,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "CT scan of the pelvis",
                    "choiceNumber": 1,
                    "correctTaken": 3016,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 1222,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hysterosalpingogram",
                    "choiceNumber": 3,
                    "correctTaken": 1512,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Laparoscopy",
                    "choiceNumber": 4,
                    "correctTaken": 8943,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional evaluation indicated",
                    "choiceNumber": 5,
                    "correctTaken": 3219,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "59",
                    "mediaDataId": 0,
                    "title": "Endometriosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20573927",
                    "mediaDataId": 0,
                    "title": "Clinical practice: endometriosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20573927",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25681842",
                    "mediaDataId": 0,
                    "title": "Current strategies for endometriosis management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25681842",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26224322",
                    "mediaDataId": 0,
                    "title": "Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26224322",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29530425",
                    "mediaDataId": 0,
                    "title": "Medical treatment of endometriosis-related pain.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29530425",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 17912,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 4774,
            "questionIndex": 4774,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>This patient&#39;s condition increases her risk for which of the following complications?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32451\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Endometriosis</strong></p></td></tr><tr><td style=\"width: 30%;\"><p align=\"center\"><strong>Pathogenesis </strong></p></td><td style=\"width: 70%;\"><ul><li>Ectopic implantation of endometrial glands</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical&nbsp;features </strong></p></td><td><ul><li>Dyspareunia</li><li>Dysmenorrhea</li><li>Chronic pelvic pain</li><li>Infertility</li><li>Dyschezia</li><li>Cyclic dysuria, hematuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Physical&nbsp;examination </strong></p></td><td><ul><li>Immobile uterus</li><li>Cervical motion tenderness</li><li>Adnexal mass</li><li>Rectovaginal septum, posterior cul-de-sac, uterosacral ligament nodules</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Direct visualization &amp; surgical biopsy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Medical (oral contraceptives, NSAIDs) &nbsp;</li><li>Surgical resection</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>NSAIDs</strong> = nonsteroidal anti-inflammatory drugs.</p></td></tr></tbody></table></div><p>Due to the chronic proliferation of ectopic <a href=\"1139\">endometrial implants</a> in the abdominopelvic cavity, patients with <strong>endometriosis</strong> develop intraperitoneal inflammation and fibrosis.&nbsp; Therefore, a <strong>common complication</strong> of endometriosis is <strong>infertility</strong>.&nbsp; In these patients, <strong>inflammation</strong> interferes with fertilization by decreasing sperm motility; in addition, <strong>adhesion formation</strong> and pelvic anatomy distortion can cause tubal obstruction and impaired implantation.&nbsp; Treatment is with laparoscopic removal of inflammatory implants and lysis of adhesions, which improves fertility by decreasing inflammation and restoring pelvic anatomy.</p><p><strong>(Choice A)</strong>&nbsp; Endometrial cancer occurs in patients with unopposed estrogen stimulation (eg, obesity, polycystic ovary syndrome) due to uncontrolled endometrial proliferation.&nbsp; Endometriosis is estrogen-responsive; however, it does not increase endometrial cancer risk because gland proliferation is outside the uterus (rather than an overproliferation of the endometrium).</p><p><strong>(Choice C)</strong>&nbsp; Intrauterine adhesions can result from pelvic inflammatory disease (eg, endometritis), which typically presents with abnormal uterine bleeding or vaginal discharge.&nbsp; Endometriosis is an extrauterine disease.</p><p><strong>(Choices D and E)</strong>&nbsp; The risk of osteoporotic fracture is higher in patients with disorders of the hypothalamic-pituitary-ovarian axis that cause low estrogen levels (eg, functional hypothalamic amenorrhea, primary ovarian insufficiency).&nbsp; Endometriosis does not involve the hypothalamic-pituitary-ovarian axis and does not affect estrogen levels.</p><p><strong>(Choice F)</strong>&nbsp; Recurrent miscarriage typically occurs in patients with intrauterine cavity abnormalities (eg, <a href=\"2431\">septate uterus</a>).&nbsp; Although endometriosis affects fertility, it is an extrauterine disease; therefore, it does not increase the risk of recurrent miscarriage.</p><p><strong>Educational objective:</strong><br>Patients with endometriosis are at increased risk of infertility due to chronic pelvic inflammation, adhesion formation, and distorted pelvic anatomy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 13887,
            "topic": "Endometriosis",
            "titleId": 13887,
            "title": "Endometriosis",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 4773,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 1,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Endometrial cancer",
                    "choiceNumber": 1,
                    "correctTaken": 2020,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Infertility",
                    "choiceNumber": 2,
                    "correctTaken": 13110,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intrauterine adhesions",
                    "choiceNumber": 3,
                    "correctTaken": 1775,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Osteoporotic fracture",
                    "choiceNumber": 4,
                    "correctTaken": 44,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary ovarian insufficiency",
                    "choiceNumber": 5,
                    "correctTaken": 108,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recurrent miscarriage",
                    "choiceNumber": 6,
                    "correctTaken": 869,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 6,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": true,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "59",
                    "mediaDataId": 0,
                    "title": "Endometriosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24696265",
                    "mediaDataId": 0,
                    "title": "Laparoscopic surgery for endometriosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24696265",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23182559",
                    "mediaDataId": 0,
                    "title": "Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23182559",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 13,
            "notes": null,
            "peopleTaken": 17928,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 13383,
            "questionIndex": 14761,
            "questionText": "<p>A 29-year-old woman comes to the office for a colposcopy after a cervical cancer screening last week revealed abnormal intraepithelial lesions.&nbsp; The patient feels well and has had no abnormal vaginal bleeding or discharge.&nbsp; She has no chronic medical conditions and has had no prior surgery.&nbsp; The patient&#39;s only medication is an oral contraceptive.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; On colposcopy, the squamocolumnar junction is not completely visualized, and an ectocervical biopsy reveals cervical intraepithelial neoplasia (CIN) 1.&nbsp; An endocervical curettage shows CIN 3.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"4803\" src=\"https://www.uworld.com/media/L29131.jpg\" ></p><p><a href=\"5031\">Colposcopy</a>, which provides an illuminated and magnified view of the vulva, vagina, and cervix, can identify precancerous cervical lesions (eg, cervical intraepithelial neoplasia [CIN]); it is performed in patients with abnormal cervical cancer screening results.&nbsp; However, patients with an unsatisfactory colposcopy (ie, squamocolumnar junction not completely visualized) and high likelihood of cervical dysplasia require an <a href=\"38054\">endocervical curettage</a> (ie, sampling of the endocervical canal) to fully evaluate the cervix for lesions.</p><p>In this patient, colposcopy with ectocervical biopsy showed CIN 1 (low risk of cancer progression); however, the results were unsatisfactory because the squamocolumnar junction was not completely visualized.&nbsp; Therefore, endocervical curettage was performed; it revealed high-grade <strong>CIN 3</strong>, a <strong>high-risk precancerous lesion</strong> with a 15%-40% risk of progression to invasive cancer.&nbsp; CIN 3 is also a significant risk factor for <strong>concurrent invasive cervical cancer</strong>.&nbsp; Therefore, treatment of CIN 3 (whether in the endo- or ectocervix) is with immediate <strong>cervical conization</strong>.&nbsp; Cervical conization is both a diagnostic and a therapeutic procedure, typically removing the entire lesion and allowing for examination of the full depth of invasion.</p><p>Management after conization depends on pathology results: If there is no evidence of invasive cancer and the specimen margins are free of disease (ie, all CIN removed), management is with Pap testing and human papillomavirus cotesting at 1 and 2 years.&nbsp; In contrast, patients with invasive cancer or margins with residual CIN require additional treatment.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"9333\">Endometrial biopsy</a> is indicated in patients with abnormal uterine bleeding to evaluate for endometrial cancer.&nbsp; This patient has no abnormal bleeding and is at low risk for endometrial cancer (eg, normal BMI, oral contraceptive use).</p><p><strong>(Choices C and D)</strong>&nbsp; Patients with CIN 3 require a prompt excisional biopsy (ie, cervical conization) due to the high risk of concurrent invasive cancer and/or progression to cancer if management is delayed.&nbsp; Therefore, repeat Pap testing in several months or years is inappropriate.</p><p><strong>(Choice E)</strong>&nbsp; Topical trichloroacetic acid can treat anogenital warts; however, it is not used to treat high-grade cervical intraepithelial lesions.</p><p><strong>Educational objective:</strong><br>Patients with cervical intraepithelial neoplasia 3 on biopsy (eg, endocervical curettage) require cervical conization, a type of excisional biopsy, due to the high risk of concurrent invasive cervical cancer and/or progression to cancer.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3372,
            "topic": "Cervical cancer",
            "titleId": 3372,
            "title": "Cervical cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cervical conization",
                    "choiceNumber": 1,
                    "correctTaken": 13999,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 1864,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat Pap and human papillomavirus cotesting in 3 months",
                    "choiceNumber": 3,
                    "correctTaken": 483,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Routine Pap testing in 3 years",
                    "choiceNumber": 4,
                    "correctTaken": 48,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Topical trichloroacetic acid",
                    "choiceNumber": 5,
                    "correctTaken": 236,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "615",
                    "mediaDataId": 0,
                    "title": "Cervical dysplasia and cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16417073",
                    "mediaDataId": 0,
                    "title": "Management of histologic abnormalities of the cervix.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16417073",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23062041",
                    "mediaDataId": 0,
                    "title": "ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23062041",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23519301",
                    "mediaDataId": 0,
                    "title": "2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23519301",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 43,
            "notes": null,
            "peopleTaken": 16630,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 84,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 3745,
            "questionIndex": 3745,
            "questionText": "<p>A 63-year-old woman comes to the office for evaluation of postmenopausal bleeding.&nbsp; The patient initially had post-coital bleeding only, but it has become more frequent despite the use of over-the-counter vaginal lubricants and moisturizers.&nbsp; For the last month, the patient has had daily vaginal spotting and is beginning to have pain with intercourse.&nbsp; Until 6 months ago, she had not been sexually active for 10 years.&nbsp; The patient has had no routine health care since the birth of her children over 30 years ago.&nbsp; She smokes a pack of cigarettes a day.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The vagina appears atrophic with minimal rugation and has a 1-cm ulcerated lesion in the upper third of the posterior wall.&nbsp; There is a malodorous watery discharge in the vagina.&nbsp; Numerous squamous epithelial cells with rare leukocytes are seen on wet mount microscopy.&nbsp; Potassium hydroxide test is negative.&nbsp; Pelvic ultrasound shows an anteverted uterus with a 3-mm endometrial stripe.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41996\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Vaginal cancer</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Age &gt;60</li><li>Human papillomavirus infection</li><li>Tobacco use</li><li>In utero DES exposure (clear cell adenocarcinoma only)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Vaginal bleeding</li><li>Malodorous vaginal discharge</li><li>Irregular vaginal lesion</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Vaginal biopsy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Surgery &plusmn; chemoradiation</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>DES</strong> = diethylstilbestrol.</p></td></tr></tbody></table></div><p>This patient&#39;s vaginal bleeding, malodorous discharge, and <strong>ulcerated vaginal lesion</strong> are concerning for <strong>vaginal squamous cell carcinoma</strong>.&nbsp; Additional clinical features may include pelvic pain, urinary symptoms (eg, hematuria), and bulk symptoms (eg, constipation), which are suggestive of metastatic disease.&nbsp; Risk factors for vaginal cancer are similar to those of cervical cancer and include <strong>chronic tobacco use</strong>, persistent human papillomavirus infection, and age &gt;60.&nbsp; Lesions typically appear as an irregular plaque or ulcer located in the upper third of the posterior vagina.</p><p>In this patient, the <strong>best next step</strong> in management is <strong>biopsy of the lesion</strong>.&nbsp; The biopsy <strong>evaluates the depth of invasion</strong> of atypical cells and differentiates between vaginal intraepithelial neoplasia (ie, noninvasive) and vaginal cancer (ie, invasive).&nbsp; Patients with noninvasive disease can be treated conservatively with topical therapy or a wide local excision <strong>(Choice F)</strong>.&nbsp; In contrast, those with invasive disease require an extensive procedure (ie, radical hysterectomy, vaginectomy, pelvic lymph node dissection) and/or chemoradiation.</p><p><strong>(Choice A)</strong>&nbsp; Endometrial biopsy is indicated to evaluate for endometrial cancer in women with postmenopausal bleeding and an endometrial lining &gt;4 mm on ultrasound.&nbsp; This patient has a thin endometrium and therefore does not require further evaluation for endometrial cancer.</p><p><strong>(Choice B)</strong>&nbsp; Oral metronidazole is used to treat bacterial vaginosis, which typically presents with a malodorous vaginal discharge.&nbsp; This patient had a negative potassium hydroxide test and no clue cells on wet mount microscopy, making this diagnosis unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Topical corticosteroids are the treatment for desquamative inflammatory vaginitis, which often presents with copious watery discharge.&nbsp; In contrast to this patient, those with desquamative inflammatory vaginitis have an inflamed erythematous vagina on pelvic examination and a predominance of leukocytes on wet mount microscopy.</p><p><strong>(Choice E)</strong>&nbsp; Vaginal estrogen therapy is indicated for atrophic vaginitis, which can cause vaginal bleeding, malodorous discharge, and dyspareunia.&nbsp; However, atrophic vaginitis rarely causes ulcerative lesions and requires further evaluation prior to estrogen therapy.</p><p><strong>Educational objective:</strong><br>Vaginal squamous cell carcinoma typically presents with vaginal bleeding, malodorous discharge, and an irregular lesion.&nbsp; Risk factors include age &gt;60, chronic tobacco use, and persistent human papillomavirus infection.&nbsp; Diagnosis is by biopsy of the lesion, which determines the depth of invasion of atypical cells.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 23748,
            "topic": "Vaginal cancer",
            "titleId": 23748,
            "title": "Vaginal cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 1,
                    "correctTaken": 4388,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oral metronidazole",
                    "choiceNumber": 2,
                    "correctTaken": 1413,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Topical corticosteroids",
                    "choiceNumber": 3,
                    "correctTaken": 54,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal biopsy",
                    "choiceNumber": 4,
                    "correctTaken": 8328,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal estrogen",
                    "choiceNumber": 5,
                    "correctTaken": 1636,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Wide local excision",
                    "choiceNumber": 6,
                    "correctTaken": 845,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25476235",
                    "mediaDataId": 0,
                    "title": "Squamous cell carcinoma of the vagina:  natural history, treatment modalities and prognostic factors.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25476235",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20658716",
                    "mediaDataId": 0,
                    "title": "Primary carcinoma of the vagina.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20658716",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 16664,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1,
            "dailyTimeSpentReview": 1,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 17592,
            "questionIndex": 19051,
            "questionText": "<p>A 42-year-old woman comes to the emergency department for severe lower abdominal pain.&nbsp; The pain started several hours ago and has progressively worsened.&nbsp; She has associated nausea and vomiting but no fever, diarrhea, or abnormal vaginal discharge.&nbsp; The patient was diagnosed with adenomyosis last month due to increasingly heavy menses and dysmenorrhea and is currently taking tranexamic acid as needed.&nbsp; Her menses started yesterday, but she reports that the pain is more severe than usual and radiates to the left lower quadrant.&nbsp; Temperature is 37.8 C (100 F), blood pressure is 110/74 mm Hg, and pulse is 110/min.&nbsp; The abdomen is soft with normoactive bowel sounds, and there is voluntary guarding in the left lower quadrant.&nbsp; On pelvic examination, the uterus is globular and boggy, and there is dark red blood with small clots in the vagina.&nbsp; The left adnexa is tender on bimanual examination, and there are no palpable adnexal masses.&nbsp; Urine pregnancy testing is negative.&nbsp; Hemoglobin is 11 g/dL.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"5096\" src=\"https://www.uworld.com/media/L29661.jpg\" ></p><p>This patient has <a href=\"1210\">adenomyosis</a>, a common cause of pelvic pain in women age &gt;40 that typically presents with heavy menstrual bleeding and a tender, globular uterus (as seen in this patient).&nbsp; However, adenomyosis typically causes chronic, dull, midline pelvic pain; therefore, this patient&#39;s sudden change in pain severity and acute onset of symptoms are concerning for another acute gynecologic condition.</p><p>This patient&#39;s <strong>sudden-onset unilateral pelvic pain</strong> accompanied by nausea/vomiting is most likely due to <strong>ovarian torsion</strong>, which represents partial or complete rotation of the ovary around the infundibulopelvic (IP) ligament.&nbsp; The IP ligament contains the ovarian vessels; rotation acutely interrupts ovarian blood flow, causing acute-onset pain.&nbsp; As ovarian ischemia progresses, patients may develop radiating pain, ovarian edema (eg, <strong>adnexal tenderness</strong> or fullness, with or without a palpable mass), and peritonitis (eg, rebound/guarding, fever).</p><p>Ovarian torsion is a <strong>gynecologic emergency</strong> that is <strong>clinically diagnosed</strong> in patients with classic symptoms.&nbsp; Although a Doppler ultrasound revealing decreased or absent ovarian blood flow can support the diagnosis, normal findings do not exclude torsion.&nbsp; Because of the risk of tissue necrosis and loss of ovarian function (eg, infertility, menopause), ovarian torsion requires urgent <strong>diagnostic laparoscopy</strong> to manually untwist the adnexa and restore blood flow.</p><p><strong>(Choices A and F)</strong>&nbsp; Tranexamic acid (an antifibrinolytic agent) and oral contraceptives can be used to decrease heavy menstrual bleeding due to adenomyosis.&nbsp; This patient&#39;s new pain symptoms are inconsistent with adenomyosis and require additional evaluation.&nbsp; In addition, discontinuation of tranexamic acid may increase this patient&#39;s menstrual bleeding.</p><p><strong>(Choice B)</strong>&nbsp; Conservative management (eg, observation with serial abdominal examinations) is appropriate for patients with self-limiting, nonurgent causes of pelvic pain (eg, ruptured simple ovarian cyst).&nbsp; This patient has severe pain and guarding consistent with an acute abdomen and requires immediate surgery.</p><p><strong>(Choices D and E)</strong>&nbsp; Endometrial ablation (ie, cauterization of the uterine lining) and uterine artery embolization can be used to treat heavy vaginal bleeding.&nbsp; This patient&#39;s bleeding is normal (dark red blood with small clots), and her hemoglobin is appropriate; therefore, these procedures are not indicated at this time.</p><p><strong>Educational objective:</strong><br>Ovarian torsion, or rotation of the ovary around the infundibulopelvic ligament, classically presents with nausea/vomiting; new-onset, severe unilateral pelvic pain; and adnexal tenderness.&nbsp; Ovarian torsion is a gynecologic emergency and requires diagnostic laparoscopy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 20413,
            "topic": "Ovarian Torsion",
            "titleId": 20413,
            "title": "Ovarian Torsion",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Discontinue tranexamic acid",
                    "choiceNumber": 1,
                    "correctTaken": 746,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observation and serial abdominal examinations",
                    "choiceNumber": 2,
                    "correctTaken": 529,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform diagnostic laparoscopy",
                    "choiceNumber": 3,
                    "correctTaken": 2574,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform endometrial ablation",
                    "choiceNumber": 4,
                    "correctTaken": 279,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform uterine artery embolization",
                    "choiceNumber": 5,
                    "correctTaken": 286,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe oral contraceptives",
                    "choiceNumber": 6,
                    "correctTaken": 557,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "62",
                    "mediaDataId": 0,
                    "title": "Ovarian torsion",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31354994",
                    "mediaDataId": 0,
                    "title": "Accuracy of pelvic ultrasound in diagnosing adnexal torsion.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31354994",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29941434",
                    "mediaDataId": 0,
                    "title": "Adnexal torsion.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29941434",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 120,
            "notes": null,
            "peopleTaken": 5055,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 4758,
            "questionIndex": 4758,
            "questionText": "<p>A 27-year-old woman, gravida 2 para 1, at 28 weeks gestation comes to the office for follow-up of an abnormal Pap test.&nbsp; She feels fetal movement, has no vaginal bleeding or contractions, and has had an uneventful pregnancy to date.&nbsp; The patient&#39;s previous pregnancy 5 years ago was uncomplicated.&nbsp; She has never had an abnormal Pap test until now.&nbsp; The last cervical cancer screening was during her prior pregnancy.&nbsp; The patient has no medical conditions and has had no surgeries.&nbsp; She takes a multivitamin and an iron supplement.&nbsp; She does not use tobacco, alcohol, or recreational drugs.&nbsp; Blood pressure is 120/74 mm Hg and pulse is 82/min.&nbsp; Fetal heart tones are normal.&nbsp; Physical examination shows a gravid, nontender uterus.&nbsp; The cervix is long, closed, firm, and posterior, and the fetal presenting part is high. The Pap test showed a high-grade squamous intraepithelial lesion.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"5031\" src=\"https://www.uworld.com/media/highresdefault/L29819.jpg\"  ></p><p>A Pap test is a screening examination for precancerous lesions of the uterine cervix.&nbsp; <strong>High-grade squamous intraepithelial lesions (HSILs)</strong> on Pap testing are concerning for underlying, severe neoplasia (eg, cervical intraepithelial neoplasia grades 2 and 3) or invasive cervical cancer.&nbsp; Pregnant patients with HSILs require evaluation with <strong>immediate colposcopy</strong> to exclude the presence of invasive cervical cancer.</p><p>Colposcopy evaluates the cervix and vagina under magnification after the application of acetic acid to contrast and distinguish abnormal (eg, acetowhite changes) from normal cells; abnormal vessels (a sign of HSILs) also become more visible.&nbsp; Cervical neoplasia typically occurs at the transformation zone or squamocolumnar junction.&nbsp; If these areas are not visualized during colposcopy (eg, an &#x22;inadequate&#x22; colposcopy), endocervical curettage is performed to evaluate the endocervical canal.</p><p>Colposcopy is <strong>safe in pregnancy</strong> and is <strong>not associated with adverse pregnancy outcomes</strong>; however, endocervical curettage is an invasive procedure and is deferred during pregnancy due to the risk of miscarriage and preterm delivery.&nbsp; Cervical biopsy is performed even in pregnancy if a lesion has high-grade features (eg, abnormal vessels) because the histopathologic diagnosis <strong>guides the timing of further management</strong> (ie, postpartum excisional procedures or early delivery).</p><p><strong>(Choice A)</strong>&nbsp; Human papillomavirus (HPV) cotesting is used to triage atypical squamous cells of undetermined significance and low-grade intraepithelial lesions; further evaluation with colposcopy is indicated if high-risk HPV is present.&nbsp; HSILs on Pap test require colposcopy regardless of HPV status.</p><p><strong>(Choice C)</strong>&nbsp; In nonpregnant patients, HSILs on Pap test can be treated with an immediate excisional procedure, such as a loop electrosurgical excision procedure, rather than a colposcopy.&nbsp; However, pregnant patients first undergo colposcopy and then cervical excision only if evidence of invasive cancer is found.&nbsp; Immediate surgical excision based on Pap testing alone is contraindicated in pregnancy due to the risk for preterm delivery.&nbsp; If colposcopic biopsy results are concerning for invasive cancer, an excisional procedure may be warranted.</p><p><strong>(Choice D)</strong>&nbsp; Repeat Pap testing postpartum is not appropriate; colposcopic tissue biopsy is required to evaluate for possible invasive cancer.</p><p><strong>(Choice E)</strong>&nbsp; Trichloroacetic acid therapy can be used to treat vulvar or vaginal warts (condylomata acuminata) caused by low-risk HPV types 6 and 11.</p><p><strong>Educational objective:</strong><br>A high-grade squamous intraepithelial lesion on Pap test in pregnancy requires colposcopic examination and biopsy of cervical abnormalities due to the high risk for progression to cervical cancer.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3372,
            "topic": "Cervical cancer",
            "titleId": 3372,
            "title": "Cervical cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Human papillomavirus cotesting",
                    "choiceNumber": 1,
                    "correctTaken": 883,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Immediate colposcopy",
                    "choiceNumber": 2,
                    "correctTaken": 2665,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Loop electrosurgical excision procedure",
                    "choiceNumber": 3,
                    "correctTaken": 562,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat Pap test postpartum",
                    "choiceNumber": 4,
                    "correctTaken": 803,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trichloroacetic acid therapy",
                    "choiceNumber": 5,
                    "correctTaken": 132,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "615",
                    "mediaDataId": 0,
                    "title": "Cervical dysplasia and cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "37915464",
                    "mediaDataId": 0,
                    "title": "Screening for cervical cancer in pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/37915464",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32243307",
                    "mediaDataId": 0,
                    "title": "2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32243307",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 5045,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1,
            "dailyTimeSpentReview": 1,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 11038,
            "questionIndex": 12178,
            "questionText": "<p>A 26-year-old nulligravid woman comes to the office to discuss treatment of cervical intraepithelial neoplasia grade 3 (CIN 3), which was revealed on a Pap test 4 weeks ago and confirmed by colposcopic biopsies.&nbsp; The patient has one dose remaining of catch-up human papillomavirus vaccination.&nbsp; She has smoked a pack of cigarettes daily for 10 years and does not use alcohol or recreational drugs.&nbsp; The patient recently married and is planning to have children in the next few years.&nbsp; She receives progesterone injections for contraception and takes no other medications.&nbsp; The risks and benefits of treatment options for CIN 3 are discussed.&nbsp; Which of the following is the most likely complication of treatment for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T81608\" style=\"overflow-x:auto;\" tid=\"5280\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Cervical excisional procedures</strong></p></td></tr><tr><td><p align=\"center\"><strong>Indications</strong></p></td><td><p>Cervical intraepithelial neoplasia grades 2 &amp; 3*</p></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Cervical stenosis</li><li>Preterm birth</li><li>Preterm prelabor rupture of membranes</li><li>Second-trimester pregnancy loss</li></ul></td></tr><tr><td colspan=\"2\"><p>*Observation preferred for cervical intraepithelial neoplasia 2 in young women.</p></td></tr></tbody></table></div><p>Human papillomavirus infection and tobacco use are important risk factors for <strong>cervical intraepithelial neoplasia (CIN)</strong> and squamous cell carcinoma (SCC).&nbsp; <a href=\"5031\">Colposcopy</a> with biopsies is the gold standard for diagnosing CIN.&nbsp; CIN 3 is a premalignant cervical lesion at high risk for progressing to SCC, and a <strong>cervical excisional procedure</strong> (ie, removal of the entire transformation zone) is the recommended treatment.&nbsp; Cervical excision procedures include <a href=\"5016\">cold knife conization</a>, in which a cone-shaped specimen is excised (most often with a scalpel), and a loop electrosurgical excision procedure (<a href=\"5281\">LEEP</a>), in which electrocautery is used for specimen removal.</p><p><strong>Cervical stenosis</strong>, an abnormal stricture of the cervical canal, is a potential complication of any cervical excisional procedure due to scar tissue.&nbsp; Cervical stenosis may impede menstrual blood flow and cause secondary dysmenorrhea or amenorrhea.&nbsp; Obstruction of the cervical outlet may prevent sperm entry, resulting in impaired fertility.</p><p>Cervical excisional procedures carry additional risks, including <strong>cervical insufficiency</strong> and <strong>preterm delivery</strong> due to weakened cervical stroma.&nbsp; These risks are related directly to the amount of cervical tissue removed.</p><p><strong>(Choice A)</strong>&nbsp; Asherman syndrome refers to the formation of intrauterine adhesions from infection (eg, severe endometritis) or intrauterine surgical interventions (eg, dilation and curettage, endometrial ablation, endometrial resection).&nbsp; It is not a complication of cervical excisional procedures because the procedure does not involve the endometrium.</p><p><strong>(Choice C)</strong>&nbsp; Cervical surgery is not associated with sexual dysfunction.&nbsp; However, episiotomy and/or obstetric vaginal lacerations may result in dyspareunia.</p><p><strong>(Choice D)</strong>&nbsp; Thromboembolism may result from immobility following major surgical interventions.&nbsp; However, brief ambulatory procedures, such as cervical conization, do not limit mobility.</p><p><strong>(Choice E)</strong>&nbsp; Urinary tract injury (eg, ureteral ligation/transection, cystotomy) may result from pelvic (hysterectomy) or vaginal surgery but not a LEEP.</p><p><strong>(Choice F)</strong>&nbsp; <a href=\"4908\">Urogenital fistula</a> may result from obstetric trauma, urogenital malignancy, pelvic irradiation, or pelvic surgery (eg, hysterectomy), not from local cervical procedures.</p><p><strong>Educational objective:</strong><br>Cervical conization is used to treat high-grade cervical intraepithelial neoplasias.&nbsp; Potential complications include cervical stenosis, cervical insufficiency, and preterm delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3372,
            "topic": "Cervical cancer",
            "titleId": 3372,
            "title": "Cervical cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Asherman syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 486,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cervical stenosis",
                    "choiceNumber": 2,
                    "correctTaken": 4105,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sexual dysfunction",
                    "choiceNumber": 3,
                    "correctTaken": 162,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thromboembolism",
                    "choiceNumber": 4,
                    "correctTaken": 101,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urinary tract injury",
                    "choiceNumber": 5,
                    "correctTaken": 156,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urogenital fistula",
                    "choiceNumber": 6,
                    "correctTaken": 114,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22851827",
                    "mediaDataId": 0,
                    "title": "LEEP verses cryotherapy in CIN.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22851827",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26643302",
                    "mediaDataId": 0,
                    "title": "Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26643302",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 5124,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 80,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 10855,
            "questionIndex": 11987,
            "questionText": "<p>A 41-year-old woman comes to the office for evaluation of urinary incontinence.&nbsp; The patient has had intermittent leaking of urine for the past 2 years and now feels like she never empties her bladder completely.&nbsp; She voids every 1-2 hours and still finds her undergarments wet with urine.&nbsp; The patient has no dysuria, constipation, or pelvic pain.&nbsp; Her menses are every 26 days and last 6 days, with heavy bleeding and passage of clots on the first 2 days.&nbsp; She had 3 term vaginal deliveries in her 30s and has had a new sexual partner for the last 6 months.&nbsp; The patient drinks 2 cups of coffee daily and takes a thiazide diuretic for well-controlled chronic hypertension.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Physical examination reveals an enlarged, anteverted, and anteflexed uterus with multiple irregular protrusions.&nbsp; The remainder of the pelvic examination is normal.&nbsp; Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34097\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Differential diagnosis of urinary incontinence </strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Etiology </strong></p></td><td><p align=\"center\"><strong>Symptoms </strong></p></td></tr><tr><td><p align=\"center\"><strong>Stress </strong></p></td><td><ul><li>&darr; Urethral sphincter tone</li><li>Urethral hypermobility</li></ul></td><td><ul><li>Leakage with coughing, sneezing, lifting</li></ul></td></tr><tr><td><p align=\"center\"><strong>Urge </strong></p></td><td><ul><li>Detrusor overactivity</li></ul></td><td><ul><li>Sudden, overwhelming urge to urinate</li></ul></td></tr><tr><td><p align=\"center\"><strong>Overflow </strong></p></td><td><ul><li>Impaired detrusor contractility</li><li>Bladder outlet obstruction</li></ul></td><td><ul><li>Incomplete emptying &amp; persistent involuntary dribbling</li></ul></td></tr></tbody></table></div><p>This patient with <strong>involuntary urine dribbling</strong> (eg, undergarments constantly wet) and <strong>incomplete bladder emptying</strong> despite increased urinary frequency (eg, every 1-2 hours) has <strong>overflow incontinence</strong>.&nbsp; <a href=\"21567\">Overflow incontinence</a> occurs when urine accumulates in the bladder, distends the bladder, and raises the intravesicular pressure higher than the urethral closing pressure, leading to urine leakage.</p><p>Common causes of overflow incontinence are detrusor underactivity (often secondary to peripheral neuropathy [eg, diabetes mellitus]) and <strong>bladder outlet obstruction</strong>.&nbsp; In this patient with a history of heavy menstrual bleeding and an enlarged uterus with multiple irregular protrusions, the most likely cause of overflow incontinence is bladder outlet obstruction due to <strong>uterine fibroids</strong> (<a href=\"4394\">leiomyomata uteri</a>).</p><p>Large fibroids can have a direct mass effect on adjacent pelvic organs and alter the position of the uterus.&nbsp; Because the bladder is anterior to the uterus, an anterior uterine fibroid or fibroids causing <a href=\"49870\">uterine anteversion and anteflexion</a> (as in this patient) can <strong>compress the bladder neck and/or urethra</strong>, increasing the urethral closing pressure and leading to urinary retention and overflow incontinence.&nbsp; Diagnosis is with pelvic ultrasound, and definitive treatment of bladder outlet obstruction in these patients is with fibroid reduction (eg, GnRH agonist, surgery).</p><p><strong>(Choice A)</strong>&nbsp; Bacterial overgrowth in the bladder can lead to cystitis, which can present with urinary frequency, incontinence, and retention (bladder outlet obstruction due to urethral inflammation/edema).&nbsp; However, these symptoms are typically acute rather than chronic, and dysuria is usually present.</p><p><strong>(Choices C and E)</strong>&nbsp; Decreased urethral sphincter tone (ie, intrinsic sphincter deficiency) and insufficient urethral support (ie, urethral hypermobility) are causes of <a href=\"21571\">stress urinary incontinence</a> (SUI), the involuntary leakage of urine with increased intraabdominal pressure (eg, coughing, Valsalva).&nbsp; Unlike overflow incontinence, SUI is not associated with constant urine dribbling or incomplete bladder emptying.</p><p><strong>(Choice D)</strong>&nbsp; Increased detrusor muscle contractility is characteristic of <a href=\"21566\">urgency incontinence</a> (or overactive bladder syndrome).&nbsp; Urgency incontinence can cause urinary frequency and a feeling of incomplete bladder emptying, but patients classically have a sudden, overwhelming urge to void followed by the immediate, involuntary loss of urine.</p><p><strong>Educational objective:</strong><br>Bladder outlet obstruction in women can result from large fibroids compressing the bladder neck and/or urethra.&nbsp; Patients can develop urinary retention and overflow incontinence (eg, persistent urine dribbling, incomplete bladder emptying).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3143,
            "topic": "Uterine fibroids",
            "titleId": 3143,
            "title": "Uterine fibroids",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bacterial overgrowth in the bladder",
                    "choiceNumber": 1,
                    "correctTaken": 100,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bladder outlet obstruction",
                    "choiceNumber": 2,
                    "correctTaken": 10408,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased urethral sphincter tone",
                    "choiceNumber": 3,
                    "correctTaken": 1845,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased detrusor muscle contractility",
                    "choiceNumber": 4,
                    "correctTaken": 1605,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insufficient urethral support",
                    "choiceNumber": 5,
                    "correctTaken": 2568,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "47",
                    "mediaDataId": 0,
                    "title": "Uterine fibroids",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "68",
                    "mediaDataId": 0,
                    "title": "Urinary incontinence",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18936006",
                    "mediaDataId": 0,
                    "title": "Female acute urinary retention caused by anterior deflection of the cervix which was augmented by an uterine myoma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18936006",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19333612",
                    "mediaDataId": 0,
                    "title": "Acute urinary retention caused by a large impacted leiomyoma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19333612",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25752469",
                    "mediaDataId": 0,
                    "title": "Urinary retention and uterine leiomyomas: a case series and systematic review of the literature.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25752469",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 16526,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 13389,
            "questionIndex": 14768,
            "questionText": "<p>A 45-year-old woman comes to the office for an annual well-woman visit.&nbsp; She feels well and has no concerns.&nbsp; The patient takes combined estrogen/progestin oral contraceptive pills and has regular monthly menses.&nbsp; She has no chronic medical conditions and has had no prior surgeries.&nbsp; The patient had 2 term vaginal deliveries in her 30s, and she has no history of abnormal Pap tests.&nbsp; The patient does not use tobacco, alcohol, or recreational drugs.&nbsp; Her last menstrual period started 2 days ago.&nbsp; Blood pressure is 110/60 mm Hg and pulse is 70/min.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Pelvic examination shows a multiparous cervix without lesions.&nbsp; Pathology from a Pap test demonstrates benign-appearing endometrial cells and no intraepithelial lesions.&nbsp; Which of the following is the best next step in management of this patient&#39;s Pap test results?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T38651\" style=\"overflow-x:auto;\" tid=\"8257\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Pap smear results requiring endometrial evaluation</strong></p></td></tr><tr><td><p align=\"center\"><strong>Result</strong></p></td><td><p align=\"center\"><strong>Group requiring endometrial sampling</strong></p></td></tr><tr><td><p align=\"center\">Benign-appearing<br>endometrial cells</p></td><td><ul><li>Premenopausal women with:<ul style=\"list-style-type:circle;\"><li>Abnormal uterine bleeding <strong>OR</strong></li><li>Risk for endometrial hyperplasia</li></ul></li><li>Postmenopausal women</li></ul></td></tr><tr><td><p align=\"center\">Atypical glandular cells</p></td><td><ul><li>Women age &#8805;35 <strong>OR</strong> at risk for endometrial hyperplasia</li></ul></td></tr><tr><td><p align=\"center\">Atypical glandular cells,<br>favor neoplastic</p></td><td><ul><li>All women</li></ul></td></tr></tbody></table></div><p>This patient has <strong>benign-appearing endometrial cells</strong> on <strong>Pap testing</strong>.&nbsp; Pap test reporting varies by age:</p><ul><li><p>In women <strong>age &lt;45</strong>, endometrial cells <strong>are not reported</strong> on Pap test results because this is a common, <strong>benign finding</strong>, particularly during the first 10 days of the <strong>menstrual cycle</strong>, as in this patient.</p></li><li><p>In women <strong>age &#8805;45</strong>, endometrial cells <strong>are reported</strong> because this finding is <strong>more concerning</strong> for <strong>endometrial hyperplasia</strong> or <strong>cancer</strong>, particularly in patients who are postmenopausal, symptomatic (eg, abnormal uterine bleeding), or at high risk (eg, unopposed estrogen from obesity, chronic anovulation).</p></li></ul><p>Although this patient is age 45, she is <strong>premenopausal</strong> and <strong>asymptomatic</strong> (eg, no abnormal uterine bleeding), and has <strong>no risk factors</strong> (eg, normal BMI).&nbsp; In addition, she is taking a combined estrogen/progestin oral contraceptive pill, which decreases the risk for endometrial hyperplasia and cancer.&nbsp; Therefore, she requires no additional evaluation (eg, endometrial biopsy) and can continue <strong>routine Pap</strong> testing.&nbsp; In contrast to benign-appearing endometrial cells, atypical glandular cells (derived from either the endocervix or endometrium) carry a significant risk for an underlying malignancy and would require management with endometrial sampling <strong>(Choice C)</strong>.</p><p><strong>(Choices A and B)</strong>&nbsp; <a href=\"4803\">Cervical conization</a> and <a href=\"5031\">colposcopy</a> are used to evaluate for cervical cancer in patients with either cervical intraepithelial lesions on Pap testing or gross abnormalities (eg, fungating lesion) of the cervix, which are not seen in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Pelvic ultrasonography can be performed in patients with postmenopausal bleeding to assess the risk for endometrial cancer (ie, as an alternative to endometrial biopsy).&nbsp; However, ultrasonography is not used to assess the risk of cancer in asymptomatic or premenopausal patients, such as this one.</p><p><strong>Educational objective:</strong><br>Endometrial cells on Pap testing are a normal finding in premenopausal women, particularly within the first 10 days of the menstrual cycle.&nbsp; These patients can continue routine Pap testing and do not require additional evaluation (eg, endometrial biopsy) unless they are symptomatic (ie, abnormal uterine bleeding) or at high risk for endometrial hyperplasia and cancer (eg, obesity).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3399,
            "topic": "Endometrial cancer",
            "titleId": 3399,
            "title": "Endometrial cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cervical conization",
                    "choiceNumber": 1,
                    "correctTaken": 38,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Colposcopy",
                    "choiceNumber": 2,
                    "correctTaken": 270,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 3,
                    "correctTaken": 749,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional management indicated",
                    "choiceNumber": 4,
                    "correctTaken": 3900,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic ultrasonography",
                    "choiceNumber": 5,
                    "correctTaken": 151,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "49",
                    "mediaDataId": 0,
                    "title": "Endometrial cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32243307",
                    "mediaDataId": 0,
                    "title": "2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32243307",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28486237",
                    "mediaDataId": 0,
                    "title": "Evaluating the age cutoff criterion for reporting benign-appearing endometrial cells in routine Pap tests: an 8-year retrospective review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28486237",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 5108,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 3367,
            "questionIndex": 3367,
            "questionText": "<p>A 32-year-old woman comes to the office due to difficulty conceiving despite frequent, unprotected intercourse with her husband over the past 3 years.&nbsp; She has had multiple sexual partners in the past and has never become pregnant despite inconsistent condom use.&nbsp; Menses started at age 12 and are irregular.&nbsp; The patient has had recurrent vaginal candidiasis for which she uses an over-the-counter vaginal suppository.&nbsp; Vital signs are normal.&nbsp; The thyroid is not enlarged.&nbsp; She has thick, dark, velvety plaques under her axillae.&nbsp; Breast examination is normal.&nbsp; Abdominal examination shows no masses.&nbsp; Pelvic examination shows normal external genitalia; a small, mobile uterus with no cervical motion tenderness; and bilaterally enlarged ovaries.&nbsp; TSH, LH, and prolactin levels are normal.&nbsp; Which of the following is the most appropriate therapy for this patient&#39;s infertility?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33552\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Polycystic ovary syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li><strong>Androgen excess</strong> (eg,&nbsp;acne, male pattern baldness, hirsutism)</li><li>Oligoovulation or anovulation (eg,&nbsp;<strong>menstrual irregularities</strong>)</li><li>Obesity</li><li><strong>Polycystic ovaries</strong> on ultrasonography</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>&uarr;&nbsp;Testosterone levels</li><li>&uarr;&nbsp;Estrogen levels</li><li>LH/FSH imbalance</li></ul></td></tr><tr><td><p align=\"center\"><strong>Comorbidities</strong></p></td><td><ul><li>Metabolic syndrome (eg,&nbsp;diabetes mellitus, hypertension)</li><li>Obstructive sleep apnea</li><li>Metabolic dysfunction&ndash;associated steatohepatitis</li><li>Endometrial hyperplasia/cancer</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment<br />options</strong></p></td><td><ul><li>Weight loss (first line)</li><li>Oral contraceptive pills for menstrual regulation</li><li>Letrozole for ovulation induction</li></ul></td></tr></tbody></table></div><p>This patient has menstrual irregularities (suggesting anovulation), <strong>infertility</strong>, and <strong>enlarged ovaries</strong>.&nbsp; In addition, the presence of acanthosis nigricans (eg, dark, velvety patches under the axillae)&nbsp;indicates insulin resistance.&nbsp; These are clinical manifestations of <strong>polycystic ovary syndrome</strong> (PCOS).&nbsp; Although patients with PCOS can have elevated serum testosterone or LH levels, serum concentrations can also be normal with symptoms due to a relative imbalance in hormone levels (ie, elevated LH/FSH ratio) rather than absolute values.</p><p>Most patients with PCOS have&nbsp;<strong>obesity</strong> and persistently high estrogen levels due to the peripheral conversion of androgens to estrogens in <a href=\"5388\">adipose tissue</a>.&nbsp; These high estrogen levels suppress the hypothalamic-pituitary-ovarian axis by creating constant negative feedback.&nbsp; Therefore, <strong>weight loss</strong> is the first-line treatment to reestablish ovulation by decreasing peripheral estrogen conversion.</p><p>If weight loss is unsuccessful, <a href=\"66556\">ovulation can be induced</a> with <strong>letrozole</strong>, an aromatase inhibitor that inhibits the conversion of androgens to estrogens.&nbsp; The resultant decreased estrogen levels cause a positive feedback mechanism to the pituitary gland, thereby normalizing LH and FSH levels and creating an LH surge that results in ovulation.&nbsp; <a href=\"44313\">Letrozole</a> is the first-line ovulation induction agent in patients with PCOS due to higher live birth rates compared with <a href=\"44319\">clomiphene citrate</a>.</p><p><strong>(Choice A)</strong>&nbsp; Dopamine agonists (eg, bromocriptine) are used to treat hyperprolactinemia, a condition that can cause anovulation and irregular menses; however, prolactin levels are normal in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Estrogen induces endometrial proliferation and progesterone stabilizes the endometrium and promotes shedding.&nbsp; Anovulatory patients with PCOS have excess estrogen but lack cyclic progesterone; therefore, they can develop an unstable endometrium (eg, abnormal uterine bleeding) and endometrial hyperplasia/cancer.&nbsp; Cyclic progesterone can be administered to treat abnormal uterine bleeding and prevent hyperplasia, but progesterone does not facilitate ovulation.&nbsp; Estrogen, LH, and FSH levels must be normalized to restore ovulation and fertility.</p><p><strong>(Choice C)</strong>&nbsp; Laparoscopic fulguration (tissue destruction using electrocautery) of lesions improves fertility in patients with endometriosis, a condition characterized by regular, painful menses (ie, dysmenorrhea) or chronic pelvic pain, which are not present in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Levothyroxine is used to treat hypothyroidism, which can cause menstrual irregularities.&nbsp; This diagnosis is unlikely in this patient with a normal TSH level.</p><p><strong>Educational objective:</strong><br>Polycystic ovary syndrome (PCOS) causes infertility due to anovulation and may present with irregular menses, enlarged ovaries, and signs of insulin resistance.&nbsp; Ovulation can be induced with letrozole (an aromatase inhibitor) in patients with PCOS.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 8274,
            "topic": "Polycystic ovary disease",
            "titleId": 8274,
            "title": "Polycystic ovary disease",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bromocriptine",
                    "choiceNumber": 1,
                    "correctTaken": 908,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cyclic progesterone",
                    "choiceNumber": 2,
                    "correctTaken": 6852,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Laparoscopic fulguration of lesions",
                    "choiceNumber": 3,
                    "correctTaken": 703,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Letrozole",
                    "choiceNumber": 4,
                    "correctTaken": 8241,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Levothyroxine",
                    "choiceNumber": 5,
                    "correctTaken": 70,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "60",
                    "mediaDataId": 0,
                    "title": "Polycystic ovary syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25006718",
                    "mediaDataId": 0,
                    "title": "Letrozole versus clomiphene for infertility in the polycystic ovary syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25006718",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27423183",
                    "mediaDataId": 0,
                    "title": "Genetic, hormonal and metabolic aspects of PCOS: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27423183",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29797697",
                    "mediaDataId": 0,
                    "title": "Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29797697",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16774,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 49,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 11178,
            "questionIndex": 12328,
            "questionText": "<p>A 42-year-old woman comes to the office for a routine health examination.&nbsp; She is sexually active with a male partner and underwent tubal ligation for contraception.&nbsp; The patient has had no abnormal bleeding or recent changes in weight.&nbsp; Menses are regular and last 3-5 days; her last menstrual period was 3 weeks ago.&nbsp; Ten years ago, the patient had genital warts successfully treated by laser ablation.&nbsp; Pap tests have been normal to date.&nbsp; She has had no other serious medical illnesses or surgeries and takes no medications.&nbsp; She has a family history of hypertension but no history of cancer.&nbsp; Pelvic examination shows a normal cervix with no visible lesions, a small anteverted uterus, and no adnexal masses.&nbsp; Pap test demonstrates atypical glandular cells.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T108249\" style=\"overflow-x:auto;\" tid=\"77788\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Evaluation of atypical glandular cells on Pap test</strong></p></td></tr><tr><td><p align=\"center\"><strong>Age &#8805;35</strong></p></td><td><ul><li>Colposcopy</li><li>Endocervical curettage*</li><li>Endometrial biopsy*</li></ul></td></tr><tr><td><p align=\"center\"><strong>Age &lt;35 with<br>risk factors**</strong></p></td><td><ul><li>Colposcopy</li><li>Endocervical curettage*</li><li>Endometrial biopsy*</li></ul></td></tr><tr><td><p align=\"center\"><strong>Age &lt;35 without<br>risk factors</strong></p></td><td><ul><li>Colposcopy</li><li>Endocervical curettage*</li></ul></td></tr><tr><td colspan=\"2\"><p>*Nonpregnant.</p><p>**Risk factors: abnormal uterine bleeding, anovulation, obesity.</p></td></tr></tbody></table></div><p><strong>Atypical glandular cells (AGCs)</strong> on Pap testing are significant markers for an underlying neoplasm and may be due to either <strong>cervical</strong> or <strong>endometrial adenocarcinoma</strong>.&nbsp; Evaluation of AGCs is dependent on age and patient history (eg, risk factors).&nbsp; Women <strong>age &#8805;35</strong> with AGCs or women age &lt;35 with AGCs and risk factors for endometrial cancer (eg, obesity, anovulation) require endometrial evaluation in addition to cervical evaluation (ie, colposcopy to rule out ectocervix as the origin of AGCs).&nbsp; It is imperative to discover the origin of the AGCs because it directs further management.&nbsp; If the atypical cells originate within the endocervix, a cervical excisional procedure (eg, cold knife conization) is indicated.&nbsp; However, if the atypical cells originate within the endometrium, a hysterectomy is indicated.</p><p>Therefore, AGCs on Pap testing in this 42-year-old require investigation with <a href=\"5031\">colposcopy</a>, endocervical curettage, and <strong>endometrial biopsy</strong> to evaluate the ectocervix, endocervix, and endometrium.&nbsp; A return to routine Pap screening is not indicated <strong>(Choice E)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Hysterectomy is a treatment option for endometrial or early cervical adenocarcinoma; it is not performed for diagnosis.</p><p><strong>(Choice C)</strong>&nbsp; Hysteroscopy is a procedure that evaluates and treats endometrial or myometrial pathology (eg, endometrial polyps, submucosal leiomyoma).&nbsp; It is more invasive than an endometrial biopsy and is not a first-line choice for evaluation of the endometrium.</p><p><strong>(Choice D)</strong>&nbsp; A <a href=\"5281\">loop electrosurgical excision procedure (LEEP)</a> is a type of cone biopsy that removes the cervical transformation zone.&nbsp; A LEEP does not evaluate the endometrium and is not used in the diagnosis of AGC on Pap test.</p><p><strong>(Choice F)</strong>&nbsp; Serum cancer antigen 125 is used to determine the likelihood of epithelial ovarian cancer in patients with an adnexal mass with malignant features.&nbsp; Ovarian cancer is not typically detected on Pap testing and is unlikely in a patient without a family history or examination findings suggestive of ovarian malignancy (eg, ascites, adnexal mass).</p><p><strong>Educational objective:</strong><br>Atypical glandular cells (AGCs) on a Pap test may be due to either cervical or endometrial adenocarcinoma.&nbsp; Evaluation of AGCs requires colposcopy, endocervical curettage, and endometrial biopsy in women age &#8805;35.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3372,
            "topic": "Cervical cancer",
            "titleId": 3372,
            "title": "Cervical cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 1,
                    "correctTaken": 2355,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hysterectomy",
                    "choiceNumber": 2,
                    "correctTaken": 56,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hysteroscopy",
                    "choiceNumber": 3,
                    "correctTaken": 440,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Loop electrosurgical excision procedure",
                    "choiceNumber": 4,
                    "correctTaken": 1282,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Return to routine Pap screening",
                    "choiceNumber": 5,
                    "correctTaken": 836,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum cancer antigen 125",
                    "choiceNumber": 6,
                    "correctTaken": 63,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "49",
                    "mediaDataId": 0,
                    "title": "Endometrial cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "615",
                    "mediaDataId": 0,
                    "title": "Cervical dysplasia and cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27198186",
                    "mediaDataId": 0,
                    "title": "Biology and treatment of cervical adenocarcinoma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27198186",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 5032,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 14835,
            "questionIndex": 16258,
            "questionText": "<p>A 58-year-old woman comes to the office for her annual examination.&nbsp; The patient is feeling well.&nbsp; She reports 3 days of light vaginal spotting 2 months ago but has had no other episodes.&nbsp; The patient previously had not had a menstrual period for over a year.&nbsp; Her medical history includes symptomatic uterine fibroids, which were controlled with oral contraceptive pills until her early 50s.&nbsp; She has no other chronic medical conditions, and her only surgeries were 2 cesarean deliveries.&nbsp; The patient is current on her cervical cancer screening and has had no abnormal tests.&nbsp; Vital signs are normal, and BMI is 31 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; On speculum examination, there is no blood at the cervical os, and the cervix has no masses or areas of friability.&nbsp; The vagina appears pale and has minimal rugation.&nbsp; On bimanual examination, the uterus has multiple nontender masses consistent with fibroids.&nbsp; There are no areas of nodularity or palpable adnexal masses.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"5477\" src=\"https://www.uworld.com/media/L16430.jpg\" ></p><p>Uterine fibroids are a common cause of abnormal uterine bleeding in premenopausal women, typically causing heavy, prolonged menses.&nbsp; This patient&#39;s vaginal spotting occurring more than a year after her last menstrual period (ie, <strong>postmenopausal bleeding [PMB]</strong>) is not likely due to her fibroids, which typically decrease in size and become asymptomatic after menopause <strong>(Choice E)</strong>.&nbsp; Because PMB is a common presenting finding for <strong>endometrial hyperplasia or cancer</strong> (particularly in older women with obesity), all patients with PMB require endometrial evaluation.</p><p>Endometrial evaluation for PMB is with either transvaginal ultrasound or <strong>endometrial biopsy</strong>.&nbsp; Endometrial biopsy can supply a histologic diagnosis, but it is an invasive and uncomfortable procedure.&nbsp; Therefore, PMB can also be evaluated initially with transvaginal ultrasound.&nbsp; Patients with an endometrial thickness &#8804;4 mm on ultrasound have a low likelihood of endometrial cancer and require no additional evaluation.&nbsp; In contrast, patients with an endometrial thickness &gt;4 mm require an endometrial biopsy to assess for endometrial hyperplasia or cancer.</p><p>Patients with endometrial hyperplasia may be managed medically (eg, progestin) or surgically (eg, hysterectomy); those with endometrial cancer are typically managed surgically.</p><p><strong>(Choice A)</strong>&nbsp; Serum FSH levels are ordered in patients with abnormal uterine bleeding to differentiate between hypothalamic (eg, functional hypothalamic amenorrhea) and ovarian (eg, perimenopause, primary ovarian insufficiency) causes of irregular bleeding.&nbsp; This patient most likely has an elevated FSH (ie, postmenopausal).&nbsp; However, this test is not useful in the evaluation of her abnormal bleeding.</p><p><strong>(Choice C)</strong>&nbsp; Progestin-containing intrauterine devices can treat endometrial hyperplasia without atypia, which may present with PMB.&nbsp; They are contraindicated in women with unexplained vaginal bleeding; therefore, this patient requires endometrial evaluation as the best next step in management.</p><p><strong>(Choice D)</strong>&nbsp; A <a href=\"21821\">progesterone withdrawal test</a> is used in premenopausal women with secondary amenorrhea to determine estrogen status (ie, no withdrawal bleed with low estrogen levels).&nbsp; It is not used in the evaluation of PMB because it cannot distinguish between benign and malignant causes.</p><p><strong>Educational objective:</strong><br>Postmenopausal bleeding is a common presenting finding of endometrial cancer.&nbsp; Therefore, all patients with postmenopausal bleeding require endometrial evaluation with either endometrial biopsy or transvaginal ultrasound.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3399,
            "topic": "Endometrial cancer",
            "titleId": 3399,
            "title": "Endometrial cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Measure a serum FSH level",
                    "choiceNumber": 1,
                    "correctTaken": 1147,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform an endometrial biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 11720,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Place a progestin-containing intrauterine device",
                    "choiceNumber": 3,
                    "correctTaken": 161,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe a progesterone withdrawal test",
                    "choiceNumber": 4,
                    "correctTaken": 462,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassure the patient that bleeding is likely due to fibroids",
                    "choiceNumber": 5,
                    "correctTaken": 2588,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "49",
                    "mediaDataId": 0,
                    "title": "Endometrial cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "80",
                    "mediaDataId": 0,
                    "title": "Evaluation of postmenopausal bleeding",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24377427",
                    "mediaDataId": 0,
                    "title": "Investigation of women with postmenopausal uterine bleeding: clinical practice recommendations.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24377427",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29683904",
                    "mediaDataId": 0,
                    "title": "ACOG committee opinion no. 734 summary: the role of transvaginal ultrasonography in evaluating the endometrium of women with postmenopausal bleeding.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29683904",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30234731",
                    "mediaDataId": 0,
                    "title": "Appropriate evaluation of postmenopausal bleeding.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30234731",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 16078,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 17046,
            "questionIndex": 18494,
            "questionText": "<p>A 30-year-old primigravida at 8 weeks gestation comes to the emergency department due to pelvic pain.&nbsp; The patient has had intermittent right lower quadrant pain for the last week, but yesterday it became constant and severe with associated nausea and vomiting.&nbsp; She takes a prenatal vitamin daily and has no chronic medical conditions.&nbsp; Blood pressure is 128/82 mm Hg and pulse is 104/min.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Ultrasound shows an intrauterine fetal pole measuring 8 weeks gestation with cardiac motion at 160/min.&nbsp; There is free fluid in the pelvis, and the right ovary is enlarged and has decreased blood flow on Doppler.&nbsp; The patient undergoes emergency laparoscopy for ovarian torsion, and the right ovary containing the corpus luteum is removed due to necrosis of the ovary.&nbsp; Postoperative ultrasound shows positive intrauterine fetal cardiac activity and free fluid in the pelvis.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"38692\" src=\"https://www.uworld.com/media/L59465.jpg\" ></p><p>Ovulation occurs when a secondary oocyte is released from the dominant ovarian follicle, leaving behind cells that form an ovarian structure called the <strong>corpus luteum</strong> (CL).&nbsp; Following fertilization, the CL enlarges and produces high levels of <strong>progesterone</strong>, which thickens the endometrial lining in preparation for implantation.&nbsp; Progesterone also promotes implantation of the embryo and <strong>maintains the pregnancy</strong>.&nbsp; In early pregnancy, the CL is the primary source of progesterone until the placenta takes over production at <strong>8-10 weeks gestation</strong> (ie, the luteal-placental shift).</p><p>If the CL is removed prior to 10 weeks gestation (as in this patient who required an emergency oophorectomy due to <a href=\"5096\">ovarian torsion</a>), progesterone levels decrease precipitously; as a result, the pregnancy becomes at high risk for spontaneous abortion <strong>(Choice E)</strong>.&nbsp; Therefore, patients with <strong>corpus luteum removal</strong> prior to 10 weeks gestation require postoperative <strong>progesterone supplementation</strong> (eg, vaginal progesterone) to <strong>prevent pregnancy loss</strong>.&nbsp; Supplementation can be discontinued after 10 weeks gestation.</p><p><strong>(Choice A)</strong>&nbsp; High-dose (4 mg) folic acid supplementation is indicated in patients at high risk for a fetus with neural tube defects (eg, prior affected pregnancy, use of folate antagonist medications).&nbsp; CL removal does not affect the risk of neural tube defects.</p><p><strong>(Choice B)</strong>&nbsp; Intramuscular methotrexate is a folate antagonist used to treat <a href=\"2769\">ectopic pregnancy</a>, which can present with pelvic pain and free fluid in the pelvis (as in this patient).&nbsp; This patient has an intrauterine pregnancy and her pelvic free fluid was likely due to torsion; therefore, methotrexate is not indicated.</p><p><strong>(Choice C)</strong>&nbsp; Daily low-dose aspirin decreases the risk of preeclampsia in high-risk patients (eg, pregestational diabetes mellitus, chronic hypertension).&nbsp; This patient has no chronic medical conditions.</p><p><strong>(Choice F)</strong>&nbsp; Vaginal misoprostol is a prostaglandin that causes uterine contractions.&nbsp; It is used for medical management of spontaneous abortions or cervical ripening during an induction of labor.</p><p><strong>Educational objective:</strong><br>During early pregnancy, the corpus luteum produces progesterone, which prepares the endometrium for implantation, promotes implantation, and maintains the pregnancy through 10 weeks gestation.&nbsp; Patients who have the corpus luteum removed (eg, oophorectomy) prior to 10 weeks gestation require progesterone supplementation to prevent pregnancy loss.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 20413,
            "topic": "Ovarian Torsion",
            "titleId": 20413,
            "title": "Ovarian Torsion",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "High-dose folic acid supplementation",
                    "choiceNumber": 1,
                    "correctTaken": 465,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intramuscular methotrexate",
                    "choiceNumber": 2,
                    "correctTaken": 335,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low-dose aspirin",
                    "choiceNumber": 3,
                    "correctTaken": 568,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progesterone supplementation",
                    "choiceNumber": 4,
                    "correctTaken": 9011,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Routine prenatal care only",
                    "choiceNumber": 5,
                    "correctTaken": 6143,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal misoprostol",
                    "choiceNumber": 6,
                    "correctTaken": 207,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28277122",
                    "mediaDataId": 0,
                    "title": "The role of progesterone therapy in early pregnancy: from physiological role to therapeutic utility.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28277122",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27662646",
                    "mediaDataId": 0,
                    "title": "Progesterone in normal and pathological pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27662646",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23810116",
                    "mediaDataId": 0,
                    "title": "Case report: ovarian torsion in pregnancydiagnosis and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23810116",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 16729,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 8935,
            "questionIndex": 8953,
            "questionText": "<p>A 36-year-old woman comes to the office due to worsening pelvic pressure over the last year.&nbsp; The patient has had increasing pelvic pressure associated with a dull, aching pain.&nbsp; She has also noticed increasing abdominal girth but has had no changes in appetite or bloody stool.&nbsp; The patient is sexually active and has had deep pelvic pain with intercourse for the past few months.&nbsp; She does not use contraception and has regular monthly menses with 7-8 days of bleeding with each cycle; she has no intermenstrual bleeding or spotting.&nbsp; Family history is significant for 2 maternal aunts with ovarian cancer in their 50s but is otherwise noncontributory.&nbsp; Vital signs are normal.&nbsp; BMI is 26 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Examination shows an enlarged midline pelvic mass that extends to the umbilicus.&nbsp; The mass is mobile and has several palpable anterior protuberances.&nbsp; There is no fluid wave or tenderness to palpation.&nbsp; Bowel sounds are normal.&nbsp; Urine pregnancy test is negative.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"4394\" src=\"https://www.uworld.com/media/highresdefault/L28497.jpg\" ></p><p>This patient with an enlarged pelvic mass likely has <strong>leiomyomata uteri</strong> (ie, uterine fibroids).&nbsp; Fibroids are benign, monoclonal tumors of the uterine myometrium.&nbsp; They are common in reproductive-age women and are usually asymptomatic.&nbsp; However, depending on their size and location, fibroids can cause bleeding symptoms (eg, heavy menses), bulk symptoms (eg, pelvic pressure), or both.</p><p>This patient likely has multiple, extremely large fibroids causing <strong>significant uterine enlargement</strong> (eg, mass extending to the umbilicus) and an <strong>irregular uterine contour</strong> (eg, palpable protuberances).&nbsp; Large fibroids commonly cause <strong>mass effect (bulk symptoms)</strong> on neighboring structures; therefore, patients may have increasing abdominal girth, <strong>pelvic pressure</strong>, and impaired urinary, gastrointestinal, and sexual function (eg, urinary frequency, constipation, deep pelvic pain with intercourse).</p><p>Treatment for bulk symptoms involves reducing fibroid size and number with either medication (ie, GnRH agonist) or surgery (eg, myomectomy).</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"14699\">Adenomyosis</a>, or endometrial proliferation within the myometrium, can present with a tender, enlarged uterus and dyspareunia.&nbsp; In contrast to this patient&#39;s protuberant, 20-week-sized uterus (ie, reaches the umbilicus), patients with adenomyosis typically have a uniformly globular uterus &#8804;12 weeks in size.&nbsp; In addition, because of the relatively smaller uterine size compared to that of fibroids, patients with adenomyosis typically do not have constant pelvic pressure.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"4775\">Endometrial polyps</a> are small growths of endometrial glands and stroma within the uterine cavity.&nbsp; They do not present with a palpable abdominal mass or pelvic pressure, and patients classically have intermenstrual spotting.</p><p><strong>(Choice C)</strong>&nbsp; Unlike fibroids, which cause pelvic pressure due to mass effect, <a href=\"1139\">endometriosis</a> can cause dyspareunia and pressure by inducing pelvic inflammation and the formation of pelvic adhesions (eg, fixed, immobile uterus).&nbsp; However, endometriosis does not cause an enlarged or irregularly shaped uterus.</p><p><strong>(Choice D)</strong>&nbsp; Gestational trophoblastic disease (GTD), caused by overproliferation of abnormal trophoblasts, can present with uterine enlargement.&nbsp; Because trophoblasts secrete &#946;-hCG, patients with GTD typically have elevated &#946;-hCG levels.&nbsp; This patient has a negative pregnancy test, making this diagnosis unlikely.</p><p><strong>(Choice F)</strong>&nbsp; Although ovarian cancer can cause pelvic pressure, increasing abdominal girth, and a large pelvic mass, it typically presents as a fixed mass (due to invasive spread into nearby structures) with ascites (ie, fluid wave on examination), findings not seen in this patient.</p><p><strong>Educational objective:</strong><br>Leiomyomata uteri (fibroids) are benign uterine tumors common in reproductive-age women.&nbsp; Extremely large fibroids cause an irregular uterine contour and bulk symptoms (eg, pelvic pressure, deep pelvic pain with intercourse).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3143,
            "topic": "Uterine fibroids",
            "titleId": 3143,
            "title": "Uterine fibroids",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adenomyosis",
                    "choiceNumber": 1,
                    "correctTaken": 98,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial polyps",
                    "choiceNumber": 2,
                    "correctTaken": 81,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometriosis",
                    "choiceNumber": 3,
                    "correctTaken": 208,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gestational trophoblastic disease",
                    "choiceNumber": 4,
                    "correctTaken": 24,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Leiomyomata uteri",
                    "choiceNumber": 5,
                    "correctTaken": 1395,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ovarian cancer",
                    "choiceNumber": 6,
                    "correctTaken": 119,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "47",
                    "mediaDataId": 0,
                    "title": "Uterine fibroids",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28084714",
                    "mediaDataId": 0,
                    "title": "Uterine fibroids: diagnosis and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28084714",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 100,
            "notes": null,
            "peopleTaken": 1925,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 72,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 13738,
            "questionIndex": 15128,
            "questionText": "<p>A 59-year-old postmenopausal woman comes to the office for evaluation of breast tenderness.&nbsp; The patient first noticed intermittent breast tenderness 4 months ago, which at first was relieved with ibuprofen, but for the past several weeks the tenderness has occurred daily.&nbsp; She has had no breast masses or nipple discharge.&nbsp; The patient has also noticed an increase in her weight, particularly around the abdomen, despite not being able to eat as much.&nbsp; She went through menopause 5 years ago.&nbsp; Mammogram history is normal, including one performed earlier this year.&nbsp; The patient has no chronic medical conditions and has had no previous surgeries.&nbsp; There is no family history of breast, ovarian, or endometrial cancer.&nbsp; Vital signs are normal.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Breast examination shows bilateral, diffuse fibrocystic changes.&nbsp; The abdomen is distended, and a large right lower quadrant mass is palpable.&nbsp; Pelvic ultrasound reveals a 12-cm complex right ovarian mass with solid components and multiple septations, a slightly enlarged uterus, and a 9-mm endometrial stripe.&nbsp; Which of the following tumor markers is most likely to be elevated in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40814\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Granulosa cell tumor</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Sex cord&ndash;stromal tumor</li><li>&#8593; Estradiol</li><li>&#8593; Inhibin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Complex ovarian mass</li><li>Juvenile subtype<ul style=\"list-style-type:circle;\"><li>Precocious puberty</li></ul></li><li>Adult subtype<ul style=\"list-style-type:circle;\"><li>Breast tenderness</li><li>Abnormal uterine bleeding</li><li>Postmenopausal bleeding</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Histopathology</strong></p></td><td><ul><li>Call-Exner bodies (cells in rosette pattern)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Endometrial biopsy (endometrial cancer)</li><li>Surgery (tumor staging)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s <strong>bilateral breast tenderness</strong> and fibrocystic changes (due to increased breast tissue proliferation) are suggestive of estrogen exposure.&nbsp; The additional symptoms of increasing abdominal girth, early satiety, and a <strong>complex ovarian mass</strong> are concerning for an ovarian malignancy&mdash;specifically, a <strong>granulosa cell tumor</strong>, a type of ovarian sex cord-stromal tumor.</p><p>Granulosa cells are the primary components of the ovarian stroma and function in converting testosterone to estradiol via aromatase.&nbsp; They secrete both <strong>estradiol</strong> (via aromatization of testosterone) and <strong>inhibin</strong> (which suppresses pituitary FSH release via negative feedback).&nbsp; Malignant proliferation of granulosa cells can cause high estradiol levels that affect the breast (eg, tenderness) and endometrium (eg, unopposed proliferation).&nbsp; Therefore, patients can have concomitant endometrial hyperplasia/cancer that presents in postmenopausal women as an <strong>enlarged uterus</strong> with abnormal uterine bleeding or a <strong>thickened (&gt;4 mm) endometrial stripe</strong> on ultrasound.&nbsp; Patients are managed surgically and require monitoring for disease progression or recurrence with serum inhibin levels.</p><p><strong>(Choice A)</strong>&nbsp; Alpha-fetoprotein is secreted by yolk sac tumors, an aggressive germ cell tumor.&nbsp; Because these tumors are rapidly-growing, patients typically present with abdominal pain.&nbsp; There is no associated breast tenderness.</p><p><strong>(Choice C)</strong>&nbsp; Elevated hCG levels occur in embryonal carcinomas (an ovarian germ cell tumor) and gestational trophoblastic disease (eg, hydatidiform mole).&nbsp; Patients with an embryonal carcinoma have rapid-onset pelvic pain.&nbsp; Those with a hydatidiform mole can have uterine enlargement, bilateral ovarian masses (ie, theca lutein cysts), hyperemesis gravidarum, or hyperthyroid symptoms.&nbsp; The breast tenderness that occurs with elevated hCG (eg, during early pregnancy) is due to elevated estrogen.</p><p><strong>(Choice D)</strong>&nbsp; Lactate dehydrogenase is secreted by dysgerminomas, malignant germ cell tumors that typically present as rapidly enlarging, painful masses.&nbsp; There is no associated breast tenderness or thickened endometrium.</p><p><strong>(Choice E)</strong>&nbsp; Sertoli-Leydig cell tumors, a sex cord-stromal ovarian tumor, secrete testosterone; therefore, patients have virilization (eg, acne, clitoromegaly) and hypoestrogenism (eg, breast atrophy, thin endometrium).</p><p><strong>(Choice F)</strong>&nbsp; Mature teratomas are benign ovarian germ cell tumors that occasionally secrete thyroxine (eg, struma ovarii).&nbsp; Most patients are asymptomatic; however, symptomatic patients typically have weight loss despite an increased appetite due to the increased metabolic rate associated with elevated thyroxine levels.</p><p><strong>Educational objective:</strong><br>Granulosa cells are the primary component of the ovarian stroma and convert testosterone to estradiol via aromatase.&nbsp; Malignant proliferation of these cells (ie, granulosa cell tumor) results in high estradiol levels that affect breast tissue (eg, tenderness, fibrocytic changes) and the uterine lining (eg, postmenopausal thickened endometrium).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3170,
            "topic": "Ovarian cancer",
            "titleId": 3170,
            "title": "Ovarian cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alpha-fetoprotein",
                    "choiceNumber": 1,
                    "correctTaken": 1659,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Estradiol",
                    "choiceNumber": 2,
                    "correctTaken": 11866,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "hCG",
                    "choiceNumber": 3,
                    "correctTaken": 1729,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lactate dehydrogenase",
                    "choiceNumber": 4,
                    "correctTaken": 1071,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Testosterone",
                    "choiceNumber": 5,
                    "correctTaken": 157,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroxine",
                    "choiceNumber": 6,
                    "correctTaken": 242,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "69",
                    "mediaDataId": 0,
                    "title": "Rare ovarian tumors",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "760",
                    "mediaDataId": 0,
                    "title": "Evaluation of an ovarian mass",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18815151",
                    "mediaDataId": 0,
                    "title": "Granulosa cell tumor of the ovary:  tumor review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18815151",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24426698",
                    "mediaDataId": 0,
                    "title": "Recent advances in granulosa cell tumor ovary:  a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24426698",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29198337",
                    "mediaDataId": 0,
                    "title": "Ovarian sex-cord stromal tumours and small cell tumours:  pathological, genetic and management aspects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29198337",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 16724,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 10917,
            "questionIndex": 12053,
            "questionText": "<p>A 42-year-old, nulliparous woman comes to the office due to abnormal uterine bleeding.&nbsp; The patient previously had regular monthly menses but, for the last 8 months, has had irregular episodes of bleeding and spotting that last 1-5 days.&nbsp; She initially attributed this irregular bleeding to stress but is now having abdominal bloating and daily breast tenderness.&nbsp; The patient has no chronic medical conditions and her Pap test 2 years ago was normal.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; The patient recently married and is hoping to conceive within the next several months.&nbsp; Vital signs are normal.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Breast examination shows bilateral diffuse tenderness and no masses.&nbsp; There is fullness in the left lower quadrant of the abdomen with no rebound or guarding.&nbsp; Pelvic examination shows a large, nontender left adnexal mass.&nbsp; A urine pregnancy test is negative.&nbsp; Pelvic ultrasound reveals a 10-cm, complex left ovarian mass and an irregular endometrial stripe.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40814\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Granulosa cell tumor</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Sex cord&ndash;stromal tumor</li><li>&#8593; Estradiol</li><li>&#8593; Inhibin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Complex ovarian mass</li><li>Juvenile subtype<ul style=\"list-style-type:circle;\"><li>Precocious puberty</li></ul></li><li>Adult subtype<ul style=\"list-style-type:circle;\"><li>Breast tenderness</li><li>Abnormal uterine bleeding</li><li>Postmenopausal bleeding</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Histopathology</strong></p></td><td><ul><li>Call-Exner bodies (cells in rosette pattern)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Endometrial biopsy (endometrial cancer)</li><li>Surgery (tumor staging)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s abnormal uterine bleeding and complex ovarian mass are suggestive of a <strong>granulosa cell tumor</strong>&mdash;an <strong>estradiol-secreting sex cord-stromal tumor</strong>.&nbsp; Other clinical features may include breast tenderness (caused by estrogen-stimulated breast tissue proliferation) and abdominal bloating/pain (eg, mass effect, ascites).&nbsp; Granulosa cell tumors secrete high levels of estradiol that cause uncontrolled endometrial proliferation; therefore, patients often have abnormal uterine bleeding (eg, irregular menses) due to the subsequent development of endometrial hyperplasia/cancer.</p><p>Granulosa cell tumors are typically diagnosed at an early cancer stage and treated surgically; however, due to the possibility of concomitant <strong>endometrial hyperplasia/cancer</strong> from excessive estrogen, the best next step is an <strong>endometrial biopsy</strong>.</p><ul><li>Premenopausal women desiring future fertility (such as this patient) who have a granulosa cell tumor and no endometrial cancer can undergo a uterus-sparing procedure (eg, unilateral salpingo-oophorectomy).</li><li>In contrast, patients with both a granulosa cell tumor and endometrial cancer require a hysterectomy and bilateral salpingo-oophorectomy.</li></ul><p>Additionally, postoperative management with chemotherapy or radiation depends on the stage of both the granulosa cell tumor and the endometrial cancer, as regimens differ.</p><p><strong>(Choices A and E)</strong>&nbsp; Both oral contraceptives and the progestin-containing intrauterine device are treatment options for patients with abnormal uterine bleeding.&nbsp; However, patients with risk factors for endometrial cancer (eg, obesity, chronic anovulation) require endometrial biopsy prior to treatment initiation as side effects from these treatments may mask symptoms.</p><p><strong>(Choice B)</strong>&nbsp; Endometrial ablation (surgical destruction of the endometrial lining) is typically used for premenopausal patients with heavy, regular menses.&nbsp; An endometrial biopsy is required prior to an endometrial ablation because it is contraindicated in patients with endometrial cancer.</p><p><strong>(Choice D)</strong>&nbsp; A hysterosalpingogram is used to evaluate the uterine cavity and fallopian tubes in patients with infertility (eg, hydrosalpinx) or uterine anomalies (eg, septate uterus).&nbsp; Hysterosalpingogram is not used in the evaluation of adnexal masses because it does not further define the mass or affect management.</p><p><strong>Educational objective:</strong><br>Granulosa cell tumors are an estradiol-secreting ovarian sex-cord stromal tumor which can cause a concomitant endometrial hyperplasia/cancer.&nbsp; Management of patients with granulosa cell tumors depends upon possible concomitant endometrial cancer (eg, uterine-sparing surgery, chemoradiation); therefore, the best next step in these patients is an endometrial biopsy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3170,
            "topic": "Ovarian cancer",
            "titleId": 3170,
            "title": "Ovarian cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Continuous oral contraceptives",
                    "choiceNumber": 1,
                    "correctTaken": 859,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial ablation",
                    "choiceNumber": 2,
                    "correctTaken": 296,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 3,
                    "correctTaken": 13134,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hysterosalpingogram",
                    "choiceNumber": 4,
                    "correctTaken": 2070,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progestin-containing intrauterine device",
                    "choiceNumber": 5,
                    "correctTaken": 322,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25527364",
                    "mediaDataId": 0,
                    "title": "Is the endometrial evaluation routinely required in patients with adult granulosa cell tumors of the ovary?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25527364",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24426698",
                    "mediaDataId": 0,
                    "title": "Recent advances in granulosa cell tumor ovary:  a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24426698",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24257556",
                    "mediaDataId": 0,
                    "title": "The incidence of endometrial hyperplasia and cancer in 1,031 patients with a granulosa cell tumor of the ovary:  long-term follow-up in a population-based cohort study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24257556",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 16681,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 10891,
            "questionIndex": 12027,
            "questionText": "<p>A 34-year-old woman is brought to the emergency department after a syncopal episode.&nbsp; The patient was at work when she became lightheaded, started sweating, and then fell to the floor.&nbsp; Now, she feels better and has no chest pain, dyspnea, or palpitations.&nbsp; The patient is currently on day 10 of her menstrual cycle.&nbsp; She reports that her menstrual periods still occur monthly but have become progressively heavier and longer over the past year, despite being on combination oral contraceptives.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 100/60 mm Hg, and pulse is 112/min.&nbsp; BMI is 27 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; On speculum examination, multiple blood clots are removed from the vaginal vault.&nbsp; The cervix has no lesions, but there is active bleeding from the cervical os.&nbsp; Bimanual examination shows a 12-week-size, irregularly shaped, enlarged uterus.&nbsp; Hemoglobin is 4.9 g/dL.&nbsp; Urine pregnancy test is negative.&nbsp; Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T73452\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Causes of heavy menstrual bleeding</strong></p></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p align=\"center\"><strong>Clinical features</strong></p></td></tr><tr><td><p align=\"center\"><strong>Adenomyosis</strong></p></td><td><ul><li>Heavy, regular menses</li><li>Dysmenorrhea, pelvic pain</li><li>Uniformly enlarged (globular), tender uterus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Endometrial cancer/hyperplasia</strong></p></td><td><ul><li>Irregular, intermenstrual, heavy, or postmenopausal bleeding</li><li>History of unopposed estrogen (eg, obesity, nulliparity, chronic anovulation)</li><li>Nontender uterus (&plusmn; enlarged)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Endometriosis</strong></p></td><td><ul><li>Uncommon cause of heavy menses</li><li>Dysmenorrhea, pelvic pain, dyspareunia</li><li>Fixed uterus, adnexal mass (endometrioma), rectovaginal nodularity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Uterine leiomyomas (fibroids)</strong></p></td><td><ul><li>Heavy, regular menses</li><li>Bulk symptoms (eg, pelvic pressure/pain, constipation)</li><li>Irregularly enlarged uterus with uneven contour</li></ul></td></tr><tr><td><p align=\"center\"><strong>Coagulopathy (eg, von Willebrand disease)</strong></p></td><td><ul><li>Heavy, regular menses</li><li>Bruising, mucocutaneous bleeding (eg, gums)</li><li>Normal uterus</li></ul></td></tr></tbody></table></div><p>This patient with heavy, prolonged menstrual bleeding likely has <strong>uterine leiomyomas</strong> (<a href=\"2335\">fibroids</a>), which are common, benign tumors formed by <strong>proliferation of smooth muscle</strong> within the <strong>myometrium</strong>.</p><p>Symptoms depend on fibroid size and location.&nbsp; Large fibroids, particularly subserosal fibroids, typically cause an <strong>irregularly shaped, enlarged uterus</strong> and bulk symptoms (eg, pelvic pressure).&nbsp; In contrast, submucosal fibroids are more likely to cause <strong>heavy, regular</strong> (eg, monthly) <strong>menses</strong> that may be prolonged because their protrusion into the endometrial cavity <strong>increases endometrial surface area</strong>.</p><p>First-line therapy for heavy menses due to fibroids is combined oral contraceptives (COCs), which can decrease bleeding by shortening the duration of menses and regulating endometrial proliferation.&nbsp; However, in patients with enlarging fibroids (likely in this patient with a 12-week-size uterus), the continued increase in endometrial surface area can increase the volume of monthly endometrial shedding to the point where COCs are no longer effective at controlling menstrual bleeding.&nbsp; Persistent heavy menstrual bleeding (eg, blood clots in the vaginal vault, active bleeding from the cervical os) can lead to <strong>symptomatic anemia</strong>, which may present with syncope.&nbsp; In these patients, more definitive fibroid treatment (eg, uterine artery embolization, myomectomy) is recommended.</p><p><strong>(Choice A)</strong>&nbsp; Cyclic bleeding of ectopic (extrauterine) endometrial glands occurs in <a href=\"1139\">endometriosis</a>.&nbsp; Endometriosis implants are intraperitoneal; therefore, cyclic shedding causes dysmenorrhea but not increased vaginal bleeding (ie, no anemia).&nbsp; In addition, endometriosis is not associated with irregular uterine enlargement.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"1210\">Adenomyosis</a>&nbsp;can cause heavy menstrual bleeding and uterine enlargement.&nbsp; However, patients typically have a uniformly enlarged, globular uterus and diffuse uterine tenderness due to shedding of endometrial glands and stroma within the myometrium.</p><p><strong>(Choice C)</strong>&nbsp; In contrast to this patient with heavy but monthly menses, those with endometrial hyperplasia typically have irregular bleeding, often having months of amenorrhea followed by heavy bleeding because of an abnormally thickened endometrium.&nbsp; Endometrial hyperplasia is unlikely in this patient with regular, monthly menses and COC use, which regulates endometrial proliferation.</p><p><strong>(Choice D)</strong>&nbsp; Patients with von Willebrand factor deficiency have impaired platelet adhesion that can lead to heavy menstrual bleeding due to coagulopathy.&nbsp; However, this condition is not associated with irregular uterine enlargement.</p><p><strong>Educational objective:</strong><br>Uterine leiomyomas (fibroids) are benign tumors formed by proliferation of smooth muscle within the myometrium.&nbsp; Fibroids are a common cause of an irregularly shaped, enlarged uterus and heavy menstrual bleeding that can lead to symptomatic anemia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3143,
            "topic": "Uterine fibroids",
            "titleId": 3143,
            "title": "Uterine fibroids",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cyclic bleeding of ectopic endometrial glands",
                    "choiceNumber": 1,
                    "correctTaken": 996,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial glands and stroma within the myometrium",
                    "choiceNumber": 2,
                    "correctTaken": 3488,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial hyperplasia with atypia",
                    "choiceNumber": 3,
                    "correctTaken": 1223,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impaired platelet adhesion",
                    "choiceNumber": 4,
                    "correctTaken": 316,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Proliferation of smooth muscle within the myometrium",
                    "choiceNumber": 5,
                    "correctTaken": 10674,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "47",
                    "mediaDataId": 0,
                    "title": "Uterine fibroids",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24080304",
                    "mediaDataId": 0,
                    "title": "Submucosal fibroids and the relation to heavy menstrual bleeding and anemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24080304",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 16697,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 8886,
            "questionIndex": 8903,
            "questionText": "<p>A 62-year-old nulligravid woman comes to the office for follow-up of a right adnexal mass.&nbsp; The patient was undergoing a pelvic examination and Pap testing 2 weeks ago when a right adnexal mass was palpated on bimanual examination.&nbsp; The Pap test was normal, and she has had no symptoms.&nbsp; Menopause occurred at age 52, and there has been no postmenopausal spotting.&nbsp; The patient&#39;s medical history is otherwise unremarkable.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; There is no family history of ovarian or breast cancer.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 120/70 mm Hg, and pulse is 72/min.&nbsp; The abdomen is soft, nondistended, and has no palpable masses.&nbsp; A pelvic ultrasound reveals a 5-cm right ovarian cyst.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"45792\" src=\"https://www.uworld.com/media/L72122.png\" ></p><p>Initial management in all women with an <strong>adnexal mass</strong> is with a pelvic ultrasound, which evaluates for malignant (solid components, thick septations, increased vascularity) versus benign (smooth and simple wall, no vascularity) features.&nbsp; Women with malignant features, regardless of age, are managed with immediate surgery (eg, laparoscopy).&nbsp; In contrast, <strong>benign-appearing</strong> masses, as in this patient whose pelvic ultrasound revealed an ovarian cyst, are further evaluated based on menopausal status.</p><ul><li>In premenopausal women, most adnexal masses are due to benign causes (eg, functional cysts) and the risk of malignancy is low; therefore, asymptomatic patients are managed with reassurance and observation <strong>(Choice D)</strong>.</li></ul><ul><li>In contrast, <strong>postmenopausal women</strong> are less likely to have benign causes of adnexal masses because menses and ovulation have ceased; however, benign masses are occasionally found.&nbsp; Therefore, in postmenopausal women, adnexal masses are <strong>risk stratified</strong> (ie, benign or malignant) with a CA-125 level.</li></ul><p><strong>Cancer antigen 125 (CA-125)</strong> is released by cells from the peritoneum and m&uuml;llerian structures (eg, uterus, Fallopian tubes).&nbsp; Conditions that irritate or stimulate these cells (eg, endometriosis, malignancy) cause elevations in this level; therefore, a CA-125 level is not used in premenopausal women because it is often falsely elevated.&nbsp; Although it is not diagnostic of ovarian cancer (ie, histopathologic diagnosis required), CA-125 testing in postmenopausal women helps further categorize simple-appearing masses as either benign or malignant.</p><ul><li>Simple masses with a <strong>normal</strong> CA-125 suggest that the mass is not growing and is not stimulating the peritoneal tissue, meaning it is likely benign.&nbsp; These are managed with <strong>observation</strong> and serial ultrasounds.</li></ul><ul><li>In contrast, simple masses with an <strong>elevated</strong> CA-125 suggest that the mass is growing and is either stimulating the peritoneal tissue or invading other pelvic structures, likely indicating malignancy.&nbsp; Further imaging (eg, CT scan) is used to assess the extent of disease and guide management (eg, laparoscopic surgical <strong>exploration</strong>) <strong>(Choice B)</strong>.</li></ul><p><strong>(Choice A)</strong>&nbsp; Endometrial biopsy investigates endometrial carcinoma and is indicated in patients with postmenopausal bleeding, abnormal uterine bleeding, age &gt;45, or thickened endometrial stripe with an ovarian mass (ie, granulosa cell tumor), none of which are seen in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Needle aspiration is contraindicated in adnexal masses due to the risk of seeding the abdomen with malignant cells, which can increase the cancer stage.</p><p><strong>Educational objective:</strong><br>Ovarian masses in postmenopausal patients are initially evaluated with a pelvic ultrasound.&nbsp; In postmenopausal women with a benign-appearing mass, a CA-125 level can further risk stratify the mass as either likely benign or malignant to further guide management (eg, observation, surgical exploration).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3170,
            "topic": "Ovarian cancer",
            "titleId": 3170,
            "title": "Ovarian cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "5",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 1,
                    "correctTaken": 261,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Laparoscopy",
                    "choiceNumber": 2,
                    "correctTaken": 2376,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Needle aspiration for cytology",
                    "choiceNumber": 3,
                    "correctTaken": 2629,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and observation only",
                    "choiceNumber": 4,
                    "correctTaken": 4897,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum CA-125 level",
                    "choiceNumber": 5,
                    "correctTaken": 6449,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "52",
                    "mediaDataId": 0,
                    "title": "Epithelial ovarian cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "760",
                    "mediaDataId": 0,
                    "title": "Evaluation of an ovarian mass",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20974354",
                    "mediaDataId": 0,
                    "title": "Adnexal masses: characterization and imaging strategies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20974354",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26904503",
                    "mediaDataId": 0,
                    "title": "The value of ultrasound monitoring of adnexal masses for early detection of ovarian cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26904503",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 16612,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 39,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 13398,
            "questionIndex": 14777,
            "questionText": "<p>A 31-year-old woman comes to the office for follow up of an abnormal Pap test.&nbsp; Two weeks ago, the patient underwent her annual well-woman examination, and Pap testing revealed a high-grade squamous epithelial lesion.&nbsp; She has no chronic medical conditions and has had no prior surgery.&nbsp; The patient smokes a half pack of cigarettes daily.&nbsp; She has been in a monogamous relationship with a female partner for the past 2 years.&nbsp; The patient has regular monthly menses, and her last menstrual period was a week ago.&nbsp; Vital signs are normal.&nbsp; BMI is 33 kg/m&sup2;.&nbsp; Colposcopy reveals a nulliparous cervix with no raised or ulcerated lesions.&nbsp; The entire squamocolumnar junction cannot be visualized.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"38054\" src=\"https://www.uworld.com/media/L60486.jpg\" ></p><p>The Pap test is a screening examination for precancerous and cancerous cervical lesions.&nbsp; <strong>High-grade squamous intraepithelial lesion (HSIL)</strong> on Pap testing is concerning for underlying high-grade cervical intraepithelial neoplasia (CIN) or invasive cancer; therefore, patients with HSIL require colposcopy.</p><p><strong>Colposcopy</strong> evaluates the cervix under <a href=\"5031\">magnification</a> to identify abnormalities (eg, acetowhite changes, abnormal vessels) that require biopsy to aid diagnosis and treatment planning.&nbsp; Cervical neoplasia typically occurs at the <strong>squamocolumnar junction</strong>, or transformation zone, because the epithelium at this location undergoes constant cell division and metaplasia (ie, simple columnar endocervix transitioning to stratified squamous ectocervix).</p><p>This patient&#39;s colposcopy reveals no raised or ulcerated lesions.&nbsp; However, the entire squamocolumnar junction is <strong>not visualized</strong>.&nbsp; Because the <strong>most at-risk area</strong> cannot be seen in its entirety, the evaluation is <strong>unsatisfactory</strong>, and occult CIN or <strong>cancer could be missed</strong>.&nbsp; Therefore, the best next step in management is <strong>endocervical curettage</strong>, which can sample tissue from the transformation zone to assess for lesions.</p><p><strong>(Choice B)</strong>&nbsp; <a href=\"9333\">Endometrial biopsy</a> is indicated in patients with abnormal uterine bleeding (eg, postmenopausal bleeding), a common sign of endometrial cancer.&nbsp; Although unopposed estrogen (eg, obesity as in this patient) is a risk factor, this patient has regular menses and, therefore, does not require endometrial biopsy.</p><p><strong>(Choices C and D)</strong>&nbsp; Women age &#8805;30 with normal cervical cancer screening results can undergo human papillomavirus testing in 5 years for routine screening.&nbsp; This patient has HSIL and requires additional management (eg, endocervical curettage, cervical biopsy) besides repeat Pap testing.</p><p><strong>(Choice E)</strong>&nbsp; Transvaginal pelvic ultrasound is used to assess patients with uterine or adnexal conditions (eg, abnormal uterine bleeding, pelvic pain, adnexal mass).&nbsp; It is not used to evaluate cervical dysplasia.</p><p><strong>Educational objective:</strong><br>Patients with high-grade squamous intraepithelial lesions on Pap testing are at high risk for cervical intraepithelial neoplasia and cervical cancer.&nbsp; Because these lesions typically arise from the transformation zone, patients with an unsatisfactory colposcopy (ie, entire squamocolumnar junction cannot be visualized) require endocervical sampling (eg, endocervical curettage).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3372,
            "topic": "Cervical cancer",
            "titleId": 3372,
            "title": "Cervical cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "1",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Endocervical curettage",
                    "choiceNumber": 1,
                    "correctTaken": 10761,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 2963,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Human papillomavirus testing in 5 years",
                    "choiceNumber": 3,
                    "correctTaken": 88,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat Pap testing in 1 year",
                    "choiceNumber": 4,
                    "correctTaken": 1723,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transvaginal pelvic ultrasound",
                    "choiceNumber": 5,
                    "correctTaken": 430,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "615",
                    "mediaDataId": 0,
                    "title": "Cervical dysplasia and cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16417073",
                    "mediaDataId": 0,
                    "title": "Management of histologic abnormalities of the cervix.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16417073",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23062041",
                    "mediaDataId": 0,
                    "title": "ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23062041",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23519301",
                    "mediaDataId": 0,
                    "title": "2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23519301",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 15965,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 3862,
            "questionIndex": 3862,
            "questionText": "<p>A 26-year-old nulliparous woman comes to the office due to severe pain during sexual intercourse.&nbsp; The pain is &#x22;particularly unbearable&#x22; with deep penetration, which has caused the patient to avoid sexual intimacy for the past few months.&nbsp; This has placed a significant strain on her relationship with her husband of 2 years, who has been her only sexual partner.&nbsp; They have been using condoms with lubrication during intercourse, but this has not improved the pain.&nbsp; Menses occur every 30 days, are painful, and last for 5 days with moderate bleeding.&nbsp; The patient has no chronic medical conditions and takes no daily medications.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Vital signs are normal.&nbsp; Speculum examination is normal.&nbsp; Which of the following is the most appropriate treatment for this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32451\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Endometriosis</strong></p></td></tr><tr><td style=\"width: 30%;\"><p align=\"center\"><strong>Pathogenesis </strong></p></td><td style=\"width: 70%;\"><ul><li>Ectopic implantation of endometrial glands</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical&nbsp;features </strong></p></td><td><ul><li>Dyspareunia</li><li>Dysmenorrhea</li><li>Chronic pelvic pain</li><li>Infertility</li><li>Dyschezia</li><li>Cyclic dysuria, hematuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Physical&nbsp;examination </strong></p></td><td><ul><li>Immobile uterus</li><li>Cervical motion tenderness</li><li>Adnexal mass</li><li>Rectovaginal septum, posterior cul-de-sac, uterosacral ligament nodules</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Direct visualization &amp; surgical biopsy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Medical (oral contraceptives, NSAIDs) &nbsp;</li><li>Surgical resection</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>NSAIDs</strong> = nonsteroidal anti-inflammatory drugs.</p></td></tr></tbody></table></div><p>This patient with severe dyspareunia and dysmenorrhea likely has <strong>endometriosis</strong>, ectopic <a href=\"1139\">implants</a> of endometrial glands and stroma in the abdomen and pelvis.&nbsp; Like normal endometrium, these intraperitoneal implants proliferate and shed during menses; however, because they have no outlet, endometriosis implants can cause recurrent, slowly progressive pelvic inflammation and fibrosis.&nbsp; The chronic inflammation, fibrosis, and subsequent adhesion formation result in the characteristic pain symptoms associated with endometriosis.&nbsp; Pain symptoms vary with implant location and severity; the most common pain symptoms are <strong>dysmenorrhea</strong> and <strong>severe dyspareunia</strong> (ie, pain with intercourse), particularly with deep penetration, due to the proximity of the vagina to the uterus, bladder, and rectum.</p><p>Patients with a presumptive diagnosis of endometriosis based on clinical symptoms are initially managed with nonsteroidal anti-inflammatory drugs (which decrease inflammation) and <strong>combination oral contraceptives</strong> (which suppress ovulation and reduce menstruation).&nbsp; When endometriosis does not improve with medical management, surgical evaluation via laparoscopy is required for definitive diagnosis (eg, biopsy) and resection of implants.</p><p><strong>(Choices A, C, D, and E)</strong>&nbsp; Vaginismus, also known as genitopelvic pain/penetration disorder, is a common cause of dyspareunia.&nbsp; In contrast to endometriosis, vaginismus causes pain with any vaginal penetration (eg, intercourse, speculum examination).&nbsp; In addition, vaginismus typically causes diffuse pain due to repeated involuntary pelvic floor muscle contractions; this pain is unrelated to menses.&nbsp; Patients with vaginismus are typically treated with multiple modalities, including cognitive-behavioral therapy, couples therapy and sex education, pelvic floor physical therapy, and vaginal dilators.</p><p><strong>Educational objective:</strong><br>Endometriosis can present with dysmenorrhea and deep dyspareunia.&nbsp; Symptomatic patients are offered empiric medical therapy with nonsteroidal anti-inflammatory drugs and/or combination oral contraceptives, which treat inflammation and suppress ovarian stimulation of endometriosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 13887,
            "topic": "Endometriosis",
            "titleId": 13887,
            "title": "Endometriosis",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cognitive-behavioral therapy",
                    "choiceNumber": 1,
                    "correctTaken": 2086,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Combination oral contraceptives",
                    "choiceNumber": 2,
                    "correctTaken": 6583,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Couples therapy and sex education",
                    "choiceNumber": 3,
                    "correctTaken": 3205,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic floor physical therapy",
                    "choiceNumber": 4,
                    "correctTaken": 2861,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaginal dilators",
                    "choiceNumber": 5,
                    "correctTaken": 1938,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "59",
                    "mediaDataId": 0,
                    "title": "Endometriosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20573927",
                    "mediaDataId": 0,
                    "title": "Clinical practice.  Endometriosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20573927",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26224322",
                    "mediaDataId": 0,
                    "title": "Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26224322",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29530425",
                    "mediaDataId": 0,
                    "title": "Medical treatment of endometriosis-related pain.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29530425",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 16674,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 39,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 13375,
            "questionIndex": 14753,
            "questionText": "<p>A 32-year-old nulliparous woman comes to the office for evaluation of heavy menstrual bleeding.&nbsp; The patient has had progressively heavier menstrual periods for the past few years; she now has a menstrual period every month that consists of 6 days of heavy bleeding and often bleeds through her clothes.&nbsp; The patient is sexually active and uses condoms for contraception.&nbsp; She is planning on becoming pregnant in the next year and has started taking a daily prenatal vitamin.&nbsp; The patient has occasional migraines with aura that cause her to miss work a few days a year; she otherwise is healthy and has had no surgeries.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 110/74 mm Hg, pulse is 78/min, and BMI is 29 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Pelvic examination shows an enlarged, 10-week&ndash;sized uterus.&nbsp; Urine pregnancy test is negative.&nbsp; Transvaginal ultrasound reveals an anteverted uterus with multiple submucosal fibroids.&nbsp; The endometrium is thickened and has multiple areas impinged by the fibroids.&nbsp; Which of the following is the best next step in management of this patient&#39;s heavy menstrual bleeding?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35149\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Uterine leiomyomas (fibroids)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Heavy, prolonged menses</li><li>Pressure symptoms<ul style=\"list-style-type:circle;\"><li>Pelvic pain</li><li>Constipation</li><li>Urinary frequency</li></ul></li><li>Obstetric complications<ul style=\"list-style-type:circle;\"><li>Impaired fertility</li><li>Pregnancy loss</li><li>Preterm labor</li></ul></li><li>Enlarged, irregular uterus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Work-up</strong></p></td><td><ul><li>Ultrasonography</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Asymptomatic: observation</li><li>Symptomatic: hormonal contraception, surgery</li></ul></td></tr></tbody></table></div><p>This patient has an enlarged uterus with multiple <strong>submucosal fibroids</strong> (leiomyomata uteri), which increase the overall endometrial surface area and thicken the endometrium, leading to <strong>heavy, prolonged menstrual bleeding</strong> (eg, bleeding through clothes).&nbsp; Submucosal fibroids can also cause infertility or pregnancy complications (eg, recurrent pregnancy loss) from endometrial impingement (ie, disruption), intrauterine cavity distortion, and altered myometrial blood flow.</p><p>In patients with <strong>symptomatic</strong> fibroids (eg, heavy bleeding, impaired fertility), treatment is based on <a href=\"4394\">fibroid location</a> and desire for future fertility.&nbsp; In those who <strong>desire future fertility</strong>, such as this patient, treatment is aimed at preserving the uterus while restoring normal intrauterine anatomy.&nbsp; This patient&#39;s submucosal fibroids are best managed with <strong>hysteroscopic myomectomy</strong>.&nbsp; This procedure corrects the abnormal intrauterine anatomy, which not only decreases heavy vaginal bleeding, but also has the added benefit of decreasing infertility and future pregnancy complications.</p><p><strong>(Choice A)</strong>&nbsp; Combination oral contraceptive pills (OCPs) can be used in patients with symptomatic uterine fibroids to decrease heavy menstrual bleeding.&nbsp; However, OCPs are less preferred in those desiring future fertility because they do not decrease the risk of fibroid-related pregnancy complications.&nbsp; In addition, this patient&#39;s migraine with aura is a contraindication to OCPs due to increased stroke risk.</p><p><strong>(Choice B)</strong>&nbsp; A copper-containing intrauterine device is not recommended for the treatment of submucosal fibroids because it will not help (and may worsen) heavy menstrual bleeding.&nbsp; In addition, there is a high risk of expulsion.</p><p><strong>(Choices C and E)</strong>&nbsp; Endometrial ablation and uterine artery embolization can treat heavy menstrual bleeding.&nbsp; Endometrial ablation destroys the endometrial lining, inducing tissue necrosis and scarring.&nbsp; Uterine artery embolization decreases uterine perfusion, leading to fibroid necrosis.&nbsp; Both are contraindicated in patients desiring future fertility due to the risk of future obstetric complications (eg, abnormal placentation, spontaneous abortion).&nbsp; In addition, many ablation devices cannot conform to irregular endometrial cavities caused by submucosal fibroids and therefore are not effective.</p><p><strong>Educational objective:</strong><br>Leiomyomata uteri (particularly submucosal fibroids) can cause heavy, prolonged menses.&nbsp; Patients with symptomatic submucosal fibroids who desire future fertility are treated with hysteroscopic myomectomy, which improves heavy menstrual bleeding and restores normal uterine anatomy, thereby decreasing infertility and future pregnancy complications (eg, recurrent pregnancy loss).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3143,
            "topic": "Uterine fibroids",
            "titleId": 3143,
            "title": "Uterine fibroids",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Combination oral contraceptive pills",
                    "choiceNumber": 1,
                    "correctTaken": 2084,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Copper-containing intrauterine device",
                    "choiceNumber": 2,
                    "correctTaken": 255,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial ablation",
                    "choiceNumber": 3,
                    "correctTaken": 954,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hysteroscopic myomectomy",
                    "choiceNumber": 4,
                    "correctTaken": 12306,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine artery embolization",
                    "choiceNumber": 5,
                    "correctTaken": 1366,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "47",
                    "mediaDataId": 0,
                    "title": "Uterine fibroids",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28084714",
                    "mediaDataId": 0,
                    "title": "Uterine fibroids: diagnosis and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28084714",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26928414",
                    "mediaDataId": 0,
                    "title": "Hysteroscopic myomectomy: techniques and preoperative assessment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26928414",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16965,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 8921,
            "questionIndex": 8939,
            "questionText": "<p>A 20-year-old woman comes to the emergency department due to 6 hours of right lower quadrant abdominal pain.&nbsp; The pain came on suddenly and has become intense and constant.&nbsp; She has had associated nausea but no vomiting or diarrhea.&nbsp; The patient has a history of dysmenorrhea and underwent placement of a progestin-releasing intrauterine device (IUD) 2 months ago.&nbsp; Since IUD placement, she has had daily light vaginal bleeding, with a moderate increase in bleeding today.&nbsp; The patient has had 3 sexual partners in the last year and has a history of chlamydial cervicitis.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 110/80 mm Hg, and pulse is 104/min.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Abdominal examination shows tenderness to deep palpation in the right lower quadrant.&nbsp; On pelvic examination, the IUD strings are visible at the cervix, and there is a palpable, tender right adnexal mass.&nbsp; Urine pregnancy test is negative.&nbsp; Leukocyte count is 8,000/mm<font size=\"2\"><sup>3</sup></font>.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34441\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Ovarian torsion</strong></p></td></tr><tr><td nowrap=\"nowrap\"><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Ovarian mass</li><li>Women of reproductive age</li><li>Infertility treatment with ovulation induction</li></ul></td></tr><tr><td nowrap=\"nowrap\"><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Sudden-onset unilateral pelvic pain</li><li>Nausea &amp; vomiting</li><li>&plusmn; Palpable adnexal mass</li></ul></td></tr><tr><td nowrap=\"nowrap\"><p align=\"center\"><strong>Ultrasonography findings</strong></p></td><td><ul><li>Adnexal mass with absent Doppler flow to ovary</li></ul></td></tr><tr><td nowrap=\"nowrap\"><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Laparoscopy with detorsion</li><li>Ovarian cystectomy</li><li>Oophorectomy if necrosis or malignancy</li></ul></td></tr></tbody></table></div><p>This patient&#39;s right lower quadrant pain and tender adnexal mass are classic for <strong>ovarian torsion</strong>, a gynecologic emergency due to partial or complete <a href=\"5096\">rotation of the ovary</a> around the infundibulopelvic (IP) ligament.&nbsp; Risk factors include an ovarian mass or ovulation induction (infertility treatment).</p><p>Ovarian torsion typically presents with <strong>sudden, unilateral lower abdominal pain</strong> due to the ovary twisting acutely around the IP ligament; the twisting occludes the ovarian vessels and compromises adnexal blood supply, causing pain.</p><ul><li><p>Patients may initially have partial torsion, which occurs due to oscillation between the twisted and untwisted positions (ie, causing pain, nausea, and vomiting when twisted and relief when untwisted).</p></li><li><p>Patients can progress to <strong>complete ovarian torsion</strong>, or persistent blood flow obstruction, which causes severe ischemia and tissue necrosis, resulting in intense, constant pain.</p></li></ul><p>Patients with complete torsion can have a <strong>tender, palpable adnexal mass</strong> (ie, enlarged, edematous ovary) and vaginal <strong>bleeding</strong> (ie, from adnexal edema and necrosis).&nbsp; Due to the severity of potential complications (eg, infertility), ovarian torsion is a <strong>clinical diagnosis</strong>.&nbsp; Pelvic ultrasound revealing an adnexal mass with absent Doppler flow can support the diagnosis (but is not required).&nbsp; Management is with emergency laparoscopy to untwist the adnexa and restore blood flow.</p><p><strong>(Choices A and E)</strong>&nbsp; Appendicitis can present with right lower quadrant pain and may eventually cause a mass due to abscess formation (eg, if untreated); however, this typically develops over days rather than presenting suddenly, as in this patient.&nbsp; In addition, although torsion can cause low-grade fever and mild leukocytosis (due to ovarian necrosis), the absence of these findings makes appendicitis and tuboovarian abscess less likely.</p><p><strong>(Choice B)</strong>&nbsp; Although an ectopic pregnancy can present with lower abdominal pain and vaginal bleeding, this patient&#39;s negative pregnancy test make this diagnosis unlikely.</p><p><strong>(Choice C)</strong>&nbsp; In contrast to this patient&#39;s clinical findings, endometriosis typically presents with chronic pelvic pain, dysmenorrhea, deep dyspareunia, and infertility.</p><p><strong>(Choice F)</strong>&nbsp; Uterine perforation is a possible complication of IUDs and may present with severe abdominal pain.&nbsp; This complication is more common during or immediately after IUD placement and is less likely in this patient with visible IUD strings (which suggests normal IUD placement).</p><p><strong>Educational objective:</strong><br>Ovarian torsion occurs due to rotation of the ovary around the infundibulopelvic ligament, causing ovarian vessel occlusion and ischemia.&nbsp; It classically presents with acute-onset, unilateral lower abdominal pain and a tender, palpable adnexal mass.&nbsp; Diagnosis is clinical, and management is with emergency laparoscopy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3170,
            "topic": "Ovarian cancer",
            "titleId": 3170,
            "title": "Ovarian cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute appendicitis",
                    "choiceNumber": 1,
                    "correctTaken": 305,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ectopic pregnancy",
                    "choiceNumber": 2,
                    "correctTaken": 847,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometriosis",
                    "choiceNumber": 3,
                    "correctTaken": 729,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ovarian torsion",
                    "choiceNumber": 4,
                    "correctTaken": 12197,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tuboovarian abscess",
                    "choiceNumber": 5,
                    "correctTaken": 2078,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine perforation",
                    "choiceNumber": 6,
                    "correctTaken": 453,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "62",
                    "mediaDataId": 0,
                    "title": "Ovarian torsion",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21876091",
                    "mediaDataId": 0,
                    "title": "Sonographic diagnosis of ovarian torsion: accuracy and predictive factors.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21876091",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29941434",
                    "mediaDataId": 0,
                    "title": "Adnexal torsion.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29941434",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31354994",
                    "mediaDataId": 0,
                    "title": "Accuracy of pelvic ultrasound in diagnosing adnexal torsion.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31354994",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 16609,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 14312,
            "questionIndex": 15720,
            "questionText": "<p>A 32-year-old woman, gravida 3 para 3, comes to the office for a 2-week postoperative follow-up after undergoing a laparoscopic bilateral tubal ligation.&nbsp; The patient has no pain or abnormal discharge from the incision sites.&nbsp; She has no chronic medical conditions, and this was her only surgery.&nbsp; The patient has a regular menstrual period that occurs every 30 days.&nbsp; She typically has abdominal cramping that resolves with ibuprofen after the first day and 5 days of bleeding.&nbsp; The tubal ligation was successfully performed; however, during the procedure, multiple subcentimeter, superficial lesions were visualized over the broad ligaments, bladder, and sigmoid colon.&nbsp; Biopsy of a lesion reveals endometrial glands, stroma, and hemosiderin-laden macrophages.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"1139\" src=\"https://www.uworld.com/media/highresdefault/L16637.jpg\"  ></p><p>This patient with multiple intraabdominal lesions revealing <a href=\"24376\">endometrial glands, stroma, and hemosiderin-laden macrophages</a> most likely has <strong>endometriosis</strong>, or ectopic implants of endometrial tissue in the abdomen and pelvis.&nbsp; Endometriosis may occur due to a combination of cellular metaplasia and retrograde menstruation into the peritoneal cavity.&nbsp; Endometriosis implants, like normal endometrium, proliferate and shed in response to pulsatile estrogen and progesterone.&nbsp; This cyclic shedding without an outlet can cause chronic intraperitoneal inflammation, pain, and fibrosis.&nbsp; However, some patients are asymptomatic and <strong>diagnosed incidentally</strong> during an unrelated surgery (eg, this patient during tubal ligation).</p><p>Indications for treatment of endometriosis include:</p><ul><li>Chronic pelvic pain</li><li>Dysmenorrhea, or increasingly worse lower abdominal cramping throughout menses, that is unrelieved by nonsteroidal anti-inflammatory drugs</li><li>Dyspareunia</li><li>Infertility (eg, due to pelvic adhesions)</li></ul><p>In contrast, those with <strong>asymptomatic</strong> endometriosis, including this patient who has minimal menstrual cramping and no longer desires fertility (eg, tubal ligation), require <strong>reassurance and observation only</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Combined oral contraceptives can treat symptomatic endometriosis by suppressing ovarian function, thereby decreasing pulsatile stimulation of ectopic implants and resultant intraabdominal inflammation and pain.&nbsp; This patient has adequate pain relief with ibuprofen during menses and does not require contraception given her recent tubal ligation.</p><p><strong>(Choice B)</strong>&nbsp; Diagnosis of endometriosis is either clinical (based on symptoms) or via biopsy during laparoscopy, as in this patient.&nbsp; Endometriosis is typically a benign condition and does not require further imaging (eg, CT scan) for evaluation or treatment.</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"64343\">GnRH agonists</a> (eg, leuprolide) can treat symptomatic endometriosis by acting on the pituitary to decrease pulsatile FSH and LH release, thereby decreasing stimulation of ectopic implants and relieving pain.&nbsp; However, they are not recommended for asymptomatic patients because the adverse side effects (eg, decreased bone density from hypoestrogenism) outweigh the benefits.</p><p><strong>(Choice E)</strong>&nbsp; Surgical resection of endometriosis may reduce pain and improve fertility in symptomatic patients, but is not recommended for asymptomatic patients due to unnecessary surgical risk.</p><p><strong>Educational objective:</strong><br>Endometriosis is the ectopic implant of endometrial tissue in the abdomen and pelvis, which may cause chronic inflammation, pain, and fibrosis.&nbsp; Indications for treatment include chronic pelvic pain, dysmenorrhea, dyspareunia, and infertility.&nbsp; Patients with asymptomatic endometriosis require observation and reassurance only.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 13887,
            "topic": "Endometriosis",
            "titleId": 13887,
            "title": "Endometriosis",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Combined oral contraceptives",
                    "choiceNumber": 1,
                    "correctTaken": 5025,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the abdomen and pelvis",
                    "choiceNumber": 2,
                    "correctTaken": 688,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "GnRH agonist therapy",
                    "choiceNumber": 3,
                    "correctTaken": 686,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and observation only",
                    "choiceNumber": 4,
                    "correctTaken": 8832,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Surgical resection of the lesions",
                    "choiceNumber": 5,
                    "correctTaken": 1355,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "59",
                    "mediaDataId": 0,
                    "title": "Endometriosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28526518",
                    "mediaDataId": 0,
                    "title": "Clinical presentation of endometriosis identified at interval laparoscopic tubal sterilization: prospective series of 465 cases.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28526518",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26363383",
                    "mediaDataId": 0,
                    "title": "Introduction: management of endometriosis: moving toward a problem-oriented and patient-centered approach.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26363383",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 16586,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 10990,
            "questionIndex": 12129,
            "questionText": "<p>A 57-year-old woman, gravida 1 para 1, comes to the office for a routine examination.&nbsp; The patient has no concerns and has been feeling well.&nbsp; She walks for 30 minutes each morning and is planning on retiring in a few years.&nbsp; The patient is sexually active with her husband and has no pain during intercourse.&nbsp; She had a light menstrual period a month ago after a lapse since age 53.&nbsp; The patient has no chronic medical conditions and has had no previous surgery.&nbsp; Her father had colon cancer, but family history is otherwise unremarkable.&nbsp; She drinks alcohol socially but does not use tobacco or illicit drugs.&nbsp; Mammography and Pap test were normal 2 years ago.&nbsp; BMI is 28 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination is normal.&nbsp; Which of the following is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"5477\" src=\"https://www.uworld.com/media/L16430.jpg\" ></p><p>This patient&#39;s light menstrual period 4 years after her previous menstrual period is consistent with <strong>postmenopausal bleeding (PMB)</strong>.&nbsp; Most cases of PMB are benign, but all women with PMB require further evaluation with <strong>(Choice E)</strong>:</p><ul><li><p><strong>Pap test</strong> for <strong>cervical cancer</strong>, regardless of when the last Pap test was performed, because cervical cancer can present with light vaginal bleeding and has a peak incidence in women age ~50.</p></li><li><p><strong>endometrial biopsy</strong> or transvaginal ultrasound for <strong>endometrial cancer</strong> because the most common presentation of endometrial cancer is PMB and the risk for this cancer increases with age and BMI.</p></li></ul><p>Endometrial biopsy is considered the gold standard for diagnosis of endometrial cancer due to its high sensitivity and specificity.&nbsp; However, in postmenopausal women, a transvaginal ultrasound may be performed initially; women with an endometrial thickness &#8804;4 mm have a low likelihood of endometrial cancer and require no additional evaluation.&nbsp; In contrast, women with an endometrial thickness of &gt;4 mm require an endometrial biopsy because the likelihood of endometrial cancer is increased.&nbsp; Patients diagnosed with endometrial cancer undergo a hysterectomy with bilateral salpingo-oophorectomy, which treats and stages the cancer.</p><p><strong>(Choice A)</strong>&nbsp; Diagnostic laparoscopy is not used in the initial evaluation of PMB.&nbsp; It is more commonly used in evaluation of ovarian cancer, which typically presents with an adnexal mass or bulk symptoms.</p><p><strong>(Choice C)</strong>&nbsp; Hysterosalpingogram, which is used to evaluate for uterine abnormalities, is relatively contraindicated in patients with PMB because the procedure could spread cancerous cells into the abdomen.</p><p><strong>(Choice D)</strong>&nbsp; Additional imaging of the abdomen and pelvis is typically not indicated for endometrial cancer because it is usually surgically staged.&nbsp; However, MRI may be used in some cases where patients cannot tolerate surgery due to comorbidities.&nbsp; It is not used in initial evaluation of PMB.</p><p><strong>(Choice F)</strong>&nbsp; In women who have historic menopause (ie, no menses &gt;12 consecutive months), a serum FSH level is not recommended because it will be elevated and does not provide diagnostic information for PMB.</p><p><strong>Educational objective:</strong><br>Women with postmenopausal bleeding require a Pap test for evaluation of cervical cancer and either an endometrial biopsy or transvaginal ultrasound to evaluate for endometrial cancer.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3399,
            "topic": "Endometrial cancer",
            "titleId": 3399,
            "title": "Endometrial cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Diagnostic laparoscopy",
                    "choiceNumber": 1,
                    "correctTaken": 109,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrial biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 12597,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hysterosalpingogram",
                    "choiceNumber": 3,
                    "correctTaken": 235,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the abdomen and pelvis",
                    "choiceNumber": 4,
                    "correctTaken": 264,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional evaluation indicated",
                    "choiceNumber": 5,
                    "correctTaken": 2207,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum FSH level",
                    "choiceNumber": 6,
                    "correctTaken": 1369,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "49",
                    "mediaDataId": 0,
                    "title": "Endometrial cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "80",
                    "mediaDataId": 0,
                    "title": "Evaluation of postmenopausal bleeding",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26977831",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of endometrial cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26977831",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30234731",
                    "mediaDataId": 0,
                    "title": "Appropriate evaluation of postmenopausal bleeding.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30234731",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 53,
            "notes": null,
            "peopleTaken": 16781,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 14300,
            "questionIndex": 15708,
            "questionText": "<p>A 19-year-old woman comes to the office for evaluation of dyspareunia.&nbsp; The patient became sexually active with her boyfriend 4 months ago but has been avoiding intercourse for the past month because it has become too painful.&nbsp; She has tried using a water-based lubricant during intercourse, but it has not relieved her pain.&nbsp; The patient is using condoms for contraception.&nbsp; She has regular menses with 3-4 days of heavy bleeding and lower abdominal cramping.&nbsp; There has been an increase in cramping over the past 2 months but no abnormal vaginal discharge.&nbsp; The patient has type 1 diabetes mellitus and uses an insulin pump; her most recent hemoglobin A1c was 7.2%.&nbsp; Vital signs are normal.&nbsp; BMI is 21 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; On pelvic examination, the vulva and cervix appear noninflamed.&nbsp; Speculum examination reveals a laterally displaced cervix.&nbsp; Bimanual examination reveals a small uterus with cervical motion tenderness.&nbsp; Which of the following is the most likely cause of this patient&#39;s dyspareunia?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32451\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Endometriosis</strong></p></td></tr><tr><td style=\"width: 30%;\"><p align=\"center\"><strong>Pathogenesis </strong></p></td><td style=\"width: 70%;\"><ul><li>Ectopic implantation of endometrial glands</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical&nbsp;features </strong></p></td><td><ul><li>Dyspareunia</li><li>Dysmenorrhea</li><li>Chronic pelvic pain</li><li>Infertility</li><li>Dyschezia</li><li>Cyclic dysuria, hematuria</li></ul></td></tr><tr><td><p align=\"center\"><strong>Physical&nbsp;examination </strong></p></td><td><ul><li>Immobile uterus</li><li>Cervical motion tenderness</li><li>Adnexal mass</li><li>Rectovaginal septum, posterior cul-de-sac, uterosacral ligament nodules</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Direct visualization &amp; surgical biopsy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Medical (oral contraceptives, NSAIDs) &nbsp;</li><li>Surgical resection</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>NSAIDs</strong> = nonsteroidal anti-inflammatory drugs.</p></td></tr></tbody></table></div><p>This patient with <strong>dyspareunia</strong> and worsening menstrual cramping most likely has <strong>endometriosis,</strong> <a href=\"1139\">ectopic endometrial implants</a> within the intraabdominal cavity.&nbsp; These ectopic glands and stroma proliferate and shed within the abdominal cavity during menses; however, because there is no outlet, patients develop intraabdominal inflammation and fibrosis, causing <strong>dysmenorrhea</strong> (ie, increase in cramping during menses).</p><p>Depending on the location of the lesions, patients may also experience <strong>dyspareunia</strong> (ie, pain with intercourse) due to proximity of the vagina to the internal pelvic structures (eg, uterus, bladder, rectum).&nbsp; Therefore, on examination, patients may have <strong>cervical motion tenderness</strong>.&nbsp; With continued inflammation, patients can also develop intraabdominal fibrosis and adhesions causing pelvic anatomy distortion, as seen in this patient&#39;s lateral <strong>cervical displacement</strong>.</p><p>Treatment options for symptomatic patients include nonsteroidal anti-inflammatory drugs, combination oral contraceptives, and surgical resection.</p><p><strong>(Choice A)</strong>&nbsp; Patients with diabetes mellitus are at higher risk for <a href=\"19613\"><em>Candida albicans</em> vulvovaginitis</a>, which may cause dyspareunia.&nbsp; However, it typically presents with vulvovaginal erythema and a thick, white vaginal discharge, which are not seen in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Genito-pelvic pain/penetration disorder (also called vaginismus) is pain caused by vaginal penetration only, possibly due to involuntary contraction of pelvic floor muscles.&nbsp; It does not cause worsening menstrual cramping or a displaced cervix.</p><p><strong>(Choice D)</strong>&nbsp; Pelvic inflammatory disease can cause dyspareunia and cervical motion tenderness; however, this patient has no fever or concomitant cervical inflammation (ie, cervicitis), making this diagnosis less likely.&nbsp; In addition, she has worsening pain with menses not typical of pelvic inflammatory disease.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"4394\">Uterine leiomyomata (fibroids)</a> can cause heavy menstrual bleeding and cervical displacement (from large, bulky fibroids).&nbsp; The patient&#39;s small uterus makes this diagnosis unlikely.&nbsp; In addition, fibroids do not typically cause cervical motion tenderness and are uncommon in teenagers.</p><p><strong>(Choice F)</strong>&nbsp; Vulvodynia can cause painful intercourse; however, patients have pain of the surrounding external genitalia (eg, vulva) only.&nbsp; Therefore, they do not have dysmenorrhea, cervical motion tenderness, or cervical displacement.</p><p><strong>Educational objective:</strong><br>Endometriosis, ectopic endometrial tissue implants within the intraabdominal cavity, can cause chronic inflammation and fibrosis.&nbsp; Therefore, patients can develop chronic pelvic pain (eg, cervical motion tenderness), dysmenorrhea, dyspareunia, and distorted pelvic anatomy (eg, cervical displacement).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 13887,
            "topic": "Endometriosis",
            "titleId": 13887,
            "title": "Endometriosis",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<em>Candida albicans</em> vulvovaginitis",
                    "choiceNumber": 1,
                    "correctTaken": 194,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometriosis",
                    "choiceNumber": 2,
                    "correctTaken": 7855,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Genito-pelvic pain/penetration disorder",
                    "choiceNumber": 3,
                    "correctTaken": 1955,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic inflammatory disease",
                    "choiceNumber": 4,
                    "correctTaken": 4828,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine leiomyomata",
                    "choiceNumber": 5,
                    "correctTaken": 1477,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vulvodynia",
                    "choiceNumber": 6,
                    "correctTaken": 378,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "59",
                    "mediaDataId": 0,
                    "title": "Endometriosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20436319",
                    "mediaDataId": 0,
                    "title": "Endometriosis and the adolescent.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20436319",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20573761",
                    "mediaDataId": 0,
                    "title": "Endometriosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20573761",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20573927",
                    "mediaDataId": 0,
                    "title": "Clinical practice: endometriosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20573927",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 16687,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 13817,
            "questionIndex": 15211,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 68 years<br><strong>Gender:</strong> F, self-identified<br><strong>Race/Ethnicity:</strong> unspecified<br><strong>Site of Care:</strong> office</p><p><u><strong>History</strong></u></p><p><strong>Reason for Visit/Chief Concern:</strong> blood-tinged vaginal discharge</p><p><strong>History of Present Illness:</strong></p><ul><li>intermittent, slightly malodorous discharge for the past several weeks</li><li>no large clots or heavy vaginal bleeding</li></ul><p><strong>Past Medical History:</strong></p><ul><li>in utero exposure to diethylstilbestrol that resulted in infertility</li></ul><p><strong>Medications:</strong></p><ul><li>no current medications</li></ul><p><strong>Obstetric and Gynecologic History:</strong></p><ul><li>menopause at age 55</li><li>used combined menopause hormone therapy for several years</li></ul><p><strong>Family History:</strong></p><ul><li>mother had endometrial cancer at age 54</li><li>uncle had colorectal cancer at age 70</li></ul><p><strong>Psychosocial History:</strong></p><ul><li>has smoked a pack of cigarettes daily for the last 40 years.</li><li>drinks a few glasses of wine each week</li></ul><p><u><strong>Physical Examination</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr style=\"text-align:center;\"><td><strong>Temp</strong></td><td><strong>Pulse</strong></td><td><strong>Resp</strong></td><td><strong>BP</strong></td><td><strong>O</strong><font size=\"2\"><sub><strong>2</strong></sub></font>&nbsp;<strong>Sat</strong></td><td><strong>Ht</strong></td><td><strong>Wt</strong></td><td><strong>BMI</strong></td></tr><tr style=\"text-align:center; vertical-align:top;\"><td>36.8 C<br>(98.2 F)</td><td>85/min</td><td>13/min</td><td>130/84<br>mm Hg</td><td>97%<br>on RA</td><td>-</td><td>-</td><td>32 kg/m<font size=\"2\"><sup>2</sup></font></td></tr></tbody></table><ul><li>Pelvic: blood-tinged, watery discharge; 3-cm ulcerated lesion on the posterior vaginal wall; cervix appears normal</li></ul><p><u><strong>Diagnostic Studies</strong></u></p><ul><li>Transvaginal ultrasonography: 2-mm endometrial stripe</li><li>Biopsy of the lesion: squamous cell carcinoma</li></ul><p><u><strong>Question:</strong></u> Which of the following is the greatest risk factor for this patient&#39;s diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T41996\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Vaginal cancer</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Age &gt;60</li><li>Human papillomavirus infection</li><li>Tobacco use</li><li>In utero DES exposure (clear cell adenocarcinoma only)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Vaginal bleeding</li><li>Malodorous vaginal discharge</li><li>Irregular vaginal lesion</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Vaginal biopsy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Surgery &plusmn; chemoradiation</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>DES</strong> = diethylstilbestrol.</p></td></tr></tbody></table></div><p>This postmenopausal woman has biopsy-confirmed <strong>vaginal squamous cell carcinoma</strong>.&nbsp; Although many women are diagnosed with vaginal cancer on routine screening, those with large, symptomatic lesions often have vaginal bleeding and malodorous vaginal discharge.&nbsp; Additional clinical features that suggest metastatic disease include pelvic pain, urinary symptoms (eg, hematuria), and bulk symptoms (eg, constipation).&nbsp; Lesions typically appear as an irregular plaque or ulcer in the <strong>upper third of the posterior vagina</strong>, as seen in this patient.</p><p>As with cervical cancer, vaginal cancer results from <strong>persistent human papillomavirus (HPV) infection</strong> with high-risk types 16 and 18.&nbsp; <strong>Chronic tobacco use</strong> decreases the immune response and prevents viral clearing.&nbsp; This increases the risk of persistent HPV infection and thereby allows continued viral replication and eventual <strong>metaplastic changes</strong> within the vaginal squamous cell epithelium.&nbsp; The diagnosis is made with biopsy of the lesion to evaluate for depth of invasion and to help determine management options.</p><p><strong>(Choices A and D)</strong>&nbsp; Obesity (BMI &#8805;30 kg/m<font size=\"2\"><sup>2</sup></font>) and a possible hereditary cancer syndrome (particularly Lynch syndrome) increase the risk of endometrial cancer.&nbsp; Advanced-stage endometrial cancer can present as a vaginal lesion; however, patients would have a concomitant thickened (&gt;4 mm) endometrial stripe.&nbsp; In addition, biopsy for endometrial cancer shows endometrioid adenocarcinoma.</p><p><strong>(Choice C)</strong>&nbsp; Diethylstilbestrol was previously used to prevent spontaneous abortion but was discontinued due to multiple adverse effects (eg, infertility due to anatomic defects).&nbsp; Women who were exposed to this medication in utero are at increased risk of vaginal clear cell adenocarcinoma, not squamous cell carcinoma.</p><p><strong>(Choice E)</strong>&nbsp; Infertility, particularly in patients who are nulliparous despite having ovulatory cycles, increases the risk of epithelial ovarian cancer due to recurrent damage and subsequent malignant transformation of the ovarian epithelium from ovulation.&nbsp; Infertility does not increase the risk of vaginal cancer.</p><p><strong>(Choice F)</strong>&nbsp; Menopause hormone therapy is associated with an increased risk of breast cancer as well as an increased risk of endometrial cancer in patients who receive estrogen-only therapy and have a uterus.&nbsp; There is no association with vaginal cancer.</p><p><strong>Educational objective:</strong><br>Vaginal squamous cell carcinoma results from persistent infection with human papillomavirus (HPV) high-risk types 16 and 18.&nbsp; Chronic tobacco use decreases the normal immune response, which allows for persistent HPV infection and squamous cell metaplastic changes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 23748,
            "topic": "Vaginal cancer",
            "titleId": 23748,
            "title": "Vaginal cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Body mass index",
                    "choiceNumber": 1,
                    "correctTaken": 290,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chronic tobacco use",
                    "choiceNumber": 2,
                    "correctTaken": 7152,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diethylstilbestrol exposure in utero",
                    "choiceNumber": 3,
                    "correctTaken": 3116,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Family history",
                    "choiceNumber": 4,
                    "correctTaken": 665,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "History of infertility",
                    "choiceNumber": 5,
                    "correctTaken": 284,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prior menopause hormone therapy",
                    "choiceNumber": 6,
                    "correctTaken": 370,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "388",
                    "mediaDataId": 0,
                    "title": "Human papillomavirus (HPV)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22366589",
                    "mediaDataId": 0,
                    "title": "Smoking cessation counseling in women with genital intraepithelial neoplasia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22366589",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "11812085",
                    "mediaDataId": 0,
                    "title": "A population-based study of squamous cell vaginal cancer: HPV and cofactors.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/11812085",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 11877,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 11051,
            "questionIndex": 12192,
            "questionText": "<p>A 47-year-old woman comes to the office due to abnormal uterine bleeding.&nbsp; The patient has had several days of heavy bleeding every 2-3 weeks for the past 4 months.&nbsp; Last week, she had heavy bleeding with passage of large clots, which prompted her to be evaluated.&nbsp; Menarche was at age 16 and the patient was on estrogen/progestin-containing oral contraceptives during most of her 20s and 30s for treatment of dysmenorrhea.&nbsp; She stopped taking oral contraceptives at age 33 when she underwent a tubal ligation after the delivery of her last child.&nbsp; She had a cervical conization at age 29 after an abnormal Pap test, but all subsequent Pap tests have been normal.&nbsp; The patient takes no daily medications.&nbsp; She smokes a pack of cigarettes daily and has a 20-pack-year history.&nbsp; Vital signs are normal.&nbsp; BMI is 39 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; An endometrial biopsy is performed and shows endometrial adenocarcinoma.&nbsp; Which of the following is the most significant risk factor for this patient&#39;s biopsy result?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40904\"><table class=\"table-default-style table-header-footer-style\" style=\"width:521px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Endometrial hyperplasia/cancer</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><p>Excess estrogen</p><ul><li>Obesity</li><li>Chronic anovulation/PCOS</li><li>Nulliparity</li><li>Early menarche or late menopause</li><li>Tamoxifen use</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Heavy, prolonged, intermenstrual &amp;/or postmenopausal bleeding</li></ul></td></tr><tr><td><p align=\"center\"><strong>Evaluation</strong></p></td><td><ul><li>Endometrial biopsy (gold standard)</li><li>Pelvic ultrasonography (postmenopausal women)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Hyperplasia: progestin therapy or hysterectomy</li><li>Cancer: hysterectomy</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>PCOS</strong> = polycystic ovary syndrome.</p></td></tr></tbody></table></div><p><strong>Endometrial adenocarcinoma</strong> is a common gynecologic malignancy that presents with either <strong>abnormal uterine bleeding</strong> (as seen in this premenopausal patient) or postmenopausal bleeding.&nbsp; Diagnosis is via endometrial biopsy, and treatment includes hysterectomy with bilateral salpingo-oophorectomy with or without chemoradiation (depending on stage).</p><p>The underlying cause of most cases of endometrial cancer is chronic <strong>unopposed estrogen exposure</strong>.&nbsp; In the uterus, estrogen causes the proliferation of the endometrium to allow for implantation associated with pregnancy.&nbsp; In ovulatory patients, an increase in progesterone protects against unopposed endometrial proliferation by downregulating estrogen receptors and regulating mitosis.</p><p>However, in conditions where estrogen levels are disproportionately high, the endometrium has unregulated proliferation, leading to development of endometrial cancer.&nbsp; The most common risk factor is <strong>obesity</strong> (ie, elevated BMI) because adipose tissue increases the conversion of androgens to estrogens, which results in increased uterine estrogen exposure and <strong>chronic anovulation</strong>.&nbsp; Other risk factors for endometrial cancer are related to unopposed estrogen and include nulliparity, tamoxifen use, and early age of menarche <strong>(Choice A)</strong>.</p><p><strong>(Choice C)</strong>&nbsp; Oral contraceptives, which contain only progestin or a combination of estrogen/progestin, are protective against endometrial cancer because the progestin component stimulates endometrial proliferation and shedding.</p><p><strong>(Choice D)</strong>&nbsp; A prior abnormal Pap test is a risk factor for cervical cancer; however, it does not affect the risk of endometrial cancer.</p><p><strong>(Choice E)</strong>&nbsp; Tobacco use decreases the risk of endometrial cancer, likely by stimulating estrogen metabolism in the liver and decreasing serum estrogen levels.</p><p><strong>Educational objective:</strong><br>Endometrial adenocarcinoma can present with abnormal uterine bleeding and is diagnosed via endometrial biopsy.&nbsp; Risk factors are related to excessive uterine estrogen exposure; the most common risk factors are obesity and chronic anovulation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 3399,
            "topic": "Endometrial cancer",
            "titleId": 3399,
            "title": "Endometrial cancer",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "2",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Age at menarche",
                    "choiceNumber": 1,
                    "correctTaken": 343,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Body mass index",
                    "choiceNumber": 2,
                    "correctTaken": 10351,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oral contraceptive use",
                    "choiceNumber": 3,
                    "correctTaken": 956,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prior abnormal Pap test",
                    "choiceNumber": 4,
                    "correctTaken": 803,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tobacco use",
                    "choiceNumber": 5,
                    "correctTaken": 4162,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "49",
                    "mediaDataId": 0,
                    "title": "Endometrial cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24313431",
                    "mediaDataId": 0,
                    "title": "Risk factors for endometrial cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24313431",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24463639",
                    "mediaDataId": 0,
                    "title": "Reproductive factors and the risk of endometrial cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24463639",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26509855",
                    "mediaDataId": 0,
                    "title": "American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review:  guide to the best practices in the evaluation and treatment of polycystic ovary syndromepart 1.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26509855",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26977831",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of endometrial cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26977831",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 16615,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 2299,
            "questionIndex": 2299,
            "questionText": "<p>A 29-year-old woman comes to the emergency department with chest pain and dyspnea for 10 days.&nbsp; The chest pain is bilateral, dull, persistent, and not worsened by exertion.&nbsp; The patient&#39;s medical history is significant for a normal spontaneous vaginal delivery 3 months ago, after which she has had frequent episodes of dark, bloody vaginal discharge.&nbsp; The most recent bleeding episode was 6 days ago.&nbsp; The patient has no fever, chills, hemoptysis, orthopnea, or leg pain.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 37.5 C (99.5 F), blood pressure is 110/68 mm Hg, pulse is 80/min, and respirations are 16/min.&nbsp; BMI is 26.2 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination reveals bilaterally clear lungs.&nbsp; The extremities are warm and well perfused.&nbsp; There is no peripheral edema.&nbsp; Pelvic examination reveals an enlarged uterus, a closed cervix, and minimal dark blood in the vagina.&nbsp; Complete blood count and serum electrolytes are within normal limits.&nbsp; Chest x-rays reveal multiple bilateral infiltrates of various shapes.&nbsp; Which of the following would be most helpful in establishing this patient&#39;s diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31093\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Choriocarcinoma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Advanced maternal age</li><li>Prior complete hydatidiform mole</li></ul></td></tr><tr><td><p align=\"center\"><strong>Presentation</strong></p></td><td><ul><li>Amenorrhea or abnormal uterine bleeding</li><li>Pelvic pain/pressure</li><li>Symptoms from metastases (lung, vagina)</li><li>Uterine mass</li><li>Elevated &beta;-hCG level</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Chemotherapy</li></ul></td></tr></tbody></table></div><p><strong>Choriocarcinoma</strong> is a form of gestational trophoblastic neoplasia, a malignancy that arises from placental trophoblastic tissue and secretes &#946;-hCG.&nbsp; Although it most commonly follows a hydatidiform mole, choriocarcinoma can occur after a normal gestation or spontaneous abortion.&nbsp; Choriocarcinoma typically presents &lt;6 months after a pregnancy.&nbsp; Presenting symptoms include <strong>irregular vaginal bleeding</strong>, an <strong>enlarged uterus</strong>, and pelvic pain.&nbsp; Choriocarcinoma is an aggressive type of gestational trophoblastic neoplasia; the most common site of metastatic spread is to the lungs.&nbsp; Symptoms of <strong>pulmonary metastasis</strong> include <strong>chest pain</strong>, hemoptysis, and <strong>dyspnea</strong>.&nbsp; When choriocarcinoma is suspected, obtaining a <strong>quantitative &#946;-hCG</strong> level helps to confirm the diagnosis.</p><p><strong>(Choice A)</strong>&nbsp; The staging system for choriocarcinoma relies on chest x-ray, rather than chest CT scan, findings.&nbsp; Therefore, in this patient with known pulmonary metastases on chest x-ray, a chest CT scan is not indicated and would not change management.&nbsp; Even among patients with choriocarcinoma who have a negative chest x-ray, the detection of metastasis on chest CT scan is not associated with worsened outcomes and does not alter management.</p><p><strong>(Choices B, C, and E)</strong>&nbsp; A ventilation perfusion scan is best at identifying pulmonary embolism.&nbsp; Echocardiogram can show evidence of myocardial infarction and heart failure, and pulmonary function tests can identify obstructive and restrictive lung diseases.&nbsp; Although pulmonary embolism, myocardial infarction, and obstructive/restrictive lung diseases could all explain this patient&#39;s dyspnea and chest pain, none of them explain her irregular vaginal bleeding or enlarged uterus.&nbsp; Furthermore, her chest x-ray findings are most consistent with metastasis.</p><p><strong>Educational objective:</strong><br>Choriocarcinoma is a metastatic form of gestational trophoblastic neoplasia that may occur after a hydatidiform mole, normal pregnancy, or spontaneous abortion.&nbsp; The lungs are the most frequent site of metastasis.&nbsp; Choriocarcinoma should be suspected in postpartum women with an enlarged uterus, irregular vaginal bleeding, pulmonary symptoms, and multiple infiltrates on chest x-ray.&nbsp; Diagnosis is confirmed by an elevated &#946;-hCG level.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 18244,
            "topic": "Gestational trophoblastic disease",
            "titleId": 18244,
            "title": "Gestational trophoblastic disease",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "4",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "CT scan of the chest",
                    "choiceNumber": 1,
                    "correctTaken": 3168,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Echocardiogram",
                    "choiceNumber": 2,
                    "correctTaken": 748,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pulmonary function tests",
                    "choiceNumber": 3,
                    "correctTaken": 380,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quantitative &#946;-hCG test",
                    "choiceNumber": 4,
                    "correctTaken": 10123,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ventilation perfusion scan",
                    "choiceNumber": 5,
                    "correctTaken": 2023,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "885",
                    "mediaDataId": 0,
                    "title": "Gestational trophoblastic neoplasia",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20728069",
                    "mediaDataId": 0,
                    "title": "Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20728069",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 16442,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 2413,
            "questionIndex": 2413,
            "questionText": "<p>A 16-year-old girl comes to the office for evaluation of acne.&nbsp; Around the time of her first menstrual period at age 10, the acne appeared only on her face, but over the past 6 years, it has spread to her chest and back.&nbsp; Topical preparations are not effective, and the patient feels anxious regarding social situations at school.&nbsp; She quit the soccer team and has since gained 9.1 kg (20 lb).&nbsp; The patient has never been sexually active.&nbsp; Menses are irregular and her last menstrual period was 3 months ago.&nbsp; She has not had a Pap test but has completed the human papillomavirus vaccination series.&nbsp; The patient takes no medications and does not use tobacco.&nbsp; Family history is noncontributory.&nbsp; Physical examination shows cystic and nodular acne over the face, back, and upper chest.&nbsp; There is no goiter or thyroid masses.&nbsp; Terminal hairs are notable on the upper lip and around the nipples.&nbsp; Development is Tanner stage V.&nbsp; The abdomen is obese and nontender, with no masses and normal bowel sounds.&nbsp; Serum total testosterone and dehydroepiandrosterone sulfate levels are normal.&nbsp; This patient is at greatest risk for developing malignancy of which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33552\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Polycystic ovary syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li><strong>Androgen excess</strong> (eg,&nbsp;acne, male pattern baldness, hirsutism)</li><li>Oligoovulation or anovulation (eg,&nbsp;<strong>menstrual irregularities</strong>)</li><li>Obesity</li><li><strong>Polycystic ovaries</strong> on ultrasonography</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>&uarr;&nbsp;Testosterone levels</li><li>&uarr;&nbsp;Estrogen levels</li><li>LH/FSH imbalance</li></ul></td></tr><tr><td><p align=\"center\"><strong>Comorbidities</strong></p></td><td><ul><li>Metabolic syndrome (eg,&nbsp;diabetes mellitus, hypertension)</li><li>Obstructive sleep apnea</li><li>Metabolic dysfunction&ndash;associated steatohepatitis</li><li>Endometrial hyperplasia/cancer</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment<br />options</strong></p></td><td><ul><li>Weight loss (first line)</li><li>Oral contraceptive pills for menstrual regulation</li><li>Letrozole for ovulation induction</li></ul></td></tr></tbody></table></div><p><strong>Polycystic ovary syndrome (PCOS)</strong> is a common condition diagnosed in adolescents due to signs of <strong>hyperandrogenism</strong> and irregular menses.&nbsp; Clinical evidence of hyperandrogenism includes <strong>severe nodulocystic acne</strong>, male pattern baldness, and <strong>hirsutism</strong>.&nbsp; Although many patients with PCOS have biochemical evidence of hyperandrogenism with elevated serum levels of total testosterone, these laboratory values may be normal in some due to decreased levels of sex hormone-binding globulin, with elevated free testosterone levels instead.&nbsp; Therefore, the diagnosis requires either clinical or biochemical evidence of hyperandrogenism.</p><p>Women with PCOS typically have decreased progesterone secretion due to chronic anovulatory cycles.&nbsp; Therefore, these patients usually have a constant and unbalanced <a href=\"5965\">proliferation of the endometrium by estrogens</a>.&nbsp; This unopposed estrogen stimulation places patients at increased risk for <strong>endometrial hyperplasia and cancer</strong>.&nbsp; Treatment with cyclic progesterone, estrogen/progestin oral contraceptives, or progesterone-releasing intrauterine devices protects the endometrium from hyperplasia and reduces cancer risk.</p><p><strong>(Choice A)</strong>&nbsp; Adrenocortical malignancies typically occur with an associated syndrome (eg, Li-Fraumeni syndrome).&nbsp; An adrenocortical tumor may cause hyperandrogenism but is unlikely in a patient with a negative family history and normal dehydroepiandrosterone sulfate.</p><p><strong>(Choices B and F)</strong>&nbsp; The main risk factor for squamous cell vulvar and cervical cancer is persistent human papillomavirus (HPV) infection.&nbsp; The HPV vaccination series reduces the risk of these cancers by preventing infection with high-risk HPV types 16 and 18.</p><p><strong>(Choice D)</strong>&nbsp; Family history and radiation exposure are the major risk factors for thyroid cancer.&nbsp; Typical presentation is a thyroid nodule and no menstrual irregularities.</p><p><strong>(Choice E)</strong>&nbsp; Clear cell vaginal cancer is linked to in utero exposure to diethylstilbestrol, not PCOS.&nbsp; Vaginal squamous cell carcinoma is linked to HPV infection.</p><p><strong>Educational objective:</strong><br>Polycystic ovary syndrome (PCOS) presents with hyperandrogenism (eg, severe acne, hirsutism, androgenic alopecia) and irregular menses.&nbsp; Patients with PCOS are at increased risk for endometrial hyperplasia and cancer due to unregulated endometrial proliferation from unopposed estrogen stimulation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": 8274,
            "topic": "Polycystic ovary disease",
            "titleId": 8274,
            "title": "Polycystic ovary disease",
            "topicAttributeId": 330600,
            "topicAttribute": "Genital tract tumors and tumor-like lesions",
            "correctAnswer": "3",
            "userAnswer": "0",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adrenal gland",
                    "choiceNumber": 1,
                    "correctTaken": 300,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cervix",
                    "choiceNumber": 2,
                    "correctTaken": 73,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Endometrium",
                    "choiceNumber": 3,
                    "correctTaken": 4510,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid",
                    "choiceNumber": 4,
                    "correctTaken": 45,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vagina",
                    "choiceNumber": 5,
                    "correctTaken": 5,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vulva",
                    "choiceNumber": 6,
                    "correctTaken": 12,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": true,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "49",
                    "mediaDataId": 0,
                    "title": "Endometrial cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "60",
                    "mediaDataId": 0,
                    "title": "Polycystic ovary syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19888063",
                    "mediaDataId": 0,
                    "title": "ACOG Practice Bulletin No. 108: polycystic ovary syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19888063",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27423183",
                    "mediaDataId": 0,
                    "title": "Genetic, hormonal and metabolic aspects of PCOS: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27423183",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 10,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 5008,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 90,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 10,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": [
        {
            "exhibits": null,
            "sequenceId": 0,
            "questionId": 0,
            "questionIndex": 123812,
            "questionText": "<p>A 26-year-old woman has a bump on her vaginal introitus.&nbsp; The patient first noticed the mass 2 days ago, but it has increased in size and now causes discomfort when she walks or exercises.&nbsp; She had unprotected sex with a new partner 6 weeks ago and has had multiple lifetime partners.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 110/60 mm Hg, and pulse is 80/min.&nbsp; On pelvic examination, there is a 4-cm, mobile, soft, nontender cystic mass behind the right posterior labium majus that extends into the vagina.&nbsp; The remainder of the examination is normal.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": null,
            "explanationText": "<p><img  draggable=\"false\" id=\"15256\" src=\"https://www.uworld.com/media/highresdefault/L40012.jpg\"  ></p><p>This patient has a <strong>Bartholin duct cyst</strong>, which occurs due to blockage of the Bartholin gland duct.&nbsp; The Bartholin glands are located bilaterally at the posterior vaginal introitus and have ducts that drain into the vulvar vestibule at the 4 and 8 o&#39;clock positions to provide vulvovaginal lubrication.&nbsp; The Bartholin glands are not palpable unless ductal blockage occurs, resulting in mucoid fluid buildup and cyst formation.</p><p>Women with small Bartholin duct cysts are often asymptomatic and may be diagnosed incidentally on routine examination.&nbsp; In contrast, larger cysts (as seen in this patient) cause increased tissue tension and friction, resulting in <strong>vaginal pressure and discomfort</strong> with sexual activity, walking, or sitting (all of which apply direct pressure on the vulva and cyst).&nbsp; On pelvic examination, a <strong>soft</strong>, <strong>mobile</strong>, <strong>nontender</strong>, <strong>cystic mass</strong> is palpated <strong>behind the posterior labium majus</strong> with possible extension into the vagina.&nbsp; Asymptomatic cysts can be managed expectantly; symptomatic cysts require incision and drainage with possible <a href=\"17364\">Word catheter placement</a>.</p><p><strong>(Choice B)</strong>&nbsp; A Bartholin gland abscess can develop from an infected cyst; however, patients have additional findings of localized erythema and induration and a tender, fluctuant mass (not seen in this patient).</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"37353\">Condylomata acuminata</a> appear as groups of smooth papules or sessile, verrucous growths typically caused by human papillomavirus types 6 and 11.</p><p><strong>(Choice D)</strong>&nbsp; Condylomata lata&mdash;a feature of secondary syphilis&mdash;are gray-white, raised lesions affecting mucous membranes (eg, mouth, perineum); there is no associated cyst formation.</p><p><strong>(Choice E)</strong>&nbsp; Epidermal inclusion cysts appear as raised, mobile, flesh-colored nodules sometimes associated with a central punctum.</p><p><strong>Educational objective:</strong><br>Large, symptomatic Bartholin duct cysts can present with vaginal discomfort and pressure with sexual activity, walking, or sitting.&nbsp; Physical examination reveals a soft, mobile, nontender mass located behind the posterior labium majus with possible extension into the vagina.&nbsp; Treatment of symptomatic Bartholin duct cysts is with incision and drainage.</p>",
            "abstractId": 0,
            "qbankId": 0,
            "sectionId": 0,
            "section": null,
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 235,
            "system": "Reproductive",
            "topicId": null,
            "topic": "Bartholin duct cyst and abscess",
            "titleId": null,
            "title": null,
            "topicAttributeId": 0,
            "topicAttribute": null,
            "correctAnswer": "1",
            "userAnswer": null,
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bartholin duct cyst",
                    "choiceNumber": 1,
                    "correctTaken": 1,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bartholin gland abscess",
                    "choiceNumber": 2,
                    "correctTaken": 0,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Condylomata acuminata",
                    "choiceNumber": 3,
                    "correctTaken": 0,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Condylomata lata",
                    "choiceNumber": 4,
                    "correctTaken": 0,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Epidermal inclusion cyst",
                    "choiceNumber": 5,
                    "correctTaken": 0,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 0,
            "highlights": null,
            "isCorrect": null,
            "isIncorrect": null,
            "isMarked": false,
            "isOmitted": null,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "40",
                    "mediaDataId": 0,
                    "title": "Bartholin gland cyst and abscess",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 0,
            "notes": null,
            "peopleTaken": 0,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "05/19/2025",
            "correctPercentile": 0,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 0,
            "hint": null,
            "allowCalculator": null,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 0,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": null,
            "dailyTimeSpentReview": null,
            "dailyTimeSpent": null,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": null,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": null,
            "questionSourceId": null,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 0,
            "questionId": 0,
            "questionIndex": 124188,
            "questionText": "<p>A 26-year-old woman has a bump on her vaginal introitus.&nbsp; The patient first noticed the mass 2 days ago, but it has increased in size and now causes discomfort when she walks or exercises.&nbsp; She had unprotected sex with a new partner 6 weeks ago and has had multiple lifetime partners.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 110/60 mm Hg, and pulse is 80/min.&nbsp; On pelvic examination, there is a 4-cm, mobile, soft, nontender cystic mass behind the right posterior labium majus that extends into the vagina.&nbsp; The remainder of the examination is normal.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": null,
            "explanationText": "<p><img  draggable=\"false\" id=\"15256\" src=\"https://www.uworld.com/media/highresdefault/L40012.jpg\"  ></p><p>This patient has a <strong>Bartholin duct cyst</strong>, which occurs due to blockage of the Bartholin gland duct.&nbsp; The Bartholin glands are located bilaterally at the posterior vaginal introitus and have ducts that drain into the vulvar vestibule at the 4 and 8 o&#39;clock positions to provide vulvovaginal lubrication.&nbsp; The Bartholin glands are not palpable unless ductal blockage occurs, resulting in mucoid fluid buildup and cyst formation.</p><p>Women with small Bartholin duct cysts are often asymptomatic and may be diagnosed incidentally on routine examination.&nbsp; In contrast, larger cysts (as seen in this patient) cause increased tissue tension and friction, resulting in <strong>vaginal pressure and discomfort</strong> with sexual activity, walking, or sitting (all of which apply direct pressure on the vulva and cyst).&nbsp; On pelvic examination, a <strong>soft</strong>, <strong>mobile</strong>, <strong>nontender</strong>, <strong>cystic mass</strong> is palpated <strong>behind the posterior labium majus</strong> with possible extension into the vagina.&nbsp; Asymptomatic cysts can be managed expectantly; symptomatic cysts require incision and drainage with possible <a href=\"17364\">Word catheter placement</a>.</p><p><strong>(Choice B)</strong>&nbsp; A Bartholin gland abscess can develop from an infected cyst; however, patients have additional findings of localized erythema and induration and a tender, fluctuant mass (not seen in this patient).</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"37353\">Condylomata acuminata</a> appear as groups of smooth papules or sessile, verrucous growths typically caused by human papillomavirus types 6 and 11.</p><p><strong>(Choice D)</strong>&nbsp; Condylomata lata&mdash;a feature of secondary syphilis&mdash;are gray-white, raised lesions affecting mucous membranes (eg, mouth, perineum); there is no associated cyst formation.</p><p><strong>(Choice E)</strong>&nbsp; Epidermal inclusion cysts appear as raised, mobile, flesh-colored nodules sometimes associated with a central punctum.</p><p><strong>Educational objective:</strong><br>Large, symptomatic Bartholin duct cysts can present with vaginal discomfort and pressure with sexual activity, walking, or sitting.&nbsp; Physical examination reveals a soft, mobile, nontender mass located behind the posterior labium majus with possible extension into the vagina.&nbsp; Treatment of symptomatic Bartholin duct cysts is with incision and drainage.</p>",
            "abstractId": 0,
            "qbankId": 0,
            "sectionId": 0,
            "section": null,
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 235,
            "system": "Reproductive",
            "topicId": null,
            "topic": "Bartholin duct cyst and abscess",
            "titleId": null,
            "title": null,
            "topicAttributeId": 0,
            "topicAttribute": null,
            "correctAnswer": "1",
            "userAnswer": null,
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bartholin duct cyst",
                    "choiceNumber": 1,
                    "correctTaken": 5,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bartholin gland abscess",
                    "choiceNumber": 2,
                    "correctTaken": 0,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Condylomata acuminata",
                    "choiceNumber": 3,
                    "correctTaken": 0,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Condylomata lata",
                    "choiceNumber": 4,
                    "correctTaken": 0,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Epidermal inclusion cyst",
                    "choiceNumber": 5,
                    "correctTaken": 0,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 0,
            "highlights": null,
            "isCorrect": null,
            "isIncorrect": null,
            "isMarked": false,
            "isOmitted": null,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "40",
                    "mediaDataId": 0,
                    "title": "Bartholin gland cyst and abscess",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 0,
            "notes": null,
            "peopleTaken": 0,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "05/19/2025",
            "correctPercentile": 0,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 0,
            "hint": null,
            "allowCalculator": null,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 0,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": null,
            "dailyTimeSpentReview": null,
            "dailyTimeSpent": null,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": null,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": null,
            "questionSourceId": null,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 0,
            "questionId": 0,
            "questionIndex": 124189,
            "questionText": "<p>A 26-year-old woman has a bump on her vaginal introitus.&nbsp; The patient first noticed the mass 2 days ago, but it has increased in size and now causes discomfort when she walks or exercises.&nbsp; She had unprotected sex with a new partner 6 weeks ago and has had multiple lifetime partners.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 110/60 mm Hg, and pulse is 80/min.&nbsp; On pelvic examination, there is a 4-cm, mobile, soft, nontender cystic mass behind the right posterior labium majus that extends into the vagina.&nbsp; The remainder of the examination is normal.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": null,
            "explanationText": "<p><img  draggable=\"false\" id=\"15256\" src=\"https://www.uworld.com/media/highresdefault/L40012.jpg\"  ></p><p>This patient has a <strong>Bartholin duct cyst</strong>, which occurs due to blockage of the Bartholin gland duct.&nbsp; The Bartholin glands are located bilaterally at the posterior vaginal introitus and have ducts that drain into the vulvar vestibule at the 4 and 8 o&#39;clock positions to provide vulvovaginal lubrication.&nbsp; The Bartholin glands are not palpable unless ductal blockage occurs, resulting in mucoid fluid buildup and cyst formation.</p><p>Women with small Bartholin duct cysts are often asymptomatic and may be diagnosed incidentally on routine examination.&nbsp; In contrast, larger cysts (as seen in this patient) cause increased tissue tension and friction, resulting in <strong>vaginal pressure and discomfort</strong> with sexual activity, walking, or sitting (all of which apply direct pressure on the vulva and cyst).&nbsp; On pelvic examination, a <strong>soft</strong>, <strong>mobile</strong>, <strong>nontender</strong>, <strong>cystic mass</strong> is palpated <strong>behind the posterior labium majus</strong> with possible extension into the vagina.&nbsp; Asymptomatic cysts can be managed expectantly; symptomatic cysts require incision and drainage with possible <a href=\"17364\">Word catheter placement</a>.</p><p><strong>(Choice B)</strong>&nbsp; A Bartholin gland abscess can develop from an infected cyst; however, patients have additional findings of localized erythema and induration and a tender, fluctuant mass (not seen in this patient).</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"37353\">Condylomata acuminata</a> appear as groups of smooth papules or sessile, verrucous growths typically caused by human papillomavirus types 6 and 11.</p><p><strong>(Choice D)</strong>&nbsp; Condylomata lata&mdash;a feature of secondary syphilis&mdash;are gray-white, raised lesions affecting mucous membranes (eg, mouth, perineum); there is no associated cyst formation.</p><p><strong>(Choice E)</strong>&nbsp; Epidermal inclusion cysts appear as raised, mobile, flesh-colored nodules sometimes associated with a central punctum.</p><p><strong>Educational objective:</strong><br>Large, symptomatic Bartholin duct cysts can present with vaginal discomfort and pressure with sexual activity, walking, or sitting.&nbsp; Physical examination reveals a soft, mobile, nontender mass located behind the posterior labium majus with possible extension into the vagina.&nbsp; Treatment of symptomatic Bartholin duct cysts is with incision and drainage.</p>",
            "abstractId": 0,
            "qbankId": 0,
            "sectionId": 0,
            "section": null,
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 235,
            "system": "Reproductive",
            "topicId": null,
            "topic": "Bartholin duct cyst and abscess",
            "titleId": null,
            "title": null,
            "topicAttributeId": 0,
            "topicAttribute": null,
            "correctAnswer": "1",
            "userAnswer": null,
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bartholin duct cyst",
                    "choiceNumber": 1,
                    "correctTaken": 5,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bartholin gland abscess",
                    "choiceNumber": 2,
                    "correctTaken": 0,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Condylomata acuminata",
                    "choiceNumber": 3,
                    "correctTaken": 0,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Condylomata lata",
                    "choiceNumber": 4,
                    "correctTaken": 1,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Epidermal inclusion cyst",
                    "choiceNumber": 5,
                    "correctTaken": 1,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 0,
            "highlights": null,
            "isCorrect": null,
            "isIncorrect": null,
            "isMarked": false,
            "isOmitted": null,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "40",
                    "mediaDataId": 0,
                    "title": "Bartholin gland cyst and abscess",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 0,
            "notes": null,
            "peopleTaken": 0,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "05/19/2025",
            "correctPercentile": 0,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 0,
            "hint": null,
            "allowCalculator": null,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 0,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": null,
            "dailyTimeSpentReview": null,
            "dailyTimeSpent": null,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": null,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": null,
            "questionSourceId": null,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 0,
            "questionId": 0,
            "questionIndex": 124190,
            "questionText": "<p>A 26-year-old woman has a bump on her vaginal introitus.&nbsp; The patient first noticed the mass 2 days ago, but it has increased in size and now causes discomfort when she walks or exercises.&nbsp; She had unprotected sex with a new partner 6 weeks ago and has had multiple lifetime partners.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 110/60 mm Hg, and pulse is 80/min.&nbsp; On pelvic examination, there is a 4-cm, mobile, soft, nontender cystic mass behind the right posterior labium majus that extends into the vagina.&nbsp; The remainder of the examination is normal.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": null,
            "explanationText": "<p><img  draggable=\"false\" id=\"15256\" src=\"https://www.uworld.com/media/highresdefault/L40012.jpg\"  ></p><p>This patient has a <strong>Bartholin duct cyst</strong>, which occurs due to blockage of the Bartholin gland duct.&nbsp; The Bartholin glands are located bilaterally at the posterior vaginal introitus and have ducts that drain into the vulvar vestibule at the 4 and 8 o&#39;clock positions to provide vulvovaginal lubrication.&nbsp; The Bartholin glands are not palpable unless ductal blockage occurs, resulting in mucoid fluid buildup and cyst formation.</p><p>Women with small Bartholin duct cysts are often asymptomatic and may be diagnosed incidentally on routine examination.&nbsp; In contrast, larger cysts (as seen in this patient) cause increased tissue tension and friction, resulting in <strong>vaginal pressure and discomfort</strong> with sexual activity, walking, or sitting (all of which apply direct pressure on the vulva and cyst).&nbsp; On pelvic examination, a <strong>soft</strong>, <strong>mobile</strong>, <strong>nontender</strong>, <strong>cystic mass</strong> is palpated <strong>behind the posterior labium majus</strong> with possible extension into the vagina.&nbsp; Asymptomatic cysts can be managed expectantly; symptomatic cysts require incision and drainage with possible <a href=\"17364\">Word catheter placement</a>.</p><p><strong>(Choice B)</strong>&nbsp; A Bartholin gland abscess can develop from an infected cyst; however, patients have additional findings of localized erythema and induration and a tender, fluctuant mass (not seen in this patient).</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"37353\">Condylomata acuminata</a> appear as groups of smooth papules or sessile, verrucous growths typically caused by human papillomavirus types 6 and 11.</p><p><strong>(Choice D)</strong>&nbsp; Condylomata lata&mdash;a feature of secondary syphilis&mdash;are gray-white, raised lesions affecting mucous membranes (eg, mouth, perineum); there is no associated cyst formation.</p><p><strong>(Choice E)</strong>&nbsp; Epidermal inclusion cysts appear as raised, mobile, flesh-colored nodules sometimes associated with a central punctum.</p><p><strong>Educational objective:</strong><br>Large, symptomatic Bartholin duct cysts can present with vaginal discomfort and pressure with sexual activity, walking, or sitting.&nbsp; Physical examination reveals a soft, mobile, nontender mass located behind the posterior labium majus with possible extension into the vagina.&nbsp; Treatment of symptomatic Bartholin duct cysts is with incision and drainage.</p>",
            "abstractId": 0,
            "qbankId": 0,
            "sectionId": 0,
            "section": null,
            "subjectId": 153,
            "subject": "Obstetrics & gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 212,
            "system": "Female Reproductive System & Breast",
            "topicId": null,
            "topic": "Bartholin duct cyst and abscess",
            "titleId": null,
            "title": null,
            "topicAttributeId": 0,
            "topicAttribute": null,
            "correctAnswer": "1",
            "userAnswer": null,
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bartholin duct cyst",
                    "choiceNumber": 1,
                    "correctTaken": 1,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bartholin gland abscess",
                    "choiceNumber": 2,
                    "correctTaken": 0,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Condylomata acuminata",
                    "choiceNumber": 3,
                    "correctTaken": 0,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Condylomata lata",
                    "choiceNumber": 4,
                    "correctTaken": 0,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Epidermal inclusion cyst",
                    "choiceNumber": 5,
                    "correctTaken": 0,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 0,
            "highlights": null,
            "isCorrect": null,
            "isIncorrect": null,
            "isMarked": false,
            "isOmitted": null,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "40",
                    "mediaDataId": 0,
                    "title": "Bartholin gland cyst and abscess",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 0,
            "othersAvgTimeSpent": 0,
            "notes": null,
            "peopleTaken": 0,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "05/19/2025",
            "correctPercentile": 0,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 0,
            "hint": null,
            "allowCalculator": null,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 0,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": null,
            "dailyTimeSpentReview": null,
            "dailyTimeSpent": null,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": null,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": null,
            "questionSourceId": null,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}